<DOCUMENT>
<TYPE>EX-10.7
<SEQUENCE>4
<FILENAME>g02538exv10w7.htm
<DESCRIPTION>EX-10.7 REPURCHASE AGREEMENT 06/30/06
<TEXT>
<HTML>
<HEAD>
<TITLE>exv10w7</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><B>Exhibit&nbsp;10.7</B>
</DIV>

<DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 100%; border-top: 1px solid #000000">&nbsp;</DIV></DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>REPURCHASE AGREEMENT</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>by and among</B>

</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>HCA INC.</B>

</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>and</B>

</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>LIFEPOINT HOSPITALS, INC.</B>

</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>Dated as of June 30, 2006</B>

</DIV>
<DIV align="center"><DIV style="font-size: 3pt; margin-top: 18pt; width: 100%; border-top: 1px solid #000000">&nbsp;</DIV></DIV>



<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>TABLE OF CONTENTS</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="4%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="8%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="83%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2">Page</TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD colspan="5" valign="top" align="left">ARTICLE I DEFINITIONS</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1.1</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Defined Terms</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="5" valign="top" align="left">ARTICLE II PURCHASE AND SALE; CLOSING</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">16</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.1</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Sale of the Ownership Interests</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">16</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.2</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Purchase Price</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">18</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.3</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Closing</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">21</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.4</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Closing Deliveries</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">21</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.5</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Order Date Closing Conditions</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">22</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.6</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Multiple Closings</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">23</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="5" valign="top" align="left">ARTICLE III REPRESENTATIONS AND WARRANTIES OF LIFEPOINT</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">24</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.1</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Organization of LifePoint and Seller Group</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">25</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.2</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Organization and Capitalization of the Acquired Companies and the
Acquired Subsidiaries</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">25</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.3</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Organization and Capitalization of the Related Companies and the
Related Subsidiaries</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">28</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.4</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Dispositions</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">31</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.5</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Authorization</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">31</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.6</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">No Conflicts</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">31</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.7</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">No Missing Assets</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">32</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.8</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Contracts</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">32</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.9</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Other Receivables</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">33</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.10</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Real Property</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">33</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.11</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Personal Property</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">35</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.12</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Employees; Labor Matters; Company Plans; ERISA</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">35</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.13</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Government Program Participation/Accreditation</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">36</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.14</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Taxes</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">37</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.15</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Inventory</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">39</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.16</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Intellectual Property</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">39</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.17</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Permits; Compliance With Laws</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">39</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.18</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Environmental Conditions</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">39</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.19</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Legal Proceedings, Court Orders</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">40</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.20</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Insurance</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">41</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.21</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Brokers</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">41</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="5" valign="top" align="left">ARTICLE IV REPRESENTATIONS AND WARRANTIES OF PURCHASER</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">41</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.1</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Organization</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">41</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.2</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Corporate Authorization</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">42</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.3</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">No Conflicts</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">42</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.4</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Legal Proceedings, etc</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">42</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">i
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="4%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="8%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="83%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2">Page</TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.5</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Brokers</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">42</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.6</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Sufficient Resources</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">42</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.7</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Solvency</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">42</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.8</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Investment Representations</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">43</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="5" valign="top" align="left">ARTICLE V COVENANTS OF LIFEPOINT</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">43</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.1</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Regulatory Approvals</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">43</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.2</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Conduct Prior to the Closing</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">44</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.3</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Employee Matters</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">45</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.4</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Investigation by Purchaser</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">45</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.5</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Reports and Pre-Closing Deliverables</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">45</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.6</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Closing Conditions</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">48</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.7</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Transfer of Hospital</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">48</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.8</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Entities Not Wholly-Owned by LifePoint</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">49</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.9</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Condition of Assets</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">49</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.10</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Consultative Process</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">50</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.11</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Intercompany Accounts</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">50</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.12</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Resignations</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">50</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.13</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Tax Filings</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">50</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.14</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Excluded Contracts</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">51</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.15</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">CON Challenges</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">51</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.16</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Closure of Facility; Alternative Arrangements</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">53</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.17</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Encumbrances</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">53</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="5" valign="top" align="left">ARTICLE VI COVENANTS OF PURCHASER; CERTAIN ADDITIONAL COVENANTS OF THE PARTIES</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">53</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.1</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Regulatory Approvals</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">53</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.2</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Post-Closing Access</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">54</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.3</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">WARN Act</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">54</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.4</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Employee Matters</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">54</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.5</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Compliance Program</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">55</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.6</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Tax Matters</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">55</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.7</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Tax Elections and Allocations</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">59</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.8</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Certain National and Regional Contracts</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">60</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.9</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Cost Reports</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">60</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.10</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Closing Conditions</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">60</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.11</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Insurance Arrangements</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">60</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.12</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">HCA Joinder Conveyance</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">61</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.13</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">PIP; Transition Patients; Government Patient Receivables; and
Misdirected Payments</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">61</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="5" valign="top" align="left">ARTICLE VII CONDITIONS TO OBLIGATIONS OF PURCHASER</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">64</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">7.1</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Representations and Warranties</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">65</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">7.2</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Compliance with Agreement</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">65</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">7.3</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Closing Certificates</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">66</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">7.4</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Secretary&#146;s Certificates</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">66</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">ii
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="4%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="8%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="83%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2">Page</TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">7.5</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Reserved</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">66</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">7.6</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Services Agreements</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">66</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">7.7</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Good Standing Certificates</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">66</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">7.8</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Title Work and Surveys</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">66</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">7.9</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Books</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">67</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">7.10</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Miscellaneous</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">67</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">7.11</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Resignations</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">67</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">7.12</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Post-Signing Breaches of Representations and Warranties</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">67</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">7.13</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Damage, Destruction or Loss</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">68</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">7.14</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Waiver of Conditions</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">68</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">7.15</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Restoration of Assets Retained in Consolidated Group</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">68</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">7.16</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Consents, Authorizations, Etc</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">69</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">7.17</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">No Action or Proceeding</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">69</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="5" valign="top" align="left">ARTICLE VIII CONDITIONS TO OBLIGATIONS OF LIFEPOINT</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">69</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">8.1</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Representations and Warranties</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">69</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">8.2</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Compliance with Agreement</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">70</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">8.3</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Closing Certificates</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">70</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">8.4</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Secretary&#146;s Certificate</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">70</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">8.5</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Consent, Authorizations, Etc</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">70</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">8.6</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">No Action or Proceeding</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">71</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">8.7</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Good Standing Certificate</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">71</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">8.8</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Constituent Documents</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">71</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">8.9</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Waiver of Conditions</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">71</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="5" valign="top" align="left">ARTICLE IX INDEMNIFICATION</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">71</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">9.1</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Survival</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">71</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">9.2</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Indemnification by LifePoint</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">72</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">9.3</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Indemnification by Purchaser</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">72</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">9.4</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Additional Provisions</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">73</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">9.5</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Tax Indemnification</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">73</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">9.6</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Claims Procedures</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">74</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="5" valign="top" align="left">ARTICLE X TERMINATION OF AGREEMENTS AND RELEASE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">75</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">10.1</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Termination</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">75</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">10.2</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Release</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">76</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="5" valign="top" align="left">ARTICLE XI ARBITRATION</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">76</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">11.1</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Arbitration</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">76</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="5" valign="top" align="left">ARTICLE XII MISCELLANEOUS</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">77</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">12.1</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Fees and Expenses</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">77</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">12.2</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Entire Agreement</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">78</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">12.3</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Waiver</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">78</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">12.4</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Amendment</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">78</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">12.5</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Counterparts; Facsimile Signatures; Reproductions</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">78</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">12.6</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">No Third Party Beneficiary</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">78</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">iii
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="4%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="8%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="83%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2">Page</TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">12.7</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Governing Law, Construction</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">78</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">12.8</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Binding Effect</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">79</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">12.9</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">No Assignment</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">79</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">12.10</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Headings, Gender, Etc</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">79</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">12.11</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Public Announcement</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">79</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">12.12</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Access to Information</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">79</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">12.13</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Severability; Invalid Provisions</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">80</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">12.14</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Cooperation</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">80</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">12.15</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Venue; Waiver of Jury Trial</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">80</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">12.16</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Damages</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">81</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">12.17</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">No Inferences</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">81</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">12.18</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Tax and Medicare Advice and Reliance</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">81</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">12.19</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Post-Closing Operations</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">81</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">12.20</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Capital Expenditures</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">81</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">12.21</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Reasonable Access</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">81</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">12.22</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Further Assurance Clause</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">82</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">12.23</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Notices</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">83</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt">iv
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>List of Exhibits and Schedules<BR>
to Repurchase Agreement</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="20%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="70%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Exhibit&nbsp;A-1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Seller Group</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Exhibit&nbsp;A-2
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Acquired Companies</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Exhibit&nbsp;A-3
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Acquired Subsidiaries</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Exhibit&nbsp;A-4
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Related Companies</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Exhibit&nbsp;A-5
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Related Subsidiaries</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Exhibit&nbsp;B-1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Disposed Entities</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Exhibit&nbsp;B-2
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Disposed Assets</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Exhibit&nbsp;B-3
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Disposed Ownership Interests</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Exhibit&nbsp;C
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Reserved</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Exhibit&nbsp;D
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">GAAP Exceptions</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Exhibit&nbsp;E
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Cost Reports</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Exhibit&nbsp;F
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Excluded Assets</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Disclosure Schedule</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Schedule&nbsp;3.8(a)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Material Contracts</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Schedule&nbsp;3.10(a)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Real Property</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Schedule&nbsp;3.12(b)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Company Plans</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Schedule&nbsp;3.12(d)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Continuation of Coverage</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Schedule&nbsp;3.12(e)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Employment Contracts</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Schedule&nbsp;3.13(a)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Provider Numbers</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Schedule&nbsp;3.19(a)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Litigation</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Schedule&nbsp;3.20
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Insurance Policies</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Schedule&nbsp;3.20(i)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Facility Repairs Recommendations</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Schedule&nbsp;3.20(ii)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Claims Notices and Denials</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Schedule&nbsp;5.13
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Tax Filings</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Schedule&nbsp;6.8
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">National Contracts</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">v
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>REPURCHASE AGREEMENT</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>THIS REPURCHASE AGREEMENT </B>(the &#147;<U>Agreement</U>&#148;) is made and entered into as of June 30, 2006, by and between HCA Inc., a Delaware corporation (&#147;<U>HCA</U>&#148; or &#147;<U>Purchaser</U>&#148;),
and LifePoint Hospitals, Inc., a Delaware corporation (&#147;<U>LifePoint</U>&#148;).
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U><B>R E C I T A L S:</B></U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A.&nbsp;HCA and LifePoint are parties to a Stock Purchase Agreement, dated as of July&nbsp;14, 2005, as
amended by Amendment No.&nbsp;1 to Stock Purchase Agreement, dated as of June&nbsp;2, 2006 (such Stock
Purchase Agreement, as so amended, and as further amended in accordance with the terms hereof, the
&#147;<U>SPA</U>&#148;).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;B.&nbsp;Pursuant to the SPA, LifePoint is acquiring, directly or indirectly, 100% of the issued and
outstanding equity securities of the Initial Acquired Entities from HCA (the &#147;<U>SPA
Transaction</U>&#148;).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;C.&nbsp;As of the date hereof, the West Virginia Health Care Authority has issued certificates of
need, each dated March&nbsp;17, 2006, with respect to LifePoint&#146;s acquisition of the three West Virginia
Hospitals included in the SPA Transaction (the &#147;<U>CONs</U>&#148;), but appeals of the CONs are pending
and more appeals, requests for injunctions, requests for stays or the like relating to the issuance
of the CONs to LifePoint&#146;s Affiliates may be filed or threatened (individually and collectively the
&#147;<U>CON Challenges</U>&#148;). Consequently, in satisfaction of a condition precedent to closing the
SPA Transaction, LifePoint and HCA are entering into this Agreement, which provides, <I>inter alia</I>,
that, subject to the terms and conditions of this Agreement, upon the occurrence of an Unwind
Trigger Event (hereinafter defined), LifePoint shall have the right (the &#147;<U>Unwind Right</U>&#148;) to
require HCA (directly or indirectly) to purchase all of the issued and outstanding equity
securities of the Acquired Entities (hereinafter defined).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;D.&nbsp;LifePoint will cause each of its applicable subsidiaries, including the Seller Group
(hereinafter defined) and the Acquired Entities to take the necessary and appropriate actions to
implement the transactions contemplated in this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;E.&nbsp;LifePoint and HCA each will derive material benefits from the consummation of the SPA
Transaction and each wishes to enter into this Agreement as an inducement to the other party to
enter into this Agreement and close the SPA Transaction.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>NOW, THEREFORE</B>, in consideration of the foregoing premises, the mutual covenants and other
agreements set forth herein, and other good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, the parties hereto covenant and agree as follows:
</DIV>

<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE I<BR>
DEFINITIONS</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.1 <U>Defined Terms</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As used in this Agreement, the following defined terms shall have the meanings indicated
below:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>AAA</U>&#148; has the meaning set forth in <U>Section&nbsp;11.1(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Acquired Companies</U>&#148; means the &#147;Acquired Companies&#148; (as defined in the SPA) other than
the Clinch Valley Entities and any Disposed Entity.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Acquired Company Ownership Interests</U>&#148; has the meaning set forth in <U>Section
3.2(b)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Acquired Entities</U>&#148; means the Acquired Companies, the Acquired Subsidiaries and the
Related Entities, taken as a whole.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Acquired Subsidiaries</U>&#148; means the &#147;Acquired Subsidiaries&#148; (as defined in the SPA)
other than the Clinch Valley Entities and any Disposed Entity.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Acquired Subsidiary Ownership Interests</U>&#148; has the meaning set forth in <U>Section
3.2(g)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Affiliate</U>&#148; means any Person that directly, or indirectly through one or more
intermediaries, controls or is controlled by or is under common control with the Person specified;
provided, however, &#147;Affiliate&#148; shall not include officers, directors or shareholders of LifePoint
or Purchaser.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Agreement</U>&#148; means this Repurchase Agreement, including the exhibits and schedules
attached hereto.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Associated Business</U>&#148; has the meaning set forth in <U>Section&nbsp;2.6(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Base Purchase Price</U>&#148; means the &#147;Purchase Price&#148; (as defined in the SPA) as finally
determined in accordance with <U>Section&nbsp;2.3</U> of the SPA less $48,000,000, which is the portion
of the &#147;Base Purchase Price&#148; (as defined in the SPA) that the parties allocated to the Clinch
Valley Entities, and less (b)&nbsp;that portion of the &#147;Capital Expenditures Adjustment Amount&#148; (as
defined in the SPA) as finally determined in accordance with <U>Section&nbsp;2.3</U> of the SPA
attributable to the Clinch Valley Entities.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Books and Records</U>&#148; has the meaning set forth in the SPA.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Business</U>&#148; means the operation of the Acquired Entities and the Facilities.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Business Day</U>&#148; has the meaning set forth in the SPA.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Business Material Adverse Effect</U>&#148; means a material adverse effect on the assets,
financial condition or operations of the Acquired Entities, taken as a whole, other than any
changes (a)&nbsp;generally affecting the healthcare industry directly or indirectly, including
changes
</DIV>

<P align="center" style="font-size: 10pt">2
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">due to actual or proposed changes in law or regulations, (b)&nbsp;that result from political or
economic turmoil, or (c)&nbsp;that are related to or result from the announcement or pendency of the
transactions contemplated by this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Capital Expenditure Adjustment Amount</U>&#148; means the amount, expressed as a positive or
negative number, equal to (a)&nbsp;the Net Book Value as of the Effective Time of any goodwill resulting
from an acquisition by an Acquired Entity that takes place during the Holding Period, plus the Net
Book Value of the property, plant and equipment of the Acquired Entities on a consolidated basis as
of the Effective Time (and calculated based on the Closing Date Balance Sheet as finally determined
in accordance with <U>Section&nbsp;2.2</U> of this Agreement), minus (b)&nbsp;the Net Book Value of the
property, plant and equipment of the Initial Acquired Entities other than the Clinch Valley
Entities on a consolidated basis as of the SPA Effective Time (calculated based on the Opening
Balance Sheet).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Claim</U>&#148; has the meaning set forth in <U>Section&nbsp;9.6(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Clinch Valley Entities</U>&#148; means the following Initial Acquired Entities: Galen-Med,
Inc., Clinch Valley Endocrinology, LLC, Orthopedics of Southwest Virginia, LLC, Clinch Valley
Urology, LLC and Clinch Valley Pulmonology, LLC.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Closing</U>&#148; has the meaning set forth in <U>Section&nbsp;2.3</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Closing Date</U>&#148; has the meaning set forth in <U>Section&nbsp;2.3</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Closing Date Balance Sheet</U>&#148; means the unaudited combined balance sheet of the
Business as of the Effective Time prepared in accordance with <U>Section&nbsp;2.2</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Closing Statement</U>&#148; has the meaning set forth in <U>Section&nbsp;2.2(c)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>COBRA</U>&#148; has the meaning set forth in the SPA.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Code</U>&#148; has the meaning set forth in the SPA.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Company Plans</U>&#148; means each &#147;employee benefit plan&#148; (within the meaning of Section&nbsp;3(3)
of ERISA) and each stock purchase, stock option, severance, change-in-control, fringe benefit,
bonus, incentive, deferred compensation and other employee benefit plan, program, policy or other
arrangement, including deferred compensation arrangements that are referenced in an employment
agreement in which any employee of the Business participates and, with respect to any employee
pension benefit plan (as defined in Section&nbsp;3(2) of ERISA), which is sponsored or maintained by
LifePoint or its Affiliates or to which any Acquired Entity is a party or has any expense,
liability or obligation.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>CON Challenges</U>&#148; has the meaning set forth in the Recitals.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>CONs</U>&#148; has the meaning set forth in the Recitals.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Constituent Documents</U>&#148; has the meaning set forth in the SPA.
</DIV>

<P align="center" style="font-size: 10pt">3
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Contract</U>&#148; means any agreement, Lease, license, sublicense, promissory note, evidence
of indebtedness, or other contract or commitment, and all amendments, waivers, extensions,
schedules, exhibits and appendices thereof to which any of the Acquired Entities is a party, by
which assets of any of the Acquired Entities are bound or by which any of the Business is benefited
or otherwise primarily related to the Facilities; provided, however, that the term &#147;Contract&#148; shall
not include any Excluded Contract.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Court Order</U>&#148; has the meaning set forth in the SPA.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Damages</U>&#148; has the meaning set forth in the SPA.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Damages Adjustment Amount</U>&#148; means an amount, expressed as a positive or negative
number, equal to (a)&nbsp;any Damages paid by LifePoint and its Affiliates during the Holding Period to
third parties, to the extent such Damages (i)&nbsp;are either (A)&nbsp;HCA Excluded Liabilities, or (B)
indemnifiable pursuant to <U>Section&nbsp;9.2(b)</U> of the SPA (or would be indemnifiable pursuant to
<U>Section&nbsp;9.2(b)</U> of the SPA but for the limitations set forth in <U>Section&nbsp;9.4(a)(i)</U> of
the SPA), and (ii)&nbsp;have not been paid or reimbursed by HCA or its Affiliates (such Damages, the
&#147;<U>Reimbursement Damages</U>&#148;), minus (b)&nbsp;the Value Diminution Amount, less the portion of the
Value Diminution Amount as is equitably attributable to the period of time between the SPA
Effective Time and the date such amount is paid to LifePoint or its Affiliates (the &#147;<U>Value
Diminution Damages</U>&#148;). Any such Reimbursement Damages shall be limited by the maximum liability
provisions set forth in <U>Section&nbsp;9.4(a)(ii)</U> of the SPA and by the offset provided in
<U>Section&nbsp;9.4(b)</U> of the SPA. Reimbursement Damages and Value Diminution Damages shall not
include any such amounts related to the Clinch Valley Entities and their assets and businesses.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Deemed Disposition</U>&#148; means (a)&nbsp;the retention of any asset or entity deemed to be a
Disposed Asset or a Disposed Entity in accordance with <U>Section&nbsp;5.7(a)(i)</U>, and (b)&nbsp;any
Deemed Disposition of assets or entities as contemplated by <U>Section&nbsp;5.8(b)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Defect</U>&#148; has the meaning set forth in the SPA.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Disclosure Schedule</U>&#148; has the meaning set forth in Section&nbsp;5.5(f).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Disposed Assets</U>&#148; means (a)&nbsp;all assets that have been sold, transferred or disposed of
in a Disposition other than Disposed Ownership Interests, and (b)&nbsp;all assets that are deemed to be
Disposed Assets in accordance with <U>Section&nbsp;5.7(a)(i)</U> or <U>Section&nbsp;5.8</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Disposed Entities</U>&#148; means (a)&nbsp;any Initial Acquired Entity (other than the Clinch
Valley Entities) that has been sold, transferred or disposed of in a Disposition, and (b)&nbsp;any
Initial Acquired Entity (other than the Clinch Valley Entities) that is deemed to be a Disposed
Entity in accordance with either <U>Section&nbsp;5.7(a)(i)</U> or <U>Section&nbsp;5.8</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Disposed Ownership Interests</U>&#148; means any Ownership Interest in any of the Acquired
Entities that is sold other than in a Disposition of all of the Ownership Interests of an entity or
a Deemed Disposition of all of the Ownership Interests of an entity.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Disposition</U>&#148; means (a)&nbsp;the sale, transfer or disposition of any of the Initial
Acquired Entities (other than the Clinch Valley Entities) or the sale, transfer or disposition as a
going
</DIV>

<P align="center" style="font-size: 10pt">4
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">concern of any assets held by any of the Initial Acquired Entities (other than the Clinch
Valley Entities) as of the SPA Effective Time, (b)&nbsp;subject to the provisions of <U>Section
5.8</U>, the sale, transfer or disposition of less than all of the Ownership Interests of an
Acquired Entity, (c)&nbsp;the sale, transfer or disposition of part (but not substantially all) of the
assets of a Related Entity or of an operation acquired during the Holding Period, (d)&nbsp;the sale,
transfer or disposition of any of the &#147;Real Property&#148; (as defined in the SPA) owned by any of the
Initial Acquired Entities (other than the Clinch Valley Entities) as of the SPA Effective Time, (e)
other than current assets, the sale, transfer or disposition of any other property held by any of
the Initial Acquired Entities (other than the Clinch Valley Entities) as of the SPA Effective Time
if either the book value of such property (net of depreciation) at the time of the disposition or
the Disposition Value of such property was greater than $100,000 (in a transaction or series of
related transactions), and (f)&nbsp;Deemed Dispositions. For the avoidance of doubt, any amount
credited to any of the Initial Acquired Entities as a trade-in allowance will not be treated as a
Disposition and only the net amount spent on the replacement item will be included in the
calculation of the Capital Expenditure Adjustment Amount.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Disposition Adjustment Amount</U>&#148; means the sum of the Disposition Amounts with respect
to all Dispositions
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Disposition Amount</U>&#148; means, (a)&nbsp;with respect to any Disposition of Disposed Assets or
Disposed Entities, the book value determined in accordance with GAAP, without any amortization or
other reduction (including any charge for impairment), of the goodwill and other intangible assets
associated with such Disposed Assets or Disposed Entities as of its Disposition date, and (b)&nbsp;with
respect to any Disposition of Disposed Ownership Interests, an amount equal to the product of (i)
the percentage ownership in the applicable Person represented by the applicable Disposed Ownership
Interests, and (ii)&nbsp;the book value determined in accordance with GAAP, without any amortization or
other reduction (including any charge for impairment), of the goodwill and other intangible assets
associated with such Person as of the Disposition date of such Disposed Ownership Interests.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Effective Time</U>&#148; has the meaning set forth in <U>Section&nbsp;2.3</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Encumbrance</U>&#148; has the meaning set forth in the SPA.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Environmental Claim</U>&#148; shall have the meaning set forth in the SPA.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Environmental Laws</U>&#148; shall have the meaning set forth in the SPA provided that the
&#147;Effective Time&#148; in that definition shall mean the Effective Time under this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Equity Security</U>&#148; and &#147;<U>equity interest</U>&#148; has the meaning set forth in the SPA.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>ERISA</U>&#148; has the meaning set forth in the SPA.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Excluded Assets</U>&#148; means any asset described on <U>Exhibit&nbsp;F</U> as agreed to by the
parties.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Excluded Contract</U>&#148; has the meaning set forth in <U>Section&nbsp;5.14</U>.
</DIV>

<P align="center" style="font-size: 10pt">5
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Facility</U>&#148; means (a)&nbsp;any &#147;Facility&#148; (as defined in the SPA) other than (i)&nbsp;such
&#147;Facilities&#148; that comprised the Clinch Valley Medical Center Hospital Group, and (ii)&nbsp;a Facility
which has been the subject of a Disposition, together with (b)&nbsp;any other healthcare facilities that
are acquired or developed by LifePoint or its Affiliates during the Holding Period that are
referenced in <U>Section&nbsp;3.7(b)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>FAS 87</U>&#148; has the meaning set forth in the SPA.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Federal Income Taxes</U>&#148; has the meaning set forth in the SPA.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Final Net Working Capital Adjustment Amount</U>&#148; means the amount, expressed as a
positive or negative number, equal to (a)&nbsp;the amount of Net Working Capital as of the Effective
Time calculated based on the Closing Date Balance Sheet as finally determined in accordance with
<U>Section&nbsp;2.2</U> of this Agreement, minus (b)&nbsp;the &#147;Net Working Capital&#148; (as defined in the SPA)
as finally determined in accordance with <U>Section&nbsp;2.3</U> of the SPA.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Final Order Date</U>&#148; means either of the following dates: (a)&nbsp;the date on which an Order
(other than a Revocation Order) becomes final and non-appealable; (b)&nbsp;the date on which an order,
decree, judgment, decision or ruling issued by a Governmental Authority of competent jurisdiction
that denies the issuance of Replacement CONs sought in accordance with <U>Section&nbsp;5.15(iii)</U>
becomes final and non-appealable, or (c)&nbsp;the date on which an Order with respect to Replacement
CONs becomes final and non-appealable.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>GAAP</U>&#148; means generally accepted accounting principles as consistently applied by
LifePoint.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Governmental Authority</U>&#148; has the meaning set forth in the SPA.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Government Patient Receivables</U>&#148; means all accounts receivable arising from the
rendering of services and provision of medicine, drugs and supplies to patients of the Business
during the Holding Period and relating to Medicare, Medicaid and other third party patient claims
due from beneficiaries or governmental third party payors; provided, however, that the &#147;Government
Patient Receivables&#148; shall not include any of the SPA Transition Patient Receivables or the
Transition Patient Receivables.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Government Programs</U>&#148; has the meaning set forth in the SPA.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Hazardous Substances</U>&#148; has the meaning set forth in the SPA.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>HCA</U>&#148; has the meaning set forth in the Preamble.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>HCA Adjustments</U>&#148; has the meaning set forth in the definition of &#147;HCA Excluded
Liabilities&#148;.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>HCA Excluded Liabilities</U>&#148; means:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;Liabilities whether arising before, at or after the SPA Effective Time, incurred in
connection with the conduct or operation of the HCA Group Business (as defined in
</DIV>


<P align="center" style="font-size: 10pt">6
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><U>Exhibit&nbsp;K</U> to the SPA), or ownership or use of the HCA Assets (as defined in
<U>Exhibit&nbsp;K</U> to the SPA); provided, however, that for purposes of this Agreement, the
following terms used in <U>Exhibit&nbsp;K</U> of the SPA will be deemed to have the following meanings
(in each such case, the terms used in such definitions to have the meanings given to them in the
SPA): (A) &#147;Purchaser Assets&#148; shall mean the assets of Purchaser and its Subsidiaries other than the
Acquired Entities; (B) &#147;Purchaser Group&#148; shall mean Purchaser and its Subsidiaries other than the
Acquired Entities; (C) &#147;Purchaser Group Business&#148; means the business now or formerly conducted by
Purchaser and its present and former Subsidiaries other than the Acquired Entities; and (D)
&#147;Purchaser Liabilities&#148; means Liabilities of Purchaser or any of its Subsidiaries other than the
Acquired Entities.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;Liabilities arising from any claim against LifePoint or any of its Affiliates (including
during the Holding Period, the Initial Acquired Entities), which claim (A)&nbsp;relates to or arises out
of the Initial Acquired Entities, the &#147;Business&#148; (as defined in the SPA) (or its operations) or the
assets of the Initial Acquired Entities, and (B)&nbsp;is based upon facts and circumstances occurring at
or prior to the SPA Effective Time; provided, that except to the extent included in the HCA
Adjustments, the HCA Excluded Liabilities described in this clause (ii)&nbsp;shall not include any
Liability of the Initial Acquired Entities existing as of the SPA Effective Time to the extent such
Liability is included in the &#147;Indebtedness Adjustment Amount&#148; or the &#147;Net Working Capital&#148; (as such
terms are defined in the SPA) (collectively, the &#147;<U>LifePoint Adjustments</U>&#148;);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;Liabilities arising from any claim against LifePoint or any of its Affiliates which
claim (A)&nbsp;relates to or arises out of the Acquired Entities, the Business or the assets owned by
the Acquired Entities or their conduct or operations, and (B)&nbsp;which relates to or arises out of or
is based upon facts and circumstances occurring at or after the Effective Time; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)&nbsp;Liabilities of the Acquired Entities as of the Effective Time to the extent such
Liabilities are included in the calculation of the Final Net Working Capital Adjustment Amount or
the Indebtedness Adjustment Amount (collectively, the &#147;<U>HCA Adjustments</U>&#148;).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Holding Period</U>&#148; means the period of time beginning immediately after the SPA
Effective Time and ending at the Effective Time.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Hospital</U>&#148; means any of the Facilities that are identified in <U>Exhibit&nbsp;B</U> to the
SPA as a Hospital other than (a)&nbsp;Clinch Valley Medical Center, and (b)&nbsp;any Hospital which has been
the subject of a Disposition.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Hospital Group</U>&#148; means an individual Hospital together with the Facilities, assets and
operations of the Acquired Entities that are related primarily to such individual Hospital.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Hospital Group Material Adverse Effect</U>&#148; means, with respect to an individual Hospital
Group, a material adverse effect on the assets, financial condition or operations of that specific
Hospital Group taken as a whole, other than any changes (a)&nbsp;generally affecting the healthcare
industry directly or indirectly, including changes due to actual or proposed changes in law or
regulations, (b)&nbsp;that result from political or economic turmoil, or (c)&nbsp;that are related to or
result from the announcement or pendency of the transactions contemplated by this Agreement.
</DIV>

<P align="center" style="font-size: 10pt">7
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>HSR Act</U>&#148; shall have the meaning set forth in the SPA.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>IBNR</U>&#148; means current liabilities of LifePoint and its Affiliates for incurred but not
reported (or incurred and reported to LifePoint but not paid by the Business) medical, dental,
self-insured workers compensation or other claims attributable to employees of the Business
pursuant to any Company Plan (including self-insured plans) that is a group health plan or provides
medical, dental, vision, worker&#146;s compensation or similar benefits, except to the extent included
in the Net Working Capital and reflected in the Closing Date Balance Sheet.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Income Taxes</U>&#148; has the meaning set forth in the SPA.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Indebtedness Adjustment Amount</U>&#148; means the amount, expressed as a positive or negative
number, equal to (a)&nbsp;the aggregate amount of indebtedness for borrowed money and capital lease
obligations and other long term liabilities of the Initial Acquired Entities reflected as
liabilities on the Initial Closing Date Balance Sheet, as finally determined in accordance with
<U>Section&nbsp;2.3</U> of the SPA, minus (b)&nbsp;the aggregate amount of indebtedness for borrowed money
and capital lease obligations and other long term liabilities of the Acquired Entities reflected as
liabilities on the Closing Date Balance Sheet, as finally determined in accordance with <U>Section
2.2</U> of this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Indemnifying Party</U>&#148; has the meaning set forth in the SPA.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Indemnitee</U>&#148; has the meaning set forth in the SPA.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Intellectual Property</U>&#148; has the meaning set forth in the SPA.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Initial Acquired Entities</U>&#148; means the &#147;Acquired Entities&#148; as defined in the SPA.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Initial Acquired Entity Ownership Interests</U>&#148; means the &#147;Acquired Company Ownership
Interests&#148; and the &#147;Acquired Subsidiary Ownership Interests&#148; as such terms are defined in the SPA.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Initial Closing</U>&#148; means the &#147;Closing&#148; under the SPA.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Initial Closing Date</U>&#148; means the &#147;Closing Date,&#148; as defined in the SPA.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Initial Closing Date Balance Sheet</U>&#148; means the &#147;Closing Date Balance Sheet&#148; as defined
in the SPA.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Initial Facilities</U>&#148; means the &#147;Facilities&#148; as set forth in the SPA.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>JCAHO</U>&#148; has the meaning set forth in the SPA.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Knowledge of LifePoint</U>&#148; (and any similar expression, including, the expression
&#147;LifePoint&#146;s Knowledge&#148;) means, as to a particular matter, the actual knowledge of LifePoint&#146;s
general counsel.
</DIV>

<P align="center" style="font-size: 10pt">8
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Knowledge of Purchaser</U>&#148; (and any similar expression) means, as to a particular
matter, the actual knowledge of Purchaser&#146;s general counsel.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Laws</U>&#148; has the meaning set forth in the SPA.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Leases</U>&#148; mean (a)&nbsp;all of those leases, subleases and occupancy agreements to which
LifePoint or any of its Affiliates is a party as the lessee/tenant or sublessee/subtenant of any
portion of the Real Property, and (b)&nbsp;all the following agreements to which LifePoint or any of its
Affiliates is a party as the landlord/lessor or sublandlord/sublessor of any portion of the Real
Property, which do not materially interfere with the operation of the Business as then currently
conducted: (i)&nbsp;leases of land to third-party developers in connection with development/construction
of health care related projects at the Facilities; (ii)&nbsp;medical office leases, subleases and
occupancy agreements; (iii)&nbsp;leases, subleases and occupancy agreements for other medical uses,
services or facilities; and (iv)&nbsp;leases, subleases and occupancy agreements for food services and
other ancillary services at the Facilities, including as examples and not as limitations, wireless
communication services, gift shops, pharmacies or florist shops.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Liabilities</U>&#148; has the meaning set forth in <U>Exhibit&nbsp;K</U> to the SPA.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>LifePoint</U>&#148; has the meaning set forth in the Preamble.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>LifePoint Adjustments</U>&#148; has the meaning set forth in the definition of &#147;HCA Excluded
Liabilities.&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>LifePoint Affiliated Group</U>&#148; means the affiliated group of corporations (as defined in
Section 1504(a) of the Code) of which LifePoint is the parent.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>LifePoint Disclosure Documents</U>&#148; has the meaning set forth in <U>Section&nbsp;5.5(f)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>LifePoint Excluded Liabilities</U>&#148; means IBNR and the LifePoint Liabilities.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>LifePoint Liabilities</U>&#148; means:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;Liabilities arising from any claim against HCA or any of its Affiliates (including, after
giving effect to the transactions contemplated by the Agreement, the Acquired Entities), which
claim (A)(1) relates to or arises out of the Initial Acquired Entities, the Business (or its
operations) or the assets of the Initial Acquired Entities, and (2)&nbsp;is based upon facts and
circumstances occurring at or after the SPA Effective Time until immediately prior to the Effective
Time; (B)(1) relates to or arises out of LifePoint&#146;s ownership of the Acquired Entities prior to
the Effective Time, (2)&nbsp;relates to or arises out of the Purchaser Assets or the Purchaser Group
Business (as such terms are defined in clauses (i)(A) and (C), respectively, of the definition of
&#147;HCA Excluded Liabilities&#148;); and (3)&nbsp;is based upon facts and circumstances occurring prior to the
Effective Time; or (C)&nbsp;relates to or arises out of the Related Entities, the business or operations
of any of the Related Entities or the assets of any of the Related Entities, and (2)&nbsp;is based upon
facts and circumstances occurring prior to the Effective Time; provided, however, that the
LifePoint Liabilities described in this clause (i)&nbsp;shall not include the Liabilities of the
Acquired Entities as of the Effective Time to the extent such Liabilities are included in the HCA
Adjustments;
</DIV>


<P align="center" style="font-size: 10pt">9
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;Liabilities of the Initial Acquired Entities as of the SPA Effective Time to the extent
such Liabilities are included in the LifePoint Adjustments except to the extent included in the HCA
Adjustments; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;Liabilities arising from any claim against HCA or any of its Affiliates (including,
after giving effect to the transactions contemplated by the Agreement, the Acquired Entities),
which claim (A)&nbsp;relates to or arises out of the Disposed Entities or the Disposed Assets, or the
business or assets of the Disposed Entities, and (B)&nbsp;is based upon facts and circumstances
occurring after the SPA Effective Time.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>LifePoint Required Schedules</U>&#148; has the meaning set forth in Section&nbsp;5.5(f).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>LifePoint Tax Period</U>&#148; has the meaning set forth in <U>Section&nbsp;6.6(b)(i)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Medicaid</U>&#148; has the meaning set forth in the SPA.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Medicare</U>&#148; has the meaning set forth in the SPA.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Multiemployer Plan</U>&#148; has the meaning set forth in the SPA.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Net Book Value</U>&#148; means the net book value as determined in accordance with GAAP;
provided that (a)&nbsp;the book value shall only be reduced by 50% of the total GAAP depreciation or
amortization; (b)&nbsp;there shall be no reduction of any intangible for impairment or any other charge,
other than 50% of amortization; (c)&nbsp;the Net Book Value of any asset resulting from amounts expended
to cure, repair, replace or remedy a matter underlying indemnified Damages shall be reduced to the
extent included in the calculation of Value Diminution Amount pursuant to subparagraphs (x)&nbsp;and (y)
thereof; and (d)&nbsp;the Net Book Value of the property, plant and equipment of any Person that is
consolidated but not wholly-owned will be the product of (i)&nbsp;the Net Book Value of such assets, and
(ii)&nbsp;the percentage ownership of such Person on a fully diluted basis held by the Acquired Entities
or the Seller Group as of the applicable date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Net Working Capital</U>&#148; means, as of any particular date, an amount equal to the current
assets reflected on the balance sheet of the Business as of such date minus the current liabilities
reflected on the balance sheet of the Business as of such date. For purposes of calculating Net
Working Capital, the amounts, if any reflected on the Business&#146; balance sheet as of the applicable
date with respect to the following matters shall be eliminated from the calculation of the Net
Working Capital: (i)&nbsp;the Excluded Assets, (ii)&nbsp;the LifePoint Excluded Liabilities (including
liabilities and reserves for Taxes and other LifePoint indemnified matters), (iii)&nbsp;any item for
which indemnification is given pursuant to <U>Section&nbsp;9.5</U> (Taxes) (iv)&nbsp;all matters for which
LifePoint is financially responsible in accordance with this Agreement, including pursuant to
<U>Section&nbsp;6.6</U> hereof, (v)&nbsp;all intercompany account balances that are to be paid, cancelled or
eliminated in accordance with <U>Section&nbsp;5.11</U> hereof. For purposes of calculating Net Working
Capital, in determining the appropriate reserves no adjustments shall be made as a result of the
loss of any CON, the Unwind Triggering Event, Unwind Notice, shutdown or related matters.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Opening Balance Sheet</U>&#148; means the &#147;Opening Balance Sheet&#148; as defined in the SPA and as
finally determined pursuant to <U>Section&nbsp;6.8(d)</U> of the SPA.
</DIV>

<P align="center" style="font-size: 10pt">10
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Order</U>&#148; means any order, decree, judgment, decision or notice from or by any
Governmental Authority of competent jurisdiction issued in connection with the CON Challenges which
declares one or more of the CONs void or otherwise results in the loss, revocation, suspension,
termination, or rescission of any of the CONs and requires LifePoint or an Affiliate of LifePoint,
as a matter of Law, to transfer or divest one or more of the Hospitals or cease or suspend
operations of one or more of the Hospitals. For the avoidance of doubt, an order, decree,
judgment, decision or notice from a Governmental Authority remanding the CONs to a lower
Governmental Authority for reconsideration will not be considered an &#147;Order&#148; unless such order,
decree, judgment, decision or notice requires LifePoint or an Affiliate of LifePoint, as a matter
of Law, to transfer or divest one or more of the Hospitals or cease or suspend operations of one or
more of the Hospitals or rescind the acquisition of one or more of the Hospitals.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Order Date</U>&#148; means, in the case of an Order, the date on which LifePoint or any of its
Affiliates must transfer or divest a Hospital or cease or suspend operation of a Hospital as a
result of the issuance of such Order.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Order Non-Compliance Conditions</U>&#148; means, with respect to an Order, (i)&nbsp;there is no
reasonable risk that any director, officer, employee or agent of LifePoint or its Affiliates will
be subject to criminal prosecution or incarceration as a result of the violation of such Order as
contemplated by this Agreement, (ii)&nbsp;neither LifePoint nor its Affiliates will commit a crime by
virtue of violating such Order as contemplated by this Agreement, as determined by counsel of
nationally recognized stature in the applicable area of the Law selected by LifePoint, (iii)
failure to comply with such Order as contemplated by this Agreement has not resulted in a breach of
any material LifePoint credit facility which is not waived during the applicable notice period (it
being agreed by LifePoint that it will use commercially reasonable efforts to obtain such waiver
during such period; provided that any fees charged to LifePoint for such waiver shall be paid by
Purchaser), (iv)&nbsp;no Hospital&#146;s license is revoked or suspended as a result of violating such order
and there are no other substantial adverse consequences to LifePoint directly resulting from
failing to comply with such Order as contemplated by this Agreement that cannot be satisfied by the
payment of money; provided that operational challenges at the Hospitals following such a violation
shall not be considered substantial adverse consequences; (v)&nbsp;if any such substantial adverse
consequences described in (iv)&nbsp;can be cured with the payment of money and Purchaser agrees to
indemnify LifePoint with respect to such Damages; and (vi)&nbsp;Purchaser agrees to fully indemnify
LifePoint, its Affiliates, and their respective officers, directors, employees or agents for any
fines, penalties or similar Damages that LifePoint, its Affiliates, or such officers, directors,
employees or agents incurs as a result of violating such Order as contemplated by this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Ownership Interests</U>&#148; means capital stock, membership interests, partnership interests
and any other similar equity interest or security.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Other Receivables</U>&#148; means all receivables generated in connection with the Business
through the Effective Time that are accounted for as &#147;Other Receivables&#148; in accordance with GAAP,
including any such receivables that have been charged off as bad debts, provided, however, that (a)
&#147;Other Receivables&#148; shall not include receivables of the type that the parties agree will not be
&#147;Other Receivables&#148; under the SPA; and (b)&nbsp;to the extent GAAP as applied by
</DIV>

<P align="center" style="font-size: 10pt">11
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">LifePoint includes any accounts receivable of the type that were &#147;Excluded Assets&#148; in the SPA
Transaction, such accounts receivable will not be considered &#147;Other Receivables&#148;.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Partial Closing</U>&#148; has the meaning set forth in <U>Section&nbsp;2.6(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Pension Plan</U>&#148; means any Company Plan that is a &#147;defined benefit plan&#148; as defined in
Section 414(j) of the Code.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Permits</U>&#148; has the meaning set forth in the SPA.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Permitted Encumbrance</U>&#148; means (i)&nbsp;in the case of Real Property that was included in
the &#147;Real Property&#148; (as defined in the SPA) as of the SPA Effective Time or other assets of the
Initial Acquired Entities as of the SPA Effective Time, the Permitted Encumbrances (as defined in
the SPA) in effect as of the Initial Closing Date and any other Defect which existed as of the
Initial Closing Date which Defect was waived by the Purchaser under the SPA, or was eliminated,
insured over or insured against by title insurance endorsement, or was indemnified against by HCA
as provided in <U>Section&nbsp;7.11(c)</U> of the SPA, and (ii)&nbsp;any of the following Encumbrances
granted, created, suffered or incurred by an Acquired Entity or LifePoint during the Holding
Period: (a)&nbsp;any Encumbrance approved in writing by Purchaser; (b)&nbsp;any Encumbrance for Taxes or
other governmental charges or assessments which are not delinquent or which are being contested in
good faith through appropriate proceedings; (c)&nbsp;any Encumbrance of any landlord, carrier,
warehouseman, mechanic or materialman and any like Encumbrance arising in the ordinary course of
business for sums that are not delinquent or which are being contested in good faith through
appropriate proceedings; (d)&nbsp;any Encumbrance of the lender, lessor or other financing source (1)
securing indebtedness for borrowed money, or (2)&nbsp;on assets leased under a capitalized lease
obligation, to the extent (in either case) that such indebtedness for borrowed money or capital
lease is included in the calculation of the Indebtedness Adjustment Amount; (e)&nbsp;easements and
rights of way that do not materially interfere with or materially impair the current use and
operation of the Real Property; (f)&nbsp;Laws regulating the use or enjoyment of the applicable
property; (g)&nbsp;all Leases; (h)&nbsp;liens securing obligations which are included in the Indebtedness
Adjustment Amount; (i)&nbsp;any consents from or notices to landlord/lessors or sublandlords/sublessors
under any of the Leases to which LifePoint or any of its Affiliates is a party as lessee/tenant or
sublessee/tenant, which consents are required to accomplish the transactions contemplated by this
Agreement; (j)&nbsp;Encumbrances which are consistent with comparable arrangements of LifePoint and its
Affiliates in similar transactions, which Encumbrances may include (subject to the standard stated
above) restrictive covenants or other restrictions agreed to by LifePoint in connection with (1)
the formation of a joint venture (i.e., a partnership, limited liability company or other entity in
which LifePoint or any of its Affiliates own in the aggregate less than a 100% interest), (2)&nbsp;the
construction of a medical office building, (3)&nbsp;the leasing of space to or provision of services in
conjunction with another health care provider, or (4)&nbsp;a Disposition or other material transaction;
(k)&nbsp;any other Encumbrances which do not (1)&nbsp;materially interfere with the use or operation of the
Business in a manner consistent with the then current use thereof or (2)&nbsp;adversely and materially
affect the value or title of the Real Property; and (l)&nbsp;with respect to leased Real Property,
Encumbrances which encumber the fee interest in such property.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Person</U>&#148; has the meaning set forth in the SPA.
</DIV>

<P align="center" style="font-size: 10pt">12
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>PIP</U>&#148; means periodic interim payment.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Preliminary Damages Adjustment Amount</U>&#148; means the parties&#146; preliminary determination
of the Damages Adjustment Amount as determined in accordance with the provisions of <U>Section
2.2(b)(iii)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Preliminary Payment Amount</U>&#148; has the meaning set forth in <U>Section&nbsp;2.2(b)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Proceeding</U>&#148; has the meaning set forth in <U>Section&nbsp;6.6(e)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Purchase Price</U>&#148; has the meaning set forth in <U>Section&nbsp;2.2(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Purchase Price Adjustments</U>&#148; has the meaning set forth in <U>Section&nbsp;2.2(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Purchased Assets</U>&#148; has the meaning set forth in <U>Section&nbsp;6.7(c)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Purchaser</U>&#148; has the meaning set forth in the Preamble.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Purchaser Affiliated Group</U>&#148; means the affiliated group of corporations (as defined in
Section 1504(a) of the Code) of which Purchaser is a member.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Purchaser Indemnitee</U>&#148; has the meaning set forth in <U>Section&nbsp;9.2</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Purchaser Tax Act</U>&#148; has the meaning set forth in <U>Section&nbsp;9.5(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Real Property</U>&#148; means all real property together with all buildings and improvements
thereon and all appurtenances and rights pertaining thereto, held by LifePoint or its Affiliates
that is used or held for use in the operation of the Business other than the Excluded Assets. At
Closing, the Real Property shall mean all &#147;Real Property&#148; (as defined in the SPA) <U>plus</U> (i)
any and all Real Property acquired since the Initial Closing by any of the Acquired Entities
(whether in an asset purchase or through a purchase of equity securities) that is used or is held
for use in operation of the Business and which is still owned by the Acquired Entities as of the
Effective Time, <U>less</U> (ii)&nbsp;any Real Property which is the subject of a Disposition during
the Holding Period (whether in a Disposition of assets or a Disposition of an entity), <U>less</U>
(iii)&nbsp;any &#147;Real Property&#148; (as defined in the SPA) owned by the Clinch Valley Entities as of the
Effective Time.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Reimbursement Damages</U>&#148; has the meaning set forth in the definition of the term
&#147;Damages Adjustment Amount.&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Related Company</U>&#148; means, subject to the provisions of <U>Section&nbsp;5.8</U>, any Person
(other than an Acquired Entity) whose sole assets and operations as of the Effective Time relate
exclusively to the Hospital Group of one or more of the Hospitals (each such Person being listed in
<U>Exhibit&nbsp;A-4</U> hereto).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Related Company Ownership Interests</U>&#148; has the meaning set forth in <U>Section
3.3(b)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Related Entities</U>&#148; means the Related Companies and the Related Subsidiaries.
</DIV>

<P align="center" style="font-size: 10pt">13
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Related Subsidiaries</U>&#148; means, subject to the provisions of <U>Section&nbsp;5.8</U>, any
Person (other than an Acquired Entity) whose sole assets and operations as of the Effective Time
relate exclusively to the Hospital Group of one or more of the Hospitals (each such Person being
listed in <U>Exhibit&nbsp;A-5</U> hereto).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Related Subsidiary Ownership Interests</U>&#148; has the meaning set forth in <U>Section
3.3(f)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Replacement CONs</U>&#148; means certificates of need sought and issued in replacement of the
CONs.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Returns</U>&#148; has the meaning set forth in the SPA.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Revocation Order</U>&#148; means an Order that (a)&nbsp;has become final and non-appealable; (b)&nbsp;is
not based on substantive grounds (e.g., that LifePoint or its Affiliates are inappropriate entities
for the ownership or operation of the Initial Facilites), but rather on (i)&nbsp;procedural grounds
(e.g., that the West Virginia Health Care Authority erred in the discovery process in connection
with the hearings on the CONs), (ii)&nbsp;a determination that a substantial change has occurred that
warrants loss, revocation, termination or rescission of the CONs (e.g., that the change in the
terms of the transactions under the SPA resulting from Amendment No.&nbsp;1 to the SPA constitutes a
substantial change) or (iii)&nbsp;other similar grounds; and (c)&nbsp;would require LifePoint or its
Affiliates to apply for Replacement CONs in order to continue its administrative and judicial
efforts to maintain (in full force and effect) certificates of need that permit LfePoint and its
Affiliates to continue to own and operate the Facilities.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Securities Act</U>&#148; has the meaning set forth in the SPA.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Selected Accounting Firm</U>&#148; has the meaning set forth in the SPA.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Seller</U>&#148; has the meaning set forth in <U>Section&nbsp;3.1(b)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Seller Group</U>&#148; has the meaning set forth in <U>Section&nbsp;3.1(b)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Seller Indemnitee</U>&#148; has the meaning set forth in <U>Section&nbsp;9.3</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Seller&#146;s Review Period</U>&#148; has the meaning set forth in <U>Section&nbsp;6.7(c)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Shares</U>&#148; means the outstanding shares of stock of any Acquired Entity that is a
corporation.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>SPA</U>&#148; has the meaning set forth in the Recitals.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>SPA Effective Time</U>&#148; means the &#147;Effective Time&#148; pursuant to the SPA.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>SPA Transaction</U>&#148; means the transactions closing as of the date hereof pursuant to the
SPA as described in the Recitals above.
</DIV>

<P align="center" style="font-size: 10pt">14
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>SPA Transition Patients</U>&#148; means, subject to the provisions of <U>Section&nbsp;6.13(</U>j),
patients admitted to any of the Initial Facilities prior to the SPA Effective Time and discharged
during the Holding Period.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>SPA Transition Patient Receivables</U>&#148; has the meaning set forth in <U>Section
6.13(b)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>SPA Transition Services</U>&#148; means the rendering of services and provision of medicine,
drugs and supplies by the Acquired Entities to SPA Transition Patients.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>State Taxes</U>&#148; has the meaning set forth in the SPA.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Straddle Period</U>&#148; has the meaning set forth in <U>Section&nbsp;6.6(b)(ii)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Surveys</U>&#148; means (a)&nbsp;in the case of Real Property that was included in the &#147;Real
Property&#148; (as defined in the SPA) as of the SPA Effective Time, an update and recertification of
those Surveys of such Real Property provided to Purchaser at the Initial Closing in accordance with
the SPA which will be delivered to Purchaser in accordance with <U>Section&nbsp;7.8</U> hereof, and (b)
in the case of Real Property that was not included in the &#147;Real Property&#148; (as defined in the SPA)
as of the SPA Effective Time, surveys that satisfy the conditions and requirements of <U>Section
7.11</U> of the SPA, which will be delivered to Purchaser in accordance with <U>Section&nbsp;7.8</U>
hereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Survival Period</U>&#148; has the meaning set forth in <U>Section&nbsp;9.1</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Tax</U>&#148; or &#147;<U>Taxes</U>&#148; has the meaning set forth in the SPA.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Tax Allocation</U>&#148; has the meaning set forth in <U>Section&nbsp;6.7(c)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Tax Filings</U>&#148; has the meaning set forth in <U>Section&nbsp;5.13</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Tax Statement</U>&#148; has the meaning set forth in <U>Section&nbsp;6.6(b)(ii)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Territory</U>&#148; means the area within 15 miles of any of the Hospitals.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Title Company</U>&#148; has the meaning set forth in <U>Section&nbsp;7.8(b)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Title Policy</U>&#148; has the meaning set forth in <U>Section&nbsp;7.8(b)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Title Work</U>&#148; means commitments to issue policies of owner&#146;s or leasehold title
insurance for the Real Property which will be delivered to Purchaser in accordance with <U>Section
7.8</U>, together (in each case) with copies of the exception documents listed thereon.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Transition Patients</U>&#148; means patients admitted to any of the Facilities prior to the
Effective Time but not yet discharged as of the Effective Time (including patients admitted to any
of the Initial Facilities&#148; prior to the SPA Effective Time but discharged after the Effective Time.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Transition Services</U>&#148; means the rendering of services and provision of medicine, drugs
and supplies by the Acquired Entities to Transition Patients.
</DIV>

<P align="center" style="font-size: 10pt">15
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Unwind Notice</U>&#148; means written notice delivered by LifePoint advising Purchaser that
the Unwind Trigger Event has occurred and that LifePoint is exercising the Unwind Right.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Unwind Right</U>&#148; has the meaning set forth in the Recitals.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Unwind Trigger Event</U>&#148; means (a)&nbsp;the issuance of a final non-appealable Order or (b)
the issuance of an Order which is not final and non-appealable provided that (i)&nbsp;the effectiveness
of such Order is not subject to an effective stay by a Governmental Authority of competent
jurisdiction; (ii)&nbsp;such Order has not been rescinded, reversed, revoked, voided, or otherwise made
ineffective by a Governmental Authority of competent jurisdiction; and (iii)&nbsp;the Order contains an
Order Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Value Diminution Amount</U>&#148; means an amount equal to any Damages paid by the Purchaser
or its Affiliates during the Holding Period to LifePoint or any of its Affiliates pursuant to the
SPA indemnification provisions except to the extent the indemnified Damages were paid to reimburse
LifePoint or its Affiliates for amounts incurred, paid or payable by them (x)&nbsp;to third parties
(whether to pay (i)&nbsp;claims made against LifePoint or its Affiliates by a third party; (ii)&nbsp;third
party costs or expenses incurred by LifePoint or its Affiliates to investigate or defend such claim
or (iii)&nbsp;third party costs and expenses to cure, repair, replace or remedy the matter underlying
such indemnified Damages) or (y)&nbsp;to cure, repair, replace or remedy the matter underlying such
indemnified Damages. The Value Diminution Amount shall not include any such amounts related to the
Clinch Valley Entities and their assets and businesses.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Value Diminution Damages</U>&#148; has the meaning set forth in the definition of the term
&#147;Damages Adjustment Amount.&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<u>WARN Act</u>&#148; has the meaning set forth in the SPA.
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">1.2</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Interpretation. Section&nbsp;1.2 of the SPA is incorporated by reference.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE II<BR>
PURCHASE AND SALE; CLOSING</B>
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">2.1</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U>Sale of the Ownership Interests</U>.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Subject to the provisions of clause (b), below, upon the occurrence of an Unwind Trigger
Event, LifePoint shall have the right to deliver the Unwind Notice to Purchaser. Subject to the
terms and conditions set forth in this Agreement (including the provisions of clause (c), below),
upon the due delivery of an Unwind Notice in accordance with this <U>Section&nbsp;2.1</U>, LifePoint
(or its Affiliate) shall be obligated to sell, assign, transfer and deliver to Purchaser, free and
clear of all Encumbrances, and Purchaser shall be obligated to purchase from LifePoint (or its
Affiliate), the Acquired Company Ownership Interests and the Related Company Ownership Interests.
At the Closing, title to the Acquired Company Ownership Interests and the Related Company Ownership
Interests shall pass to Purchaser, as record and beneficial owner, and Purchaser shall then be
entitled to all rights, including, without limitation, voting rights, as the sole owner of the
Acquired Company Ownership Interests and the Related Company Ownership Interests and the Related
Company Ownership Interests).
</DIV>


<P align="center" style="font-size: 10pt">16
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;If LifePoint does not deliver an Unwind Notice to Purchaser within the period specified
below following the occurrence of an Unwind Trigger Event described in clause (a)&nbsp;of the definition
of &#147;Unwind Trigger Event,&#148; the Unwind Right shall expire and this Agreement will terminate and be
of no further force or effect.
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="20%">
&nbsp;</TD>
    <TD width="50%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">Period Between Issue Date </TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Maximum Period</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">of Order and the </TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Permitted for Delivery</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000">Order Date </TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000">of Unwind Notice</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">90&nbsp;days or less
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">15 Days</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD nowrap valign="top"><DIV style="margin-left:0px; text-indent:-0px">More than 90&nbsp;days and less than 6
months
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">30 Days</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">More than 6&nbsp;months and less than 1&nbsp;year
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">90 Days.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">One year or more
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">The earlier of 180&nbsp;days prior to
the Order Date or one year.</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Additionally, if LifePoint does not deliver an Unwind Notice at least 30&nbsp;days prior to the Order
Date (or, if the Order Date is within 40&nbsp;days of the date the Order is issued, as soon as
commercially practicable after the issue date of the Order), the Unwind Right shall expire and this
Agreement will terminate and be of no further force or effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Upon an Unwind Trigger Event, both parties shall use commercially reasonable efforts, if
requested by Purchaser, in addition to disputing the CON Challenges in accordance with <U>Section
5.15</U> to identifying and negotiating with third parties relating to the potential sale of some
or all of the assets which may otherwise be subject to an unwind.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;If, following LifePoint&#146;s delivery of an Unwind Notice (but before the Closing), a
Governmental Authority of competent jurisdiction issues a Court Order that (i)&nbsp;stays the
effectiveness of the Order that formed the basis of the Unwind Trigger Event; (ii)&nbsp;rescinds,
reverses, revokes, voids, overturns or otherwise makes ineffective such Order; (iii)&nbsp;clarifies,
amends or modifies such Order such that (or confirms that) such Order does not require LifePoint,
as a matter of Law, to transfer or divest any of the Hospitals or cease or suspend operation of
any of the Hospitals; or (iv)&nbsp;eliminates the Order Date from the Order, such Unwind Notice will be
void and of no further force or effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;If (i)&nbsp;LifePoint has delivered an Unwind Notice relative to an Order, (ii)&nbsp;Purchaser has
notified LifePoint in writing within the time periods set forth below that Purchaser wants such
Unwind Notice suspended and has agreed to provide the indemnification required under subsection (v)
of the definition of &#147;Order Non-Compliance Conditions,&#148; and (iii)&nbsp;the Order Non-Compliance
Conditions relative to such Order are met, (A)&nbsp;such Unwind Notice will be suspended until the Order
Non-Compliance Conditions are no longer met with respect to such Order, and (B)&nbsp;Purchaser shall
promptly, timely and currently pay all fines, penalties and similar
</DIV>



<P align="center" style="font-size: 10pt">17
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Damages that LifePoint (and its Affiliates and their respective directors, officers, employees and
agents) incurs as a result of violating such Order as requested by Purchaser. Once Purchaser has
delivered notice of its intent to suspend an Unwind Notice, if Purchaser wishes to terminate such
suspension, Purchaser shall deliver to LifePoint written notice of its intent to terminate said
suspension and (x)&nbsp;the parties shall then use their best efforts to close the transactions
contemplated hereby as quickly as possible (subject to Section&nbsp;2.5), and (y)&nbsp;Purchaser&#146;s obligation
to provide the indemnification required under subsection (v)&nbsp;of the definition of &#147;Order
Non-Compliance Conditions&#148; shall continue with respect to fines, penalties and similar Damages
arising through Closing. Unless Purchaser delivers its written notice that Purchaser wants to
suspend an Unwind Notice to LifePoint at least 30&nbsp;days in advance of an Order Date (or, if the
Order Date is within 40&nbsp;days of the date Purchaser receives the Unwind Notice, as soon after
Purchaser&#146;s receipt of the Unwind Notice as is commercially practicable), LifePoint will not be
required to suspend the Unwind Notice.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.2 <U>Purchase Price</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The consideration to be paid by Purchaser for the Acquired Company Ownership Interests and
the Related Company Ownership Interests (the &#147;<U>Purchase Price</U>&#148;) shall be an amount equal to
the Base Purchase Price (1) <U>plus</U> the Final Net Working Capital Adjustment Amount, (2)
<U>plus</U> the Capital Expenditure Adjustment Amount, (3) <U>minus</U> the Disposition
Adjustment Amount, (4) <U>plus</U> the Indebtedness Adjustment Amount, and (5) <U>plus</U> the
Damages Adjustment Amount (collectively, (1)&nbsp;through (5)&nbsp;the &#147;<U>Purchase Price Adjustments</U>&#148;).
The Purchase Price shall be allocated in accordance with Code Section&nbsp;1060 and <U>Section&nbsp;6.7</U>
of this Agreement, as applicable.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) (i)&nbsp;At the Closing, Purchaser will pay LifePoint an amount (the &#147;<U>Preliminary Payment
Amount</U>&#148;) equal to the Purchase Price as adjusted based upon the preliminary determinations of
the Purchase Price Adjustments pursuant to <U>Sections&nbsp;2.2(b)(ii) and (iii)</U>, below.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;LifePoint shall prepare preliminary determinations of the Final Net Working Capital
Adjustment Amount, the Capital Expenditure Adjustment Amount, the Disposition Adjustment Amount and
the Indebtedness Adjustment Amount using the then most recent available month end balance sheet of
the Business. LifePoint shall deliver to Purchaser (A)&nbsp;a copy of the month-end balance sheet upon
which such calculations are based, (B)&nbsp;such other documents and financial information as is
reasonably required to support the calculation of such preliminary Purchase Price Adjustments, and
(C)&nbsp;a schedule showing the calculation of such preliminary Purchase Price Adjustments not less than
ten days prior to the Closing Date. If Purchaser objects to any of such proposed preliminary
Purchase Price Adjustments and the parties are unable to agree upon the preliminary amount of such
Purchase Price Adjustments, (1)&nbsp;the Closing will not be delayed as a result of the parties&#146;
inability to agree upon such preliminary Purchase Price Adjustments, (2)&nbsp;the schedule delivered by
LifePoint pursuant to this clause (ii)&nbsp;and the amounts reflected thereon for such preliminary
Purchase Price Adjustments shall be used in determining the Preliminary Payment Amount to be
delivered at the Closing, (3)&nbsp;such Purchase Price Adjustments will be adjusted after Closing in
accordance with the applicable dispute resolution procedures as provided in <U>Section&nbsp;2.2(d)</U>,
and (4)&nbsp;the parties will be required to
</DIV>

<P align="center" style="font-size: 10pt">18
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">pay one another interest in connection with any adjustments to such amounts as provided in
<U>Section&nbsp;2.2(e)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;Not less than ten Business Days prior to the Closing Date, LifePoint shall deliver to
Purchaser a schedule of all Reimbursement Damages it claims to have incurred as of such date,
together with a reasonably detailed description of the claim, cost or expense giving rise to the
Damages and documentation substantiating such damages and the payment thereof by LifePoint or its
Affiliates. Not less than ten Business Days prior to the Closing Date, Purchaser shall deliver to
LifePoint a schedule of the Damages that Purchaser or its Affiliates have paid to LifePoint or its
Affiliates that Purchaser believes are Value Diminution Damages. Following delivery of such
schedules to one another, Purchaser and LifePoint shall consult in good faith to determine which,
if any, of the claims set forth in such schedules the parties agree upon and, in the case of each
such claim, the extent to which the parties agree upon the amount of the Value Diminution Damages
or Reimbursement Damages for such claim. Prior to the Closing, the parties will prepare a schedule
showing (A)&nbsp;the claims upon which the parties are in agreement, (B)&nbsp;the amount of each such claim
upon which the parties are in agreement, (C)&nbsp;the amount of each such claim that remains in
controversy, and (D)&nbsp;the claims which remain in controversy, and (E)&nbsp;based upon the information in
clauses (A)&nbsp;and (B), above, the Preliminary Damages Adjustment Amount. To the extent the parties
do not jointly agree on whether any claim is an appropriate claim for Value Diminution Damages or
Reimbursement Damages (or the amount of such claim which constitutes Value Diminution Damages or
Reimbursement Damages) prior to the Closing Date, such unresolved claims will be submitted to
arbitration pursuant to the provisions of <U>Section&nbsp;11.1</U> following the Closing Date. To the
extent unresolved by the parties, such arbitration proceedings will be used for both the
determination of the merits of any unresolved Claim and the amount of Damages, if any, resulting
from any such Claim.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Within 60&nbsp;days after the Closing, LifePoint shall deliver to Purchaser (i)&nbsp;the Closing
Date Balance Sheet (ii)&nbsp;such other documents and financial information as is reasonably required to
support the calculation of the Final Net Working Capital Adjustment Amount, the Capital Expenditure
Adjustment Amount, the Disposition Adjustment Amount and the Indebtedness Adjustment Amount not
delivered pursuant to <U>Section&nbsp;2.2(b)(ii)</U>, above, and (iii)&nbsp;a Schedule setting forth
LifePoint&#146;s determination of the Final Net Working Capital Adjustment Amount, the Capital
Expenditure Adjustment Amount, the Disposition Adjustment Amount and the Indebtedness Adjustment
Amount based upon the Closing Date Balance Sheet and the aggregate adjustment to the Preliminary
Payment Amount resulting from such Purchase Price Adjustments (collectively, the &#147;<U>Closing
Statement</U>&#148;). After the Closing, Purchaser shall (A)&nbsp;permit representatives of LifePoint, during
normal business hours, to have reasonable access to, and to examine and make copies of, all books
and records of the Acquired Entities which are in the possession of Purchaser or its Affiliates
(including the Acquired Entities) for purposes of preparing the Closing Statement, and (B)&nbsp;cause
the employees of Purchaser and its Affiliates (including the Acquired Entities) to cooperate with
and assist LifePoint in the preparation of the Closing Statement. The Closing Statement shall be
prepared in accordance with GAAP.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Purchaser may object to any of the information or computations contained in the Closing
Statement which could affect the Purchase Price. Any such objection must be made by delivery of a
written statement of objections (stating the basis of the objections with

<P align="center" style="font-size: 10pt">19
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">reasonable specificity) to LifePoint within 30&nbsp;days following delivery of the Closing
Statement to Purchaser. To the extent that Purchaser does not so object within such 30-day period,
the Closing Statement, as delivered to Purchaser, shall be considered final and binding upon the
parties.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;In the event that Purchaser and LifePoint are unable to resolve a dispute or disagreement
relating to the Final Net Working Capital Adjustment Amount or the Indebtedness Adjustment Amount
set forth in a written objection pursuant to this <U>Section&nbsp;2.2(d)</U> within 30&nbsp;days of
LifePoint&#146;s receipt of such objection, either party may elect, by written notice to the other
party, to have all such unresolved disputes or disagreements resolved by the Selected Accounting
Firm. The Selected Accounting Firm shall resolve each issue submitted to it in accordance with
this Agreement and, based upon such resolution (and in accordance with this Agreement), determine
the Final Net Working Capital Adjustment Amount and the Indebtedness Adjustment Amount and
calculate the aggregate adjustment to the Preliminary Payment Amount based on such Purchase Price
Adjustments, which determination of the Selected Accounting Firm shall be final and binding upon
the parties. The Selected Accounting Firm shall be instructed to use every reasonable effort to
perform its services within 15&nbsp;days after submission of the Closing Statement and the description
of the unresolved objections to it and, in any case, as soon as practicable after such submission.
The parties will cooperate fully with the Selected Accounting Firm, and shall cause the Acquired
Entities to cooperate fully with the Selected Accounting Firm, in connection with its resolution of
objections and, based upon (A)&nbsp;such resolution, (B)&nbsp;the parties&#146; resolution of any other
objections, and (C)&nbsp;the Closing Statement, its determination of such Purchase Price Adjustments and
calculation of aggregate adjustment to the Preliminary Payment Amount based on such Purchase Price
Adjustments. The costs and expenses for the services of the Selected Accounting Firm shall be
borne equally by Purchaser and LifePoint.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;In the event that Purchaser and LifePoint are unable to resolve a dispute or disagreement
relating to the Capital Expenditure Adjustment Amount or the Disposition Adjustment Amount set
forth in a written objection pursuant to this <U>Section&nbsp;2.2(d)</U> within 30&nbsp;days of LifePoint&#146;s
receipt of such objection, the provisions of clause (d)(i) will be applicable to the resolution of
such dispute or disagreement; provided, however, that in lieu of the procedures described in such
clause (d)(i), either party may elect, by written notice to the other party, to have all such
unresolved disputes or disagreements submitted to arbitration pursuant to the provisions of
<U>Section&nbsp;11.1</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) (i)&nbsp;Within ten days after the Final Net Working Capital Adjustment Amount and the
Indebtedness Adjustment Amount (and the resulting calculation of the aggregate adjustment to the
Preliminary Payment Amount relating to such Purchase Price Adjustments) shall have been agreed upon
or otherwise determined pursuant to <U>Section&nbsp;2.2(d)</U>, LifePoint or Purchaser, as appropriate,
shall pay the other party cash (by wire transfer of immediately available funds) in the amount of
such aggregate adjustment to the Preliminary Payment Amount, together with interest thereon for a
period from (and including) the Closing Date to (but excluding) the date of payment, at the prime
rate as quoted in the Money Rates section of <I>The Wall Street Journal </I>from time to time.
</DIV>


<P align="center" style="font-size: 10pt">20
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;Within ten days after the Capital Expenditures Adjustment Amount and the Disposition
Adjustment Amount (and the resulting calculation of the aggregate adjustment to the Preliminary
Payment Amount relating to such Purchase Price Adjustments) shall have been agreed upon or
otherwise determined pursuant to <U>Section&nbsp;2.2(d)</U> or <U>Section&nbsp;11.1</U>, as applicable,
LifePoint or Purchaser, as appropriate, shall pay the other party cash (by wire transfer of
immediately available funds) in the amount of such aggregate adjustment to the Preliminary Payment
Amount, together with interest thereon for a period from (and including) the Closing Date to (but
excluding) the date of payment, at the prime rate as quoted in the Money Rates section of <I>The Wall
Street Journal </I>from time to time.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.3 <U>Closing</U>. The closing of the transactions contemplated by this Agreement (the
&#147;<U>Closing</U>&#148;) will take place at the offices of Waller Lansden Dortch &#038; Davis, LLP, 511 Union
Street, Suite&nbsp;2700, Nashville, Tennessee, or such other place as shall be mutually agreed upon by
the parties hereto, at 10:00&nbsp;a.m., Central Time, on the earliest practicable day following
LifePoint&#146;s due exercise of the Unwind Right in accordance with Section&nbsp;2.1 hereof that is a
month-end (or, in the event that such month-end falls on a day that is not a Business Day, the
Business Day preceding such month-end) following the satisfaction (or due waiver) of the conditions
set forth in <U>Articles VII</U> and <U>VIII</U>, or such other date as may be mutually agreed
upon by the parties hereto but in no event later than the last day of the calendar month in which
such satisfaction or waiver occurs and, subject to the provisions of <U>Section&nbsp;2.5</U>, in no
event later than the Order Date. The date on which the Closing takes place is referred to herein
as the &#147;Closing Date.&#148; The Closing shall be deemed to occur at 11:59&nbsp;p.m., Central Time, on the
Closing Date (or if the Closing takes place on a Business Day preceding the relevant month-end, at
11:59&nbsp;p.m. on such month-end) or at such other time as shall be mutually agreed upon in writing by
the parties hereto. The time at which the transactions contemplated hereby are deemed to become
effective is referred to herein as the &#147;Effective Time&#148;. The parties shall use their respective
best efforts to cause the conditions to Closing to occur as promptly as is commercially reasonable
under the circumstances but, subject to the provisions of <U>Section&nbsp;2.5</U>, in no event later
than the Order Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.4 <U>Closing Deliveries</U>. At the Closing, the following events will occur:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <U>Ownership Interests</U>. LifePoint will deliver to Purchaser certificates
representing the Acquired Company Ownership Interests, the Acquired Subsidiary Ownership Interests
and the Related Entity Ownership Interests, such certificates representing the Acquired Company
Ownership Interests and the Related Company Ownership Interests to be duly endorsed or accompanied
by duly executed blank stock powers or other appropriate instruments of conveyance.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <U>Payment for Ownership Interests</U>. At the Closing, Purchaser shall deliver the
Preliminary Payment Amount in immediately available funds by electronic wire transfer to an account
designated by LifePoint.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <U>Closing Certificates and Documents</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;LifePoint shall deliver the other certificates and documents required to be delivered by
LifePoint pursuant to <U>Article&nbsp;VII</U>; and
</DIV>

<P align="center" style="font-size: 10pt">21
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;Purchaser shall deliver the other certificates and documents required to be delivered by
Purchaser pursuant to <U>Article&nbsp;VIII</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.5 <U>Order Date Closing Conditions</U>. (a) (i)&nbsp;If (A)&nbsp;LifePoint has delivered an Unwind
Notice relative to an Order, (B)&nbsp;Purchaser has not elected to suspend such Unwind Notice in
accordance with <U>Section&nbsp;2.1(e)</U>, (C)&nbsp;any of the conditions to Purchaser&#146;s obligation to
close the transactions as set forth in Article&nbsp;VII have not been satisfied or waived by Purchaser,
(D)&nbsp;Purchaser notifies LifePoint in writing that Purchaser wants to delay the Closing past the
Order Date until such conditions are satisfied or waived, and (E)&nbsp;the Order Non-Compliance
Conditions relative to such Order are met, (1)&nbsp;the Closing will be delayed until the earliest of
(x)&nbsp;the satisfaction (or waiver by Purchaser) of Purchaser&#146;s conditions to close the transactions
contemplated hereby as set forth in Article&nbsp;VII, (y)&nbsp;the time Purchaser notifies LifePoint in
writing that Purchaser no longer wishes to delay the Closing, and (z)&nbsp;the time that the Order
Non-Compliance Conditions are no longer met with respect to such Order; and (2)&nbsp;Purchaser shall
promptly, timely and currently pay all fines, penalties and similar Damages that LifePoint (and its
Affiliates, and their respective directors, officers, employees and agents) incurs as a result of
violating such Order due to Purchaser&#146;s request to delay the Closing in accordance with this
<U>Section&nbsp;2.5</U>. Following the delay of the Closing in accordance with this <U>Section
2.5(a)</U>, the parties will use commercially reasonable efforts to close the transactions as soon
as commercially practicable; provided that the Closing will take place as of the end of a month
unless otherwise agreed by the parties; and provided further, that except to the extent provided in
<U>Section&nbsp;2.5(b)</U>, Purchaser&#146;s obligations to close the transactions on such delayed Closing
Date will still be subject to satisfaction or waiver of the Closing conditions set forth in
<U>Articles VII</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;Notwithstanding the provisions of clause (i), above, if all other conditions to the
parties&#146; obligations have been satisfied or waived as of an Order Date, (A)&nbsp;the failure of the
conditions to Purchaser&#146;s obligation to close the transactions contemplated hereby that are set
forth in <U>Sections&nbsp;7.7, 7.9</U> and <U>7.10</U> to be satisfied on or before such Order Date
will not excuse Purchaser&#146;s obligation to perform on such Order Date, and failure of the conditions
to LifePoint&#146;s obligation to close the transactions contemplated hereby that are set forth in
<U>Sections&nbsp;8.7</U> and <U>8.8</U> to be satisfied on or before such Order Date will not excuse
LifePoint&#146;s obligation to perform on such Order Date; provided that in either case such conditions
have not been satisfied as of an Order Date other than as a result of the breach of this Agreement
by the other party hereto.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;In addition to the closing conditions specified in <U>Section&nbsp;2.5(a)(ii)</U>, above, and
subject to the provisions of <U>Section&nbsp;2.1</U>, if the Order Non-Compliance Conditions are not
met as of an Order Date, failure of the conditions to Purchaser&#146;s obligation to close the
transactions contemplated hereby that are set forth in <U>Sections&nbsp;7.12, 7.16</U> and <U>7.17</U>
to be satisfied on or before such Order Date will not excuse Purchaser&#146;s obligation to perform on
such Order Date; provided, however, that solely for purposes of closing in accordance with this
<U>Section&nbsp;2.5(b</U>), the closing conditions set forth in <U>Section&nbsp;7.8</U> will be deemed to
have been satisfied if LifePoint delivers a written instrument to Purchaser (i)&nbsp;certifying that as
of the Effective Time the Acquired Entities own fee simple title to the Real Property subject only
to Permitted Encumbrances, (B)&nbsp;identifying all such Permitted Encumbrances created by, through or
under LifePoint (or, in the case of Real Property acquired since the SPA Effective Time, all
Permitted Encumbrances on such Real Property), and (ii)&nbsp;indemnifying Purchaser for Damages
resulting from any breach of

<P align="center" style="font-size: 10pt">22
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">or inaccuracy in such certificate from the first dollar of Damages without regard to the
limitations set forth in <U>Section&nbsp;9.4(a)(i)</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;If, in accordance with this <U>Section&nbsp;2.5</U>, a Closing occurs and some or all of the
Closing conditions specified in this Section&nbsp;2.5 have not been satisfied or waived by the
applicable party prior to the Closing (such conditions, the &#147;<U>Order Date Closing
Conditions</U>&#148;), the parties will cooperate in good faith and use their respective best efforts to
cause such Order Date Closing Conditions to be satisfied as soon as commercially practicable after
the Closing.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.6 <U>Multiple Closings</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;If the conditions precedent in <U>Article&nbsp;VII</U> are met for all Facilities other than
for certain Acquired Entities which are not a Hospital (the &#147;<U>Associated Business</U>&#148;) whose
operations are immaterial to the operation of the associated Hospital, the Closing will proceed
with respect to all Acquired Entities other than the Associated Business in accordance with this
Agreement (any such Closing, a &#147;<U>Partial Closing</U>&#148;). From and after the Partial Closing,
LifePoint and Purchaser shall use commercially reasonable efforts to complete the acquisition of
the Associated Business. From and after the Partial Closing LifePoint shall cooperate in any
reasonable arrangement to provide Purchaser the benefit under any and all rights of the Associated
Business including but not limited to economic benefits and control of management decisions until
the earlier of the date described in clause (ii)&nbsp;below, and such time as the Associated Business is
acquired by Purchaser as described in the remainder of this <U>Section&nbsp;2.6(a)</U>. If, after such
Partial Closing and prior to the later of (i)&nbsp;termination of this Agreement and (ii)&nbsp;the date that
is 180&nbsp;days after the Effective Time of such Partial Closing, the conditions precedent in
<U>Article&nbsp;VII</U> are subsequently satisfied with respect to any such excluded Acquired Entities,
Purchaser shall be obligated to consummate the purchase of and LifePoint shall be obligated to
consummate the sale of all such excluded Acquired Entities for which the conditions in <U>Article
VII</U> have been satisfied at a Closing in accordance with and subject to <U>Article&nbsp;II</U>.
Such Closing will be held within ten business days after satisfaction of the conditions set forth
in <U>Articles VII</U> and <U>VIII</U> with respect to such Acquired Entities, or such other date
as may be mutually agreed upon by the parties hereto. Such Closing will take place without regard
to whether the conditions in <U>Article&nbsp;VII</U> have been satisfied for all such excluded Acquired
Entities.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;In the event that (i)&nbsp;the parties conclude in good faith that LifePoint was not able to
deliver the economic benefits of the Associated Business between the Partial Closing and
acquisition of the Associated Business by Purchaser or (ii)&nbsp;the Associated Business is not acquired
by Purchaser, LifePoint and Purchaser will negotiate in good faith to determine an appropriate
adjustment to the Purchase Price as a result of such failure to deliver economic benefit or
exclusion of an Acquired Entity.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;If the parties are unable to agree upon such a price reduction, (1)&nbsp;the Preliminary
Payment Amount will not be reduced as of the Closing Date, (2)&nbsp;the Partial Closing will not be
delayed as a result of the parties&#146; inability to agree upon such adjustment, (3)&nbsp;the Purchase Price
will be adjusted after the Closing in accordance with dispute resolution procedures agreed upon by
the parties, and (4)&nbsp;LifePoint will be required to pay Purchaser interest on such price adjustment
from the date of the Partial Closing to the date of payment of
</DIV>

<P align="center" style="font-size: 10pt">23
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">such price adjustment at the rate of interest set forth in <U>Section&nbsp;2.3(e)</U> of the SPA.
Either LifePoint or Purchaser may initiate such proceedings to determine the adjustment to the
Purchase Price at any time following the Partial Closing.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;If the parties have not determined the amount of the price adjustment with respect to an
excluded Acquired Entity as of the date of a subsequent Closing at which Purchaser acquires such
Acquired Entity, the parties will negotiate in good faith to determine the amount of interest to
which Purchaser is entitled for having delivered the Purchase Price for such Acquired Entity at an
earlier Closing. Such amount will be equal to interest at the rate set forth in <U>Section
2.3(e)</U> of the SPA on the portion of the Purchase Price attributable to such Acquired Entity
from the date of the Partial Closing until the date of the subsequent Closing. If the parties are
unable to agree upon such amount, (1)&nbsp;the Closing for the Acquired Entity will not be delayed as a
result of the parties&#146; inability to agree upon such amount, and (2)&nbsp;the amount of such interest
payment will be determined after the Closing in accordance with dispute resolution procedures
agreed upon by the parties. Either LifePoint or Purchaser may initiate such proceedings to
determine the adjustment to the Purchase Price at any time following the Partial Closing.
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">If the parties have determined the adjustment to the Purchase Price applicable to an excluded
Acquired Entity (and, if such adjustment shall have been determined after the Partial Closing,
LifePoint shall have paid Purchaser the amount due under clause (A), above, in respect of such
excluded Acquired Entity), at any subsequent Closing of the sale of such Acquired Entity to
Purchaser, the Purchase Price for such Acquired Entity will be the previously determined adjustment
amount.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE III<BR>
REPRESENTATIONS AND WARRANTIES OF LIFEPOINT</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;LifePoint&#146;s representations and warranties in this Article&nbsp;III are subject to the following
limitations:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;With respect to any of the Initial Acquired Entities that is an Acquired Entity, and with
respect to the assets and operations of the Acquired Entities that are owned and operated by the
Acquired Entities as of the Closing Date, each such representation and warranty is subject to: (a)
matters which existed as of the SPA Effective Time (after giving effective to the closing of the
SPA Transaction) or which involve a continuation of the business practices which existed at the
Initial Closing Date, and (b)&nbsp;matters for which Purchaser is providing indemnification in
connection with the Initial Closing pursuant to either <U>Section&nbsp;9.2(f)</U> of the SPA or the
Environmental Indemnity Agreement delivered in accordance with the SPA;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;Each of such representations and warranties is subject to any matters caused by, or
resulting from, the CON Challenges; an Unwind Trigger Event; the delivery of an Unwind Notice; the
closing of the transactions contemplated hereby; or the closure or suspension of operations of a
Facility in accordance with <U>Section&nbsp;5.16</U>; and
</DIV>


<P align="center" style="font-size: 10pt">24
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;Subject to the provisions of <U>Section&nbsp;5.5(f)</U>, each of such representations and
warranties is subject to the matters disclosed in the Exhibits and the LifePoint Disclosure
Documents delivered in accordance with <U>Section&nbsp;5.5(f)</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject to the foregoing, LifePoint represents and warrants to Purchaser, which
representations and warranties shall be true and correct as of the Closing (except to the extent
such representations and warranties specifically speak as of another date, in which case as of such
date), as follows:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.1 <U>Organization of LifePoint and Seller Group</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;LifePoint is a corporation duly organized, validly existing and in good standing under the
Laws of the State of Delaware.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <U>Exhibit&nbsp;A-1</U> lists the LifePoint subsidiaries that as of the Effective Time will
own the Acquired Company Ownership Interests and the Related Company Ownership Interests (each, a
&#147;<U>Seller</U>&#148; and collectively the &#147;<U>Seller Group</U>&#148;). Each Seller is a corporation,
limited partnership, limited liability company or other legal entity duly organized, validly
existing and in good standing under the Laws of the state indicated as the state of organization in
<U>Exhibit&nbsp;A-1</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.2 Organization and Capitalization of the Acquired Companies and the Acquired Subsidiaries.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;As of the Effective Time, each Acquired Company (i)&nbsp;will be a corporation, limited
partnership, limited liability company or other legal entity duly organized, validly existing and
in good standing under the Laws of the state of its organization, as identified on <U>Exhibit
A-2</U>, (ii)&nbsp;will have the corporate, partnership, limited liability company or other legal entity
power and authority to own or lease and to operate its assets and to conduct its business as
conducted throughout the Holding Period, and (iii)&nbsp;will be duly qualified to transact business as a
foreign corporation, limited partnership, limited liability company or other legal entity in the
jurisdictions specified in <U>Exhibit&nbsp;A-2</U> and will not be required to be so qualified by any
Laws in any other jurisdiction in which it has material operations or assets.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <U>Exhibit&nbsp;A-2</U> sets forth (i)&nbsp;the authorized capital stock, partnership interests,
membership interests or other legal entity equity interest as of the Effective Time of each
Acquired Company, (ii)&nbsp;the number or amount (as appropriate) of shares (or other applicable
ownership interest) of such Acquired Company that will be issued and outstanding as of the
Effective Time, (iii)&nbsp;the number or amount (as appropriate) of such issued and outstanding shares
(or other applicable ownership interest) of such Acquired Company that will be beneficially owned
by the Seller Group as of the Effective Time (such issued and/or outstanding shares or other
ownership interests for all of the Acquired Companies beneficially owned by the Seller Group as of
the Effective Time, the &#147;<U>Acquired Company Ownership Interests</U>&#148;), (iv)&nbsp;the name of each
owner of any of the issued and/or outstanding shares (or other applicable ownership interests) of
each Acquired Company (other than the members of the Seller Group) and the number (or amount), type
and class of all ownership interests owned by each such owner, and (v)&nbsp;the par value for each class
of outstanding shares or other ownership interests where applicable.
</DIV>


<P align="center" style="font-size: 10pt">25
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The Acquired Company Ownership Interests have been (or, as of the Effective Time, will have
been) duly authorized and validly issued and as of the Effective Time, will be fully paid and
non-assessable. Except for the Acquired Company Ownership Interests and the ownership interests
disclosed in accordance with clause (b)(iv), above, as of the Effective Time there will be no
outstanding equity securities of any of the Acquired Companies, including (i)&nbsp;securities which are
convertible into or exchangeable for any capital stock, partnership interests or membership
interests of an Acquired Company, (ii)&nbsp;contracts, arrangements, commitments or restrictions
relating to the issuance, sale, transfer, purchase or obtaining of capital stock or other equity
securities of an Acquired Company, or (iii)&nbsp;options, warrants, rights, calls or commitments of any
character granted or issued by an Acquired Company governing the issuance of shares of its capital
stock, partnership interests or membership interests. As of the Effective Time, each Person listed
in <U>Exhibit&nbsp;A-2</U> will meet all of the requirements set forth in <U>Section&nbsp;5.8(a)</U>
necessary for a Person to be an Acquired Entity.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;As of the Effective Time, (i)&nbsp;the Seller Group will have good and marketable title to, and
will own, all of the Acquired Company Ownership Interests, beneficially and of record; (ii)&nbsp;the
Acquired Company Ownership Interests will be free and clear of all Encumbrances; (iii)&nbsp;Seller Group
will have full voting power over the Acquired Company Ownership Interests, subject to no proxy,
shareholders&#146; agreement, voting trust or other agreement relating to the voting of any of the
Acquired Company Ownership Interests; and (iv)&nbsp;other than this Agreement and any Contract
identified in <U>Exhibit&nbsp;A-2</U>, there will be no agreement between LifePoint or any of its
Affiliates (including the Seller Group) and any other Person with respect to the disposition of the
Acquired Company Ownership Interests (provided, however, that if the existence of the Contracts
identified in <U>Exhibit&nbsp;A-2</U>, the consummation of the transactions contemplated thereby, or
the performance of the obligations thereunder will, individually or collectively, cause any of the
requirements set forth in <U>Section&nbsp;5.8</U> necessary for such Person to be an Acquired Company
fail to be satisfied with respect to the applicable Person then such entity will not be an Acquired
Company and the failure to satisfy such requirements will not be considered a breach of this
Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;As of the Effective Time, except veto rights and super-majority approval rights held by
the holders of such ownership interests which are consistent with comparable arrangements of
LifePoint and its Affiliates in similar entities that are not wholly owned by LifePoint, (i)&nbsp;no
Person will have any preemptive right to purchase any equity security in any of the Acquired
Companies, and (ii)&nbsp;other than the Acquired Company Ownership Interests and the other ownership
interests disclosed in accordance with clause (b)(iv), above, there will be no outstanding equity
securities in any of the Acquired Companies giving the owner or holder thereof the right to vote on
any matters on which shareholders, partners or members of the applicable Acquired Company may vote.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;Except for the Acquired Subsidiaries and the Related Subsidiaries, as of the Effective
Time, the Acquired Entities will not directly or indirectly own, of record or beneficially, any
equity security of any Person.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;Each Acquired Subsidiary (i)&nbsp;as of the Effective Time, will be a corporation, limited
partnership, limited liability company or other legal entity duly organized, validly existing and
in good standing under the Laws of the state of its organization, as identified

<P align="center" style="font-size: 10pt">26
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">on <U>Exhibit&nbsp;A-3</U>, (ii)&nbsp;as of the Effective Time, will have the corporate, partnership,
limited liability company power or other legal entity and authority to own or lease and to operate
its assets and to conduct its business as conducted as of the Effective Time, and (iii)&nbsp;as of the
Effective Time, will be duly qualified to transact business as a foreign corporation, limited
partnership, limited liability company or other legal entity in each of the jurisdictions listed in
<U>Exhibit&nbsp;A-3</U> and as of the Effective Time will not be required to be so qualified by any
Laws in any other jurisdiction in which it has material operations or assets.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) <U>Exhibit&nbsp;A-3</U> sets forth (i)&nbsp;the authorized capital stock, partnership interests or
membership interests as of the Effective Time of each Acquired Subsidiary, (ii)&nbsp;the number or
amount (as appropriate) of shares (or other applicable ownership interest) of such Acquired
Subsidiary that will be issued and outstanding as of the Effective Time, (iii)&nbsp;the number or amount
(as appropriate) of such issued and outstanding shares (or other applicable ownership interest) of
such Acquired Subsidiary that will be beneficially owned by the Acquired Companies as of the
Effective Time (such issued and/or outstanding shares or other ownership interests for all of the
Acquired Subsidiaries beneficially owned by the Acquired Companies as of the Effective Time, the
&#147;<U>Acquired Subsidiary Ownership Interests</U>&#148;), (iv)&nbsp;the name of each owner of any of the
issued and/or outstanding shares (or other applicable ownership interests) of each Acquired
Subsidiary (other than the Acquired Companies) and the number (or amount), type and class of all
ownership interests owned by each such owner, and (v)&nbsp;the par value for each class of outstanding
shares or other ownership interests where applicable. The Acquired Subsidiary Ownership Interests
have been (or, as of the Effective Time, will have been) duly authorized and validly issued and as
of the Effective Time, will be fully paid and non-assessable. Except for the Acquired Subsidiary
Ownership Interests and the ownership interests disclosed in accordance with clause (b)(iv), above,
as of the Effective Time, there will be no outstanding equity securities of any of the Acquired
Subsidiaries, including (A)&nbsp;securities which are convertible into or exchangeable for any capital
stock, partnership interests or membership interests of an Acquired Subsidiary, (B)&nbsp;contracts,
arrangements, commitments or restrictions relating to the issuance, sale, transfer, purchase or
obtaining of capital stock or other equity securities of an Acquired Subsidiary, or (C)&nbsp;options,
warrants, rights, calls or commitments of any character granted or issued by an Acquired Subsidiary
governing the issuance of shares of its capital stock, partnership interests or membership
interests. As of the Effective Time, each Person listed in <U>Exhibit&nbsp;A-4</U> will meet all of
the requirements set forth in <U>Section&nbsp;5.8(a)</U> necessary for a Person to be an Acquired
Entity.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;As of the Effective Time, (i)&nbsp;the Acquired Entities will have good and marketable title
to, and will own, directly or indirectly, all of the Acquired Subsidiary Ownership Interests,
beneficially and of record; (ii)&nbsp;the Acquired Subsidiary Ownership Interests will be free and clear
of all Encumbrances, (iii)&nbsp;the Acquired Entities will have full voting power over the Acquired
Subsidiary Ownership Interests, subject to no proxy, shareholders&#146; agreement, voting trust or other
agreement relating to the voting of any of the Acquired Subsidiary Ownership Interests, and (iv)
other than this Agreement and any Contract identified in <U>Exhibit&nbsp;A-3</U>, there will be no
agreement between LifePoint or any of its subsidiaries and any other Person with respect to the
disposition of the Acquired Subsidiary Ownership Interests or otherwise relating to the Acquired
Subsidiary Ownership Interests (provided, however, that if the existence of the Contracts
identified in <U>Exhibit&nbsp;A-3</U>, the consummation of the transactions contemplated thereby, or
the performance of the obligations thereunder will, individually or collectively, cause any of

<P align="center" style="font-size: 10pt">27
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">the requirements set forth in <U>Section&nbsp;5.8</U> necessary for such Person to be an Acquired
Subsidiary fail to be satisfied with respect to the applicable Person then such entity will not be
an Acquired Subsidiary and the failure to satisfy such requirements will not be considered a breach
of this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;As of the Effective Time, except veto rights and super-majority approval rights held by
the holders of such ownership interests which are consistent with comparable arrangements of
LifePoint and its Affiliates in similar entities that are not wholly owned by LifePoint, (i)&nbsp;no
Person will have any preemptive right to purchase any equity security in any of the Acquired
Subsidiaries, and (ii)&nbsp;other than the Acquired Subsidiary Ownership Interests and the other
ownership interests disclosed in accordance with clause (g)(iv), above, there will be no
outstanding equity securities in any of the Acquired Subsidiaries giving the owner or holder
thereof the right to vote on any matters on which shareholders, partners or members of the
applicable Acquired Subsidiary may vote.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.3 <U>Organization and Capitalization of the Related Companies and the Related
Subsidiaries</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;As of the Effective Time, each Related Company (i)&nbsp;will be a corporation, limited
partnership, limited liability company or other legal entity duly organized, validly existing and
in good standing under the Laws of the state of its organization, as identified on <U>Exhibit
A-4</U>, (ii)&nbsp;will have the corporate, partnership, limited liability company or other legal entity
power and authority to own or lease and to operate its assets and to conduct its business as
conducted throughout the Holding Period, and (iii)&nbsp;will be duly qualified to transact business as a
foreign corporation, limited partnership, limited liability company or other legal entity in the
jurisdictions specified in <U>Exhibit&nbsp;A-4</U> and will not be required to be so qualified by any
Laws in any other jurisdiction in which it has material operations or assets.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <U>Exhibit&nbsp;A-4</U> sets forth (i)&nbsp;the authorized capital stock, partnership interests,
membership interests or other legal entity equity interest as of the Effective Time of each Related
Company, (ii)&nbsp;the number or amount (as appropriate) of shares (or other applicable ownership
interest) of such Related Company that will be issued and outstanding as of the Effective Time,
(iii)&nbsp;the number or amount (as appropriate) of such issued and outstanding shares (or other
applicable ownership interest) of such Related Company that will be beneficially owned by the
Seller Group as of the Effective Time (such issued and/or outstanding shares or other ownership
interests for all of the Related Companies that are beneficially owned by the Seller Group as of
the Effective Time, the &#147;<U>Related Company Ownership Interests</U>&#148;), (iv)&nbsp;the name of each owner
of any of the issued and/or outstanding shares (or other applicable ownership interests) of each
Related Company and the number (or amount), type and class of all ownership interests owned by each
such owner, and (v)&nbsp;the par value for each class of outstanding shares or other ownership interests
where applicable. The Related Company Ownership Interests have been (or, as of the Effective Time,
will have been) duly authorized and validly issued and as of the Effective Time, will be fully paid
and non-assessable. Except for the Related Company Ownership Interests and the ownership interests
disclosed in accordance with clause (b)(iv), above, as of the Effective Time, there will be no
outstanding equity securities of any of the Related Companies, including (i)&nbsp;securities which are
convertible into or exchangeable for any capital stock, partnership interests or membership
interests of a Related Company, (ii)contracts, arrangements,

<P align="center" style="font-size: 10pt">28
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">commitments or restrictions relating to the issuance, sale, transfer, purchase or obtaining of
capital stock or other equity securities of a Related Company, or (iii)options, warrants, rights,
calls or commitments of any character granted or issued by a Related Company governing the issuance
of shares of its capital stock, partnership interests or membership interests. As of the Effective
Time, each Person listed in <U>Exhibit&nbsp;A-4</U> will meet all of the requirements set forth in
<U>Section&nbsp;5.8</U> necessary for such Person to be an Acquired Entity.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;As of the Effective Time, (i)&nbsp;the Seller Group will have good and marketable title to, and
will own, all of the Related Company Ownership Interests, beneficially and of record; (ii)&nbsp;the
Related Company Ownership Interests will be free and clear of all Encumbrances; (iii)&nbsp;Seller Group
will have full voting power over the Related Company Ownership Interests, subject to no proxy,
shareholders&#146; agreement, voting trust or other agreement relating to the voting of any of the
Related Company Ownership Interests; and (iv)&nbsp;other than this Agreement and any Contract identified
in <U>Exhibit&nbsp;A-4</U>, there will be no agreement between LifePoint or any of its Affiliates
(including the Seller Group) and any other Person with respect to the disposition of the Related
Company Ownership Interests (provided, however, that if the existence of the Contracts identified
in <U>Exhibit&nbsp;A-4</U>, the consummation of the transactions contemplated thereby, or the
performance of the obligations thereunder will, individually or collectively, cause any of the
requirements set forth in <U>Section&nbsp;5.8</U> necessary for such Person to be a Related Company
fail to be satisfied with respect to the applicable Person then such entity will not be a Related
Company and the failure to satisfy such requirements will not be considered a breach of this
Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;As of the Effective Time, except veto rights and super-majority approval rights held by
the holders of such ownership interests which are consistent with comparable arrangements of
LifePoint and its Affiliates in similar entities that are not wholly owned by LifePoint, (i)&nbsp;no
Person will have any preemptive right to purchase any equity security in any of the Related
Companies, and (ii)&nbsp;other than the Related Company Ownership Interests and the other ownership
interests disclosed in accordance with clause (b)(iv), above, there will be no outstanding equity
securities in any of the Related Companies giving the owner or holder thereof the right to vote on
any matters on which shareholders, partners or members of the applicable Related Company may vote.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;Each Related Subsidiary (i)&nbsp;as of the Effective Time, will be a corporation, limited
partnership, limited liability company or other legal entity duly organized, validly existing and
in good standing under the Laws of the state of its organization, as identified on <U>Exhibit
A-5</U>, (ii)&nbsp;as of the Effective Time, will have the corporate, partnership, limited liability
company power or other legal entity and authority to own or lease and to operate its assets and to
conduct its business as conducted as of the Effective Time, and (iii)&nbsp;as of the Effective Time,
will be duly qualified to transact business as a foreign corporation, limited partnership, limited
liability company or other legal entity in each of the jurisdictions listed in <U>Exhibit&nbsp;A-5</U>
and as of the Effective Time will not be required to be so qualified by any Laws in any other
jurisdiction in which it has material operations or assets.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) <U>Exhibit&nbsp;A-5</U> sets forth (i)&nbsp;the authorized capital stock, partnership interests or
membership interests as of the Effective Time of each Related Subsidiary, (ii)&nbsp;the number or amount
(as appropriate) of shares (or other applicable ownership interest) of such Related

<P align="center" style="font-size: 10pt">29
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Subsidiary that will be issued and outstanding as of the Effective Time, (iii)&nbsp;the number or
amount (as appropriate) of such issued and outstanding shares (or other applicable ownership
interest) of such Related Subsidiary that will be beneficially owned by an Acquired Company, an
Acquired Subsidiary or a Related Company as of the Effective Time (such issued and/or outstanding
shares or other ownership interests for all of the Related Subsidiaries that are owned by an
Acquired Company, an Acquired Subsidiary or a Related Company as of the Effective Time, the
&#147;<U>Related Subsidiary Ownership Interests</U>&#148;), (iv)&nbsp;the name of each owner of any of the issued
and/or outstanding shares (or other applicable ownership interests) of each Related Subsidiary and
the number (or amount), type and class of all ownership interests owned by each such owner, and (v)
the par value for each class of outstanding shares or other ownership interests where applicable.
The Related Subsidiary Ownership Interests have been (or, as of the Effective Time, will have been)
duly authorized and validly issued and as of the Effective Time, will be fully paid and
non-assessable. Except for the Related Subsidiary Ownership Interests and the ownership interests
disclosed in accordance with clause (f)(iv), above, as of the Effective Time, there will be no
outstanding equity securities of any of the Related Subsidiaries, including (i)&nbsp;securities which
are convertible into or exchangeable for any capital stock, partnership interests or membership
interests of a Related Subsidiary, (ii)&nbsp;contracts, arrangements, commitments or restrictions
relating to the issuance, sale, transfer, purchase or obtaining of capital stock or other equity
securities of a Related Subsidiary, or (iii)&nbsp;options, warrants, rights, calls or commitments of any
character granted or issued by a Related Subsidiary governing the issuance of shares of its capital
stock, partnership interests or membership interests. As of the Effective Time, each Person listed
in <U>Exhibit&nbsp;A-5</U> will meet all of the requirements set forth in Section&nbsp;5.8 necessary for a
Person to be an Acquired Entity and the failure to satisfy such requirements will not be considered
a breach of this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;As of the Effective Time, (i)&nbsp;the Acquired Entities will have good and marketable title
to, and will own, directly or indirectly, all of the Related Subsidiary Ownership Interests,
beneficially and of record; (ii)&nbsp;the Related Subsidiary Ownership Interests will be free and clear
of all Encumbrances, (iii)&nbsp;the Acquired Entities will have full voting power over the Related
Subsidiary Ownership Interests, subject to no proxy, shareholders&#146; agreement, voting trust or other
agreement relating to the voting of any of the Related Subsidiary Ownership Interests, and (iv)
other than this Agreement and any Contract identified in <U>Exhibit&nbsp;A-5</U>, there will be no
agreement between LifePoint or any of its subsidiaries and any other Person with respect to the
disposition of the Related Subsidiary Ownership Interests (provided, however, that if the existence
of the Contracts identified in <U>Exhibit&nbsp;A-5</U>, the consummation of the transactions
contemplated thereby, or the performance of the obligations thereunder will, individually or
collectively, cause any of the requirements set forth in <U>Section&nbsp;5.8</U> necessary for such
Person to be a Related Subsidiary fail to be satisfied with respect to the applicable Person then
such entity will not be a Related Subsidiary.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;As of the Effective Time, except veto rights and super-majority approval rights held by
the holders of such ownership interests which are consistent with comparable arrangements of
LifePoint and its Affiliates in similar entities that are not wholly owned by LifePoint,, (i)&nbsp;no
Person will have any preemptive right to purchase any equity security in any of the Related
Subsidiaries, and (ii)&nbsp;other than the Related Subsidiary Ownership Interests and the other
ownership interests disclosed in accordance with clause (g)(iv), above, there will be no
outstanding equity securities in any of the Related Subsidiaries giving the owner or holder

<P align="center" style="font-size: 10pt">30
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">thereof the right to vote on any matters on which shareholders, partners or members of the
applicable Related Subsidiary may vote.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.4 <U>Dispositions</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <U>Exhibit&nbsp;B-1</U> sets forth (i)&nbsp;the list of all Disposed Entities; and (ii)&nbsp;a summary
of each Disposition of a Disposed Entity which includes, without limitation, (A)&nbsp;the name of the
purchaser in each such Disposition, (B)&nbsp;a description of each Disposed Entity in such Disposition,
and (C)&nbsp;all information necessary to calculate the Disposition Amount with respect to each Disposed
Entity.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <U>Exhibit&nbsp;B-2</U> sets forth (i)&nbsp;the list of all Disposed Assets; and (ii)&nbsp;a summary of
each Disposition of Disposed Assets which includes, without limitation, (A)&nbsp;the name of the
purchaser in each such Disposition, (B)&nbsp;a description of each Disposition transaction, (C)&nbsp;the book
value of the Disposed Assets, and (D)&nbsp;the Net Book Value of the Disposed Assets as of the date of
such Disposition.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <U>Exhibit&nbsp;B-3</U> sets forth (i)&nbsp;the list of all Disposed Ownership Interests; and (ii)
a summary of each Disposition of a Disposed Ownership Interests which includes, without limitation,
(A)&nbsp;the name of the Acquired Entity whose Ownership Interests were disposed in such Disposition,
(B)&nbsp;the name of each purchaser in such Disposition, and (C)&nbsp;all information necessary to calculate
the Disposition Amount with respect to each Disposed Ownership Interest.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.5 <U>Authorization</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The execution, delivery and performance by LifePoint of this Agreement and by LifePoint of
the other agreements to be entered into by it pursuant to the terms of this Agreement, and the
consummation by LifePoint of the transactions contemplated hereby and thereby are within
LifePoint&#146;s corporate powers, are not in contravention of the terms of LifePoint&#146;s Constituent
Documents, and have been duly authorized and approved by the board of directors of LifePoint. No
other corporate proceedings on the part of LifePoint are necessary to authorize the execution,
delivery and performance of this Agreement or the other agreements to be entered into by LifePoint
pursuant to the terms of this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;This Agreement has been duly and validly executed and delivered by LifePoint. As of the
Closing, the other agreements and Closing documents to be entered into by LifePoint pursuant to the
terms of this Agreement will have been duly and validly executed and delivered by LifePoint. This
Agreement constitutes (and upon their execution and delivery by LifePoint, the other agreements and
Closing documents to be entered into pursuant to the terms of this Agreement by LifePoint will
constitute) the legal, valid and binding obligations of LifePoint, enforceable against LifePoint in
accordance with their respective terms (assuming the valid authorization, execution and delivery
hereof and thereof by Purchaser), subject to bankruptcy, insolvency, reorganization, moratorium and
similar Laws of general application relating to or affecting creditors&#146; rights and to general
principles of equity, including principles of commercial reasonableness, good faith and fair
dealing.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.6 <U>No Conflicts</U>. Neither the execution and delivery of this Agreement or any of the
other agreements to be entered into by LifePoint, any Seller or any Acquired Entity pursuant to
</DIV>

<P align="center" style="font-size: 10pt">31
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">the terms of this Agreement nor the consummation of any of the transactions contemplated
hereby or thereby will violate, conflict with or result in a breach of the terms of the respective
Constituent Documents of LifePoint, any Seller or any of the Acquired Entities.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.7 <U>No Missing Assets</U>. The Facilities include (a)&nbsp;all of the Initial Facilities and
other ancillary businesses that were owned or operated by any of the Initial Acquired Entities
(other than the Clinch Valley Entities) as of the SPA Effective Time other than those that were
owned by a Disposed Entity or that otherwise have been sold, transferred or disposed of in a
Disposition that, in any such case, is listed in <U>Exhibit&nbsp;B-1</U> or <U>B-2</U>, and (b)&nbsp;all
other businesses and facilities that LifePoint or any of its Affiliates has acquired or developed
in the Territory during the Holding Period, including all ambulatory surgery centers, imaging and
diagnostic centers, psychiatric care hospitals, clinical laboratories, clinics, home health
agencies, durable medical equipment suppliers and all other related healthcare businesses, except
any such acquired or developed business or facility that LifePoint or its Affiliates has sold or
terminated prior to the Effective Time. Except for the Excluded Assets, the Acquired Entities
shall hold all right, title and interest then held by LifePoint or any of its Affiliates, whether
ownership, by virtue of contractual rights or otherwise, in all assets, tangible and intangible,
real and personal, used by LifePoint or its Affiliates in connection with operating the Business
and the Facilities (including the following (but nothing herein shall be deemed to include the
Excluded Assets): the Real Property, the personal property described in <U>Section&nbsp;3.11(a)</U>,
the Books and Records, the Contracts, the Acquired Company Ownership Interests, the Acquired
Subsidiary Ownership Interests, the Related Company Ownership Interests, the Related Subsidiary
Ownership Interests, the Permits and the Intellectual Property). The assets and contractual rights
described in this <U>Section&nbsp;3.7</U> which will be held by the Acquired Entities at the Effective
Time are sufficient for the continued conduct of the Business after Closing in substantially the
same manner as conducted prior to the Closing other than assets related to (i)&nbsp;the business
functions provided by HCA through the Services Agreements and the Computer and Data Processing
Agreement (as such terms are defined in the SPA), (ii)&nbsp;other services normally provided by the
LifePoint corporate, division and regional offices (including group purchasing and other corporate
or centrally provided services), and (iii)&nbsp;the Excluded Contracts.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.8 <U>Contracts</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <U>Schedule&nbsp;3.8(a)</U> hereto sets forth a complete and accurate list of all material
Contracts. Contracts which are material shall include, but not be limited to any contract: to which
a party thereto is a referral source (including physicians) to any Facility; which involves an
expenditure of greater than $50,000 per contract per year; which is not cancelable upon less than
120&nbsp;days notice during the remaining term and upon cancellation without penalty, payment or
obligation; which an Acquired Entity is bound by a covenant not to compete; which is an employment
agreement; and which is a joint venture or partnership agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;As of the Effective Time, each material Contract that was in place as of the SPA Effective
Time and is still in place as of the Effective Time will be valid, binding and enforceable in all
material respects (after giving effect to the closing of the SPA Transaction), subject, in each
case, to bankruptcy, insolvency, reorganization, moratorium and similar Laws of general application
relating to or affecting creditors&#146; rights and to general principles of equity, including
principles of commercial reasonableness, good faith and fair dealing. As of the

<P align="center" style="font-size: 10pt">32
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Effective Time, each other material Contract that is in place as of the Effective Time will be
valid, binding and enforceable in all material respects against LifePoint or the applicable
Acquired Entity, subject, in each case, to bankruptcy, insolvency, reorganization, moratorium and
similar Laws of general application relating to or affecting creditors&#146; rights and to general
principles of equity, including principles of commercial reasonableness, good faith and fair
dealing. As of the Effective Time, each Acquired Entity shall have duly performed in all material
respects its obligations under each material Contract to which it is a party (to the extent that
such obligations to perform shall have accrued during the Holding Period).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;As of immediately prior to the Effective Time, neither LifePoint nor its Affiliates will
be in material default (nor would they be in material default with notice or lapse of time or both
as a result of events that have occurred) under any material Contract, except to the extent of any
material default existing as of the SPA Effective Time (after giving effect to the closing of the
SPA Transaction).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;As of the Effective Time, none of the Acquired Entities will have any outstanding purchase
commitments in excess of its respective ordinary business requirements.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;As of the Effective Time, except for (i)&nbsp;encumbrances that exist on any of the Contracts
as of the Effective Time, and (ii)&nbsp;Permitted Encumbrances, no Encumbrance will exist on any
interest created under any of the Contracts.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.9 <U>Other Receivables</U>. The Other Receivables included in the Closing Date Balance
Sheet, to the extent uncollected as of the Effective Time, are valid and existing and represent
monies due for goods sold and delivered, services performed and/or other consideration given in the
ordinary course of business; provided that LifePoint makes no representation or warranty with
respect to the collectibility of the Other Receivables.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.10 <U>Real Property</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;As of the Effective Time, the Real Property shall be accurately described in <U>Schedule
3.10(a)</U> and include all real estate used or held for use in connection with the Business as of
the Effective Time.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;As of the Effective Time, all title, leasehold interests and other rights held by
LifePoint or its Affiliates with respect to the Real Property will be held by the Acquired
Entities.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;As of the Effective Time, (i)&nbsp;none of the Real Property that was not a part of in the
&#147;Real Property&#148; as of the SPA Effective Time shall be subject to any Encumbrance other than a
Permitted Encumbrance, and (ii)&nbsp;neither LifePoint nor any of its Affiliates shall have allowed the
creation of, suffered, assumed, or agreed to any Encumbrance (other than Permitted Encumbrances) on
any of the Real Property that was included in the &#147;Real Property&#148; (as defined in the SPA) as of the
SPA Effective Time.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;As of the Effective Time, none of the Real Property, the buildings or the improvements
situated thereon will be in material violation of any zoning or land use ordinances and regulations
applicable thereto or to the ownership or operation thereof except, in the case of

<P align="center" style="font-size: 10pt">33
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Real Property that was included in the &#147;Real Property&#148; (as defined in the SPA) as of the SPA
Effective Time, to the extent they were in violation of such ordinances or regulations as of the
SPA Effective Time (after giving effect to the closing of the SPA Transaction); provided, however,
that LifePoint makes no representation or warranty with respect to such violations to the extent
that the violations result from changes in such ordinances or regulations during the Holding Period
other than at the request of LifePoint or its Affiliates. As of the Effective Time, except, in the
case of buildings and improvements owned by the Initial Acquired Entities as of the SPA Effective
Time, to the extent they were not in compliance as of the SPA Effective Time (after giving effect
to the closing of the SPA Transaction), the buildings and improvements constituting the Facilities
on the Real Property will be in material compliance with all applicable public health, fire safety
or building codes and regulations; provided, however, that LifePoint makes no representation or
warranty with respect to such compliance to the extent that non-compliance results from changes in
such codes or regulations during the Holding Period other than at the request of LifePoint or its
Affiliates. As of the Effective Time, certificates of occupancy and/or use required (i)&nbsp;as a
result of acts of the Acquired Entities during the Holding Period, or (ii)&nbsp;with respect to
properties that were not leased, occupied or owned by the Initial Acquired Entities as of the SPA
Effective Time shall been duly issued by the applicable Governmental Authority having jurisdiction
for all of the Facilities.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;As of the Effective Time, LifePoint shall not have caused any of the Real Property that
was included in the &#147;Real Property&#148; (as defined in the SPA) as of the SPA Effective Time to be
subject to any conditions, restrictions, ordinances, or other limitations, other than those that
existed on the Initial Closing Date that would make such property unusable for its then current use
or the title to such property unmarketable, or which materially restrict or impair the then current
use of such Real Property; provided, however, that LifePoint makes no representation or warranty
with respect to such matters to the extent that they result from changes in such restrictions,
ordinances or other limitations during the Holding Period other than at the request of LifePoint or
its Affiliates. As of the Effective Time, none of the Real Property that was not included in the
&#147;Real Property&#148; (as defined in the SPA) as of the SPA Effective Time will be subject to any
conditions, restrictions, ordinances, or other limitations that would make such property unusable
for its then current use or the title to such property unmarketable, or which materially restrict
or impair the then current use of such Real Property; provided, however, that LifePoint makes no
representation or warranty with respect to such matters to the extent that they result from changes
in such restrictions, ordinances or other limitations since the acquisition of such Real Property
other than at the request of LifePoint or its Affiliates.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;As of the Effective Time, (i)&nbsp;all utilities serving the Real Property shall be installed
and operating, and shall be adequate to operate the Real Property in the manner it is then operated
(except, in the case of Real Property that was included in the &#147;Real Property&#148; (as defined in the
SPA) as of the SPA Effective Time, to the extent of any inadequacies that existed as of the SPA
Effective Time after giving effect to the closing of the SPA Transaction); and (ii)&nbsp;any tap fees,
hook-up fees or other associated charges that accrued during the Holding Period shall have been
fully paid with respect to all potable and industrial water and all gas, electrical, steam,
compressed air, telecommunication, sanitary and storm sewage lines and systems and other similar
systems serving the Facilities except as reflected in the Closing Date Balance Sheet.
</DIV>


<P align="center" style="font-size: 10pt">34
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;As of the Effective Time, there will be no outstanding options to purchase, rights of
first offer, rights of first refusal or any similar rights to purchase any parcel of the Real
Property owned by the Acquired Entities, or any portion thereof or interest therein not shown by
the Title Work or the Contracts or Leases; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;Except as set forth in each Lease or the Title Work, (i)&nbsp;none of the Leases under which an
Acquired Entity is the lessor is subject to any option to renew, options to purchase, rights of
first refusal, rights of first offer or any similar rights that were created during the Holding
Period; and (ii)&nbsp;as to any of the Leases under which an Acquired Entity is the lessor (a)&nbsp;which
Leases were entered into or amended during the Holding Period, no tenant is entitled to any rebate,
concession or free rent, other than as set forth in the Lease or Contract with such tenant; and no
commitments have been made to any tenant for material repairs or improvements other than for normal
repairs and maintenance in the future except as otherwise provided in the Lease or Contract and (b)
the Acquired Entity&#146;s obligations as lessor for any such commitments for material repairs or
improvements in the future that have accrued as of the Effective Time will have been fully
performed; and no rents due under any leases with tenants have been assigned or hypothecated to, or
encumbered by, the lessor which have not been released by the Effective Time.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.11 <U>Personal Property</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;As of the Effective Time, the Acquired Entities will be in possession of and will have
good title to, or will have valid leasehold interests in or valid rights under contract to use,
free and clear of any Encumbrance (other than Permitted Encumbrances), all of the personal property
used by LifePoint or any of its Affiliates at that time in the conduct of the Business, including
all Books and Records, other than the Excluded Assets and Excluded Contracts.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;As of the Effective Time, there will be no outstanding rights (including purchase options,
rights of first refusal, rights of first offers), agreements or other commitments (other than
rights agreements or commitments that existed as of the Effective Time) that give any Person a
current or future right to require the Acquired Entities to sell or transfer to a third party any
material interests in the personal property owned by them.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.12 <U>Employees; Labor Matters; Company Plans; ERISA</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) &#091;Reserved.&#093;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <U>Schedule&nbsp;3.12(b)</U> contains a list of each Company Plan. There is no Multiemployer
Plan under which any employee of the Business has any present or future right to benefits or under
which any Acquired Entity has any present or future liability. For each Company Plan that is a
&#147;defined benefit plan,&#148; as defined in Section 414(j) of the Code (collectively, the &#147;<U>Pension
Plans</U>&#148;), the funded status of each Pension Plan is disclosed on <U>Schedule&nbsp;3.12(b)</U> in a
manner consistent with the Statement of Financial Accounting Standards No.&nbsp;87 (&#147;<U>FAS 87</U>&#148;)
prepared by the Financial Accounting Standards Board. With respect to any Company Plans that are
subject to the minimum funding requirements of Code Section&nbsp;412, such requirements have been
satisfied, there are no accumulated funding deficiencies, and no funding

<P align="center" style="font-size: 10pt">35
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">waiver has been applied for since the Initial Closing Date. There is no Pension Plan under
which any employee of the Business or any Acquired Entity has any present or future right to
benefits. No Acquired Entity has any present or future liability with respect to any Pension Plan.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Any contributions, including salary deferrals, required to be made under the terms of the
Company Plans as of the date of this Agreement have been made in a timely fashion.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Except as provided in <U>Schedule&nbsp;3.12(d)</U>, no Company Plans provide for, and no
written or oral agreements have been entered into promising or guaranteeing, the continuation of
medical, dental, vision, life or disability insurance coverage for any employees of the Acquired
Entities or their beneficiaries for any period of time beyond the earlier of (i)&nbsp;the end of the
plan year which includes the Closing Date or (ii)&nbsp;the termination of employment (except to the
extent of coverage required under Title I, Part&nbsp;6 of ERISA (&#147;<U>COBRA</U>&#148;)). The Company Plans
are in material compliance with the continuation coverage provisions of COBRA. As promptly as
possible after the execution of this Agreement, LifePoint shall make available for review and copy
by Purchaser of each Company Plan listed on <U>Schedule&nbsp;3.12(d)</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) <U>Schedule&nbsp;3.12(e)</U> lists all written employment contracts and agreements relating to
the Facilities that provide for employment for a term or restrictions upon LifePoint&#146;s right to
terminate employment without any post-termination payment obligation. No employment agreement
(including, without limitation, any professional services agreement or recruiting agreement listed
on <U>Schedule&nbsp;3.8(a)</U>) creates or modifies any Company Plan or promises to provide benefits
that cannot be terminated by LifePoint, the Acquired Entities, or the Purchaser without the prior
consent of the other party thereto and without prior notice.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;Except as described in <U>Schedule&nbsp;3.12(b)</U>, no Company Plan has any unfunded
liabilities with respect to any employee of the Business for which the Acquired Entities have any
responsibility or liability, other than for salary contributions made pursuant to Section 401(k) of
the Code that have been withheld from employees&#146; compensation but may not have been deposited to
such Plan as of the date of the Closing.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;To LifePoint&#146;s Knowledge, any Company Plan subject to the qualification requirements of
Section 401(a) or 501(a) of the Code is in compliance with such qualification requirements.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.13 <U>Government Program Participation/Accreditation</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;As of the Effective Time, each of the Facilities that has historically received Medicare
or Medicaid reimbursement will be eligible to receive payment without restriction under Title XVIII
of the Social Security Act (&#147;<U>Medicare</U>&#148;) and Title XIX of the Social Security Act including
under any experimental, pilot or demonstration project(s) implemented pursuant to Section&nbsp;1115 of
the Social Security Act and generally applicable to similar acute care hospitals in the State of
West Virginia (&#147;<U>Medicaid</U>&#148;) and will be a &#147;provider&#148; with valid and then current provider
agreements and with one or more provider numbers with the federal Medicare, all applicable state
Medicaid and successor programs (the &#147;<U>Government Programs</U>&#148;) through intermediaries, and a
complete list of all Part&nbsp;A and Part&nbsp;B provider numbers is included in
</DIV>


<P align="center" style="font-size: 10pt">36
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><U>Schedule&nbsp;3.13(a)</U>. As of the Effective Time, each of the Facilities that has
historically received payments under Tricare or its predecessor or successor programs will be a
&#147;provider&#148; with valid and then current provider agreements and with one or more provider numbers
with Tricare and successor programs through intermediaries. As of the Effective Time, each of the
Facilities will be in compliance with the conditions of participation for the Government Programs
in all material respects (except to the extent of any non-compliance that existed as of the SPA
Effective Time). As of the Effective Time, there will not be any pending proceedings or
investigations under the Government Programs involving the Business or any of the Acquired Entities
related to the operation of Business during the Holding Period.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;As of the Effective Time, the Acquired Entities shall have filed and caused to be filed
all cost reports for cost reporting periods ended after the SPA Effective Time and all other
material reports with respect to such cost reporting periods that are required by Law or contract
to have been filed or made as of that time with respect to the purchase of services of the
Facilities by third party payors, including Government Programs and other insurance carriers. As
of the Effective Time, the Acquired Entities shall be, and during the Holding Period shall have
been, in material compliance with filing requirements with respect to cost reports of the
Facilities for cost reporting periods ended after the SPA Effective Time, and such reports will not
claim, and none of the Facilities shall have received, payment or reimbursement in excess of the
amount provided by applicable law or any applicable agreement with respect to such periods, except
where excess reimbursement was noted on the cost report.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;As of the Effective Time, all of LifePoint&#146;s billing practices with respect to the
Facilities (with respect to cost reporting periods ended after the SPA Effective Time and at or
before the Effective Time) to all third party payors, including the Government Programs and private
insurance companies, shall have been and will be in compliance in all material respects with all
applicable Laws, regulations and polices of such third party payors and Government Programs. As of
the Effective Time, the Facilities shall not have billed or received any payment or reimbursement
in excess of amounts allowed by Law with respect to the Holding Period or cost reporting periods
ended after the SPA Effective Time and at or before the Effective Time.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;As of the Effective Time, each of the Hospitals and other Facilities for which such
accreditation is available will be duly accredited with no material contingencies by the JCAHO.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;As of the Effective Time, to LifePoint&#146;s knowledge as of such time (following its ordinary
practice), (i)&nbsp;no then current employee of the Business shall have been excluded from participating
in any federal health care program (as defined in 42 U.S.C. &#167;1320a-7b(f)) and (ii)&nbsp;none of the
Facilities, or the Acquired Entities&#146; then current officers, directors, governing board members,
agents or managing employees (as such term is defined in 42 U.S.C. &#167;1320a-5(b)) shall have been
excluded from Medicare or any federal health care program (as defined in 42 U.S.C. &#167;1320a-7b(f)) or
been subject to sanction pursuant to 42 U.S.C. &#167;1320a-7a or 1320a-8 or been convicted of a crime
described at 42 U.S.C. &#167;1320a-7b.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.14 <U>Taxes</U>.
</DIV>

<P align="center" style="font-size: 10pt">37
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;As of the Effective Time, LifePoint will have duly filed or caused to be filed in a timely
manner (taking into account all extensions of due dates) with the appropriate Governmental
Authorities all Returns for which LifePoint is responsible under the SPA and which are required to
be filed by or on behalf of the Acquired Entities on or before the Effective Time. All such
Returns will be correct and complete in all material respects. All Taxes of the Acquired Entities
whether or not shown to be due on such Returns filed during the Holding Period will have been paid
in full within the time permitted under the Code or applicable Laws. As of the Effective Time,
there will be no material Encumbrances on any of the assets of the Acquired Entities with respect
to Taxes, other than Permitted Encumbrances. As of the Effective Time, all Taxes (other than
Income Taxes) will have been properly and fully accrued through the Effective Time.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;With respect to State Tax liabilities of the Acquired Entities, as of the Effective Time,
(i)&nbsp;no material deficiencies for State Taxes will have been claimed, proposed or assessed in
writing by any state and local Governmental Authority for which the Acquired Entities may have any
liability, (ii)&nbsp;there will be no pending or threatened audits, investigations or claims for or
relating to any material liability in respect of State Taxes of which LifePoint has Knowledge based
upon personal contact with any agent of such state and local Governmental Authority, and (iii)
there will be no matters under discussion by LifePoint with any state and local Governmental
Authorities with respect to State Taxes that may result in a material additional amount of State
Taxes for which the Acquired Entities may have any liability.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Except with respect to obligations of any Acquired Entity in existence as of the closing
SPA Effective Time, as of the Effective Time, none of the Acquired Entities will have made any
payments, will be obligated to make any payments, or will be a party to any agreement that under
certain circumstances could obligate it to make any payments that (i)&nbsp;would be considered &#147;excess
parachute payments&#148; under Code Section&nbsp;280G (or any corresponding provision of state or local law),
(ii)&nbsp;that will not be deductible under Code Section&nbsp;280G (or any corresponding provision of state
or local law), or (iii)&nbsp;that would not be fully deductible as a result of Code Section 162(m) (or
any corresponding provision of state or local law). As of the Effective Time, no consent under
Code Section 341(f) concerning collapsible corporations will have been filed by or on behalf of the
Acquired Entities and none of the Acquired Entities will have been a United States real property
holding corporation within the meaning of Code Section&nbsp;897(c)(2) during the applicable period
specified in Code Section&nbsp;897(c)(1)(A)(ii).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;As of the Effective Time, none of the Acquired Entities will have any liability for the
Taxes of any Person other than the Acquired Entities or other members of the LifePoint Affiliated
Group under Treas. Reg. Section&nbsp;1.1502-6 (or any similar provision of state, local or foreign
law), as a transferee or successor for any tax periods ending after the Effective Time.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;As of the Effective Time, no statute of limitations in respect of Taxes (other than
Federal Income Taxes) will have been waived and no extension of time with respect to a Tax
assessment or deficiency (other than Federal Income Taxes) will have been agreed to by or on behalf
of the Acquired Entities.
</DIV>


<P align="center" style="font-size: 10pt">38
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.15 <U>Inventory</U>. As of the Effective Time, the inventory, supplies, food,
pharmaceuticals, janitorial and office supplies and other similar disposables located at the
Facilities and reflected on the Closing Date Balance Sheet will be of a quality and quantity
useable in the Business in the ordinary course of business, except to the extent of reserves
reflected in the Net Working Capital as of the Effective Time.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.16 <U>Intellectual Property</U>. As of the Effective Time, each Acquired Entity shall own
or have the right to use all patents, trademarks, trade names, service marks, trade secrets,
copyrights and other intellectual property rights and licenses as are necessary to conduct the
Business as then conducted (the &#147;<U>Intellectual Property</U>&#148;).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.17 <U>Permits; Compliance With Laws</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;As of the Effective Time, the Acquired Entities will have all material Permits necessary
for the conduct of the Business and the operation of the Facilities as then conducted. As of the
Effective Time, each Acquired Entity will be the duly authorized holder of such Permits. As of the
Effective Time, each Facility&#146;s pharmacies, laboratories and all other material ancillary
departments located at such Facility or operated for the benefit of such Facility (and which are
owned or operated by any LifePoint Affiliate), which is required to be specially licensed, will be
licensed by the appropriate Governmental Authority.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;As of the Effective Time, each Facility will be in material compliance with all Permits
required by Law. As of the Effective Time, there will be no provisions in, or agreements relating
to, any such Permits which preclude or limit in any material respect any Acquired Entity from
operating any of the Facilities as then operated. As of the Effective Time, all of the material
Permits will be in good standing.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;As of the Effective Time, the Acquired Entities will be, and since the SPA Effective Time
shall have been, in material compliance with all Laws of any Governmental Authority having
jurisdiction over the Business or the assets of the Acquired Entities.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;No representation or warranty is made with respect to the Facilities&#146; compliance with the
requirements of the Americans with Disabilities Act.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.18 <U>Environmental Conditions</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;As of the Effective Time, each of the Acquired Entities will be in material compliance
with all Environmental Laws. As of the Effective Time, all operations or activities upon, or any
use, occupancy or operation of the Real Property, or any portion thereof by LifePoint or its
Affiliates will be (and during the Holding Period shall have been) performed or carried on in
material compliance with all Environmental Laws;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;As of the Effective Time, no Acquired Entity shall have stored, manufactured, used,
generated or dumped any Hazardous Substances on, in, under or upon any of the Real Property since
the SPA Effective Time, except for uses and temporary storage of Hazardous Substances reasonably
necessary to the customary operation of a general acute care hospital in material compliance with
applicable Environmental Laws (including the presence of asbestos maintained in compliance with
applicable Environmental Laws);
</DIV>


<P align="center" style="font-size: 10pt">39
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;As of the Effective Time, no Acquired Entity shall have disposed of, discharged or
released any Hazardous Substances on, in, under or upon, or from any of the Real Property since the
SPA Effective Time, except for uses and temporary storage of Hazardous Substances reasonably
necessary to the customary operation of a general acute care hospital in material compliance with
applicable Environmental Laws (including the presence of asbestos maintained in compliance with
applicable Environmental Laws);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;As of the Effective Time, no material work, repairs, remedy, construction or capital
expenditures will be required by any Environmental Laws that were not required as of the SPA
Effective Time with respect to the Real Property in order for the continued lawful use of the Real
Property as used throughout the Holding Period; provided however that LifePoint makes no
representation or warranty with respect to such matters to the extent that they result from changes
in Environmental Laws during the Holding Period.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;As of the Effective Time, each of the Acquired Entities will be in material compliance
with OSHA requirements respecting friable asbestos, if any, located on the Real Property, or any
portion thereof and in this regard, as of the Effective Time, each Acquired Entity shall have
properly implemented an operations and maintenance training program (&#147;<U>O &#038; M Program</U>&#148;) where
required for certain of its employees in the proper handling and removal of asbestos, except to the
extent that the inability of an Acquired Entity to do so is the result of its failure to have
properly implemented an O &#038; M Program where required prior to the SPA Effective Time;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;As of the Effective Time, no portion of the Real Property shall have been used as a
landfill, garbage or refuse dump site, waste disposal facility, transfer station or other type of
facility for the processing, treatment or disposal of waste materials since the SPA Effective Time
other than in material compliance with applicable Environmental Laws;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;Promptly after delivery of the Unwind Notice, LifePoint shall notify Purchaser in writing
of any order, notice of violation or noncompliance with any applicable Environmental Laws, or
order, threatened or pending action by any regulatory agency or other Governmental Authority, or
any claims made by any third party, in each case, of which it is aware, relating to Hazardous
Substances on, emanations on or from, releases on or from, or threats of releases on or from any of
the Real Property which relate to the period prior to Closing; and shall promptly furnish Purchaser
with copies of any correspondence, notices, or legal pleadings in connection therewith; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;As of the Effective Time, all above or underground storage tanks then operated on any of
the Real Property by the Acquired Entities will be in compliance in all material respects with
applicable Environmental Laws.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.19 <U>Legal Proceedings, Court Orders</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <U>Schedule&nbsp;3.19(a)</U> contains an accurate list of and summary description of all
material litigation filed since the SPA Effective Time with respect to the Facilities, the Business
and the Acquired Entities to which LifePoint and its Affiliates are a party. Other than as set
forth in <U>Schedule&nbsp;3.19(a)</U>, there are no material actions, suits, proceedings, audits or

<P align="center" style="font-size: 10pt">40
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">investigations pending, which have been filed since the SPA Effective Time or to the Knowledge
of LifePoint, threatened against LifePoint or any of its Affiliates with respect to the Facilities,
the Business or the Acquired Entities which could reasonably be expected to result in a Hospital
Group Material Adverse Effect or materially impair the ability of LifePoint to perform its
obligations hereunder or under the other agreements contemplated hereby to be entered into by
LifePoint or could reasonably be expected to delay or prevent the consummation of the transactions
contemplated hereby or thereby. <U>Schedule&nbsp;3.19(a)</U> contains an accurate list of and summary
description of the status and disposition of all material litigation in existence on the SPA
Effective Time.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Neither LifePoint nor any Acquired Entity is subject to any Court Order with respect to
the Facilities, the Business or the Acquired Entities.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.20 <U>Insurance</U>. <U>Schedule&nbsp;3.20</U> includes a list of all material insurance
policies maintained by or for the benefit of any Facility or Acquired Entity, including fire and
extended coverage and casualty, professional liability, general liability and other forms of
insurance. All of such policies are valid, outstanding, in full force and effect, and enforceable
with no premium arrearages. Except as set forth on <U>Schedules 3.20(i)</U> and <U>(ii)</U>, (i)
there is no outstanding written requirement or recommendation by any insurance company that issued
any such policy or by any board of fire underwriters or other similar body (including any
Governmental Authority) exercising similar functions prepared and delivered during the Holding
Period which requires or recommends any repairs or other work to be done or with respect to any of
the Facilities, (ii)&nbsp;LifePoint has given to its insurer in a timely manner all notices required to
be given under its insurance policies with respect to all claims and actions covered by insurance
with respect to the Business and the assets thereof, and no insurer has denied coverage of any such
claims or actions or reserved its rights with respect to or rejected any such claims, and (iii)
LifePoint has not as of the date of this Agreement (A)&nbsp;received any notice or other written
communication from any such insurance company canceling or materially amending any of said
insurance policies with respect to the Business or its assets, and to the knowledge of LifePoint no
such cancellation or amendment is threatened, or (B)&nbsp;failed to give any required notice or present
any claim which is still outstanding under any of said policies with respect to the Business or its
assets.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.21 <U>Brokers</U>. Neither LifePoint nor any of its Affiliates has paid or become
obligated to pay any fee or commission to any broker, finder or intermediary for or on account of
the transactions contemplated by this Agreement.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE IV</B>
</DIV>

<DIV align="center" style="font-size: 10pt"><B>REPRESENTATIONS AND WARRANTIES OF PURCHASER</B></DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchaser represents and warrants to LifePoint, which representations and warranties shall be
true and correct as of the date hereof and as of the Closing as if then restated (except to the
extent such representations and warranties specifically speak only as of one of those dates or
specifically speak as of another date, in which case as of such date), as follows:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.1 <U>Organization</U>. Purchaser is a corporation duly organized, validly existing and in
good standing under the Laws of the State of Delaware.
</DIV>

<P align="center" style="font-size: 10pt">41
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.2 <U>Corporate Authorization</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The execution, delivery and performance by Purchaser of this Agreement and the other
agreements to be entered into by Purchaser pursuant to this Agreement, and the consummation by
Purchaser of the transactions contemplated hereby and thereby are within Purchaser&#146;s corporate
powers, are not in contravention of the terms of Purchaser&#146;s Constituent Documents, and have been
duly authorized and approved by the board of directors of Purchaser. No other corporate
proceedings on the part of Purchaser are necessary to authorize Purchaser&#146;s execution, delivery and
performance of this Agreement or the other agreements to be entered into by Purchaser pursuant to
this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;This Agreement has been duly and validly executed and delivered by Purchaser, and as of
the Closing, the other agreements to be entered into by Purchaser pursuant to the terms of this
Agreement will have been duly and validly executed and delivered by Purchaser. This Agreement
constitutes, and upon their execution and delivery, such other agreements will constitute, the
legal, valid and binding obligations of Purchaser, enforceable against Purchaser in accordance with
their respective terms (assuming the valid authorization, execution and delivery hereof and thereof
by LifePoint, the Seller Group and any other unaffiliated entity that is a party thereto), subject,
in each case, to bankruptcy, insolvency, reorganization, moratorium and similar Laws of general
application relating to or affecting creditors&#146; rights and to general principles of equity,
including principles of commercial reasonableness, good faith and fair dealing.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.3 <U>No Conflicts</U>. Neither the execution and delivery of this Agreement or any of the
other agreements to be entered into by Purchaser pursuant to this Agreement nor the consummation of
any of the transactions contemplated hereby or thereby will violate, conflict with or result in a
breach of the terms of the Constituent Documents of Purchaser.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.4 <U>Legal Proceedings, etc</U>. There are no material actions, suits or proceedings
pending or, to the Knowledge of Purchaser, threatened against Purchaser which would materially and
adversely affect the financial condition or operations of Purchaser or materially impair the
ability of Purchaser to perform its obligations hereunder or under the other agreements
contemplated hereby to be entered into by Purchaser or could reasonably be expected to delay or
prevent the consummation of the transactions contemplated hereby or thereby.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.5 <U>Brokers</U>. Purchaser has not paid or become obligated to pay any fee or commission
to any broker, finder or intermediary for or on account of the transactions contemplated by this
Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.6 <U>Sufficient Resources</U>. Purchaser has sufficient financial resources, and at the
Closing Purchaser will possess sufficient funds, to permit Purchaser to deliver the Purchase Price
in accordance with <U>Section&nbsp;2.2(b)</U>, subject to satisfaction of the conditions precedent to
Purchaser&#146;s obligations to close the transactions contemplated by this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.7 <U>Solvency</U>. At the Effective Time, Purchaser will be solvent and able to pay its
debts as they become due and will not become insolvent or otherwise unable to pay its debts as
</DIV>

<P align="center" style="font-size: 10pt">42
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">they become due as a result of the consummation of the transactions contemplated by this
Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.8 <U>Investment Representations</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Purchaser is acquiring the Acquired Company Ownership Interests and the Related Company
Ownership Interests for its own account and not with a view to the distribution thereof within the
meaning of the Securities Act.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Except as set forth in this Agreement, Purchaser is not relying upon any representation or
warranty of LifePoint, any of its Affiliates or any of the officers, directors, employees, agents
or representatives thereof.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Purchaser has such knowledge and experience in financial and business matters as to be
capable of evaluating the merits and risks of purchasing the Acquired Company Ownership Interests
and to understand the risks of, and other considerations relating to, its purchase of the Acquired
Company Ownership Interests and the Related Company Ownership Interests.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Purchaser is aware that as of the Closing Date, (i)&nbsp;neither the Acquired Company Ownership
Interests, the Acquired Subsidiary Ownership Interests nor the Related Entity Ownership Interests
will have been registered under the Securities Act or any state&#146;s securities laws, and (ii)&nbsp;no
securities issued by any of the Acquired Entities will be subject to the reporting requirements of
the Exchange Act. Purchaser further understands that the certificates representing the Acquired
Company Ownership Interests, the Acquired Subsidiary Ownership Interests and the Related Company
Ownership Interests will include an appropriate legend to the effect that such securities have not
been registered under the Securities Act or any state&#146;s securities laws and that such securities
may not be sold or transferred except in compliance with the Securities Act and applicable state
securities laws.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE V</B>
</DIV>

<DIV align="center" style="font-size: 10pt"><B>COVENANTS OF LIFEPOINT</B></DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.1 <U>Regulatory Approvals</U>. From and after delivery of the Unwind Notice, LifePoint
will, and will cause the Acquired Entities to, (a)&nbsp;use commercially reasonable efforts to obtain,
as promptly as practicable, each of the Permits, approvals, authorizations and clearances of
Governmental Authorities that LifePoint believes it must obtain in order to satisfy its closing
conditions under <U>Section&nbsp;8.5(a)</U>, (b)&nbsp;provide such information and communications to
applicable Governmental Authorities necessary in connection with the foregoing or in connection
with the Purchaser&#146;s obtaining any Permits, approvals, authorizations and clearances of
Governmental Authorities or making any filings or declarations with Governmental Authorities in
accordance with <U>Section&nbsp;6.1</U> as such Governmental Authorities or Purchaser may reasonably
request, and (b)&nbsp;cooperate with Purchaser in obtaining or making, as soon as practicable, any
Permits, approvals, authorizations, clearances, filings and declarations of or with Governmental
Authorities that Purchaser is required to obtain pursuant to <U>Section&nbsp;6.1</U>. Additionally,
LifePoint will use commercially reasonable efforts to (i)&nbsp;make any required filing and to assist
Purchaser in making its filing of a pre-merger notification report form, if required pursuant to
the HSR Act,
</DIV>

<P align="center" style="font-size: 10pt">43
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">within 20&nbsp;days following the delivery of the Unwind Notice and to cause the waiting period
under the HSR Act to expire as soon as commercially practicable, and (ii)&nbsp;assist Purchaser in
filing the initial letter of intent and subsequent certificate of need applications to the extent
required under applicable state Law within 30&nbsp;days after the delivery of the Unwind Notice.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.2 <U>Conduct Prior to the Closing</U>. From occurrence of an Unwind Trigger Event until
Closing, except as directly relates to the CON Challenges, Unwind Trigger Event, Unwind Notice or
matters resulting therefrom or the effect of any shutdown, closure or suspension of operations
pursuant to <U>Section&nbsp;5.16</U>, or otherwise consented to or approved in writing by an authorized
officer of Purchaser or as contemplated by this Agreement:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;LifePoint shall not act or omit to act, and shall cause the Acquired Entities not to act
or omit to act, otherwise than in accordance with the following:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;None of the Acquired Entities shall amend its respective Constituent Documents;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;No change shall be made in the number or amount of authorized or issued capital stock,
partnership interests or membership interests of any of the Acquired Entities; nor shall any other
equity security of any kind be granted or issued by any of the Acquired Entities; nor shall any
Seller enter into or permit any of the Acquired Entities to enter into any other agreement with
respect to any equity security of the Acquired Entities;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;The Acquired Entities shall not declare or pay dividends or make any other distributions
in respect of their Ownership Interests, except as contemplated by or provided in <U>Section
5.7</U>;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)&nbsp;LifePoint will not make or enter into any commitment to make any capital expenditure at
the Facilities or otherwise on behalf of any Acquired Entity in an aggregate amount greater than
$50,000;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v)&nbsp;LifePoint will not change or permit any change to be made in any accounting policy,
practice or method of the Acquired Entities except any such changes as are required to conform to
modifications in generally accepted accounting principles;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi)&nbsp;The Acquired Entities will not (A)&nbsp;incur any indebtedness for borrowed money, other than
intercompany indebtedness which will be forgiven at Closing in accordance with <U>Section&nbsp;5.11</U>
hereof or included in the Indebtedness Adjustment Amount; (B)&nbsp;assume, guaranty, endorse or
otherwise become liable or responsible for the obligations of any Person other than another
Acquired Entity; (C)&nbsp;make any loans, advances or capital contributions to, or investments in, any
Person other than another acquired Entity, other than intercompany loans which will be forgiven at
Closing in accordance with <U>Section&nbsp;5.11</U> hereof; or (D)&nbsp;make any commitments to do any of
the foregoing;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vii)&nbsp;The insurance maintained with respect to the Facilities and the Business, or comparable
insurance, shall be maintained in full force and effect until the Effective Time;
</DIV>

<P align="center" style="font-size: 10pt">44
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(viii)&nbsp;No Acquired Entity shall terminate or amend any material Contract, Lease or other
agreement to which any Acquired Entity is a party, other than in the ordinary course of business;
and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ix)&nbsp;No Acquired Entity shall agree, whether in writing or otherwise, to take any of the
actions set forth above and not otherwise permitted by this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;LifePoint shall use commercially reasonable efforts not to act or omit to act, and shall
cause the Acquired Entities to use commercially reasonable efforts not to act or omit to act,
otherwise than in accordance with the following:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;The operations, activities and practices of the Business shall be conducted consistent
with the ordinary course of business and in conformity with past practice;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;The respective business organizations of the Acquired Entities will be preserved intact,
and the services of the present employees, agents and representatives of the Business will be kept
available for Purchaser (except with respect to those employees or relationships terminated for
cause); and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;The relationships with, and the goodwill of, the customers of the Business and others
having business relations with the Business will be preserved.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.3 <U>Employee Matters</U>. From the occurrence of an Unwind Trigger Event until Closing,
except as otherwise consented to or approved in writing by an authorized officer of Purchaser,
LifePoint will cause the Acquired Entities not to (a)&nbsp;make any general increase in the rate of
compensation payable to any employees of the Business, other than normal and customary increases
consistent with past practice or increases that otherwise may be required by obligations pursuant
to Contracts or applicable Law, or (b)&nbsp;increase severance or termination obligations to any
employees of the Business (except increases that are the result of increases to an employee&#146;s
underlying compensation that are permitted under this <U>Section&nbsp;5.3</U>). Neither LifePoint nor
any of its subsidiaries shall terminate any Pension Plan prior to the later of the day following
(i)&nbsp;the Closing or (ii)&nbsp;the Effective Time.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.4 <U>Investigation by Purchaser</U>. Between the delivery of the Unwind Notice and the
Closing Date, to the extent permitted by Law, LifePoint will provide Purchaser and its counsel,
accountants and other representatives with reasonable access to information, assets, employees,
Books and Records, etc. all on the same terms and conditions as set forth in <U>Section&nbsp;5.4</U> of
the SPA.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.5 <U>Reports and Pre-Closing Deliverables</U>.
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">(a)&nbsp;As soon as practicable following the end of each month, but no later than the 15th day of the
immediately succeeding month (and each fiscal year) from and after the delivery of the Unwind
Notice and prior to the Closing Date, LifePoint will deliver to Purchaser true and complete copies
of the Business&#146; unaudited balance sheets and the related unaudited statements of income for each
month (and each fiscal year) then ended. As soon as practicable following the delivery of an
Unwind Notice, LifePoint will deliver to Purchaser true and complete copies of the Business&#146;
unaudited balance sheets and the related unaudited statements of income for each month (and each
fiscal year) ended after the Initial Closing Date and during the Holding
</DIV>
<P align="center" style="font-size: 10pt">45
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Period. Such financial statements will be prepared from and in accordance with the Books and
Records of the Business, will be prepared in accordance with GAAP, subject to the exceptions set
forth in <U>Exhibit&nbsp;D</U> and will fairly present the Business&#146; financial position and results of
operations, as of the date and for the period indicated. To the extent the scope of the exceptions
to GAAP set forth in <U>Exhibit&nbsp;D</U> is broader than the scope of the exceptions to &#147;GAAP&#148; (as
defined in the SPA) listed in <U>Schedule&nbsp;3.6</U> to the SPA, LifePoint will cooperate with
Purchaser in all reasonable respects to provide analyses of the adjustments to the financial
statements provided under this <U>Section&nbsp;5.5(a)</U> necessary to conform such financial
statements to GAAP.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Reserved.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;As promptly as possible after the delivery of the Unwind Notice (or if any of the
following occurs after the delivery of an Unwind Notice, as promptly as possible following such
occurrence), LifePoint shall give Purchaser notice of any material damage, destruction or loss with
respect to the assets of any Hospital Group.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Within five Business Days after delivery of the Unwind Notice, LifePoint shall deliver to
Purchaser a list of (i)&nbsp;all material Permits issued or granted by a Governmental Authority and
owned or held by or issued to any LifePoint Affiliate in connection with the then current operation
of the Business; and (ii)&nbsp;a list of Permits LifePoint reasonably believes that it will need to have
received in order to satisfy its closing conditions under <U>Section&nbsp;8.5(a)</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;Within five (5)&nbsp;Business Days after the delivery of the Unwind Notice, LifePoint shall
deliver to Purchaser a list of all of the names, trade names or fictitious names under which the
Business has been operated for the last five years.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) (i)&nbsp;The parties acknowledge that none of the Exhibits and Schedules specifically
referenced or identified in this Agreement have been prepared or attached to this Agreement as of
the execution of this Agreement, except <U>Exhibits E and F</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;Within 20&nbsp;days after the delivery of the Unwind Notice, LifePoint shall deliver to
Purchaser (A)&nbsp;all other exhibits and schedules required by this Agreement, and (B)&nbsp;a schedule (the
&#147;<U>Disclosure Schedule</U>&#148;) in which LifePoint (i)&nbsp;will disclose any inaccuracies in or
exceptions to any of LifePoint&#146;s representations and warranties in this Agreement, and (ii)&nbsp;may
modify any of LifePoint&#146;s other representations and warranties in this Agreement (provided,
however, that the effect of any such modifications for purposes of LifePoint&#146;s indemnification
obligations and the conditions to HCA&#146;s obligation to close the transactions contemplated hereby
will be limited as contemplated in clause (iii), below) (such exhibits and schedules, including the
Disclosure Schedule, the &#147;<U>LifePoint Disclosure Documents</U>&#148;). Disclosures in each individual
exhibit or schedule required hereby will pertain solely to the representations and warranties made
in the sentences to which the applicable exhibit or schedule applies. Each matter disclosed in the
Disclosure Schedule will apply solely to the portions of the representations and warranties
specified in the Disclosure Schedule for such matter. The disclosure of any information in the
LifePoint Disclosure Schedules shall not be deemed to constitute an acknowledgment by LifePoint
that such information is required to be disclosed in connection with the representations and
warranties made by LifePoint in the Agreement or that it is material, nor shall such

<P align="center" style="font-size: 10pt">46
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">information be deemed to establish a level or standard of materiality for purposes of the
Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;For purposes of LifePoint&#146;s indemnification obligations under this Agreement and the
conditions to HCA&#146;s obligation to close the transactions contemplated hereby, any disclosure in the
LifePoint Disclosure Documents beyond the scope of the intended purposes of such LifePoint
Disclosure Documents will not be deemed to modify or amend any of LifePoint&#146;s representations or
warranties. In illustration (but not in limitation) of the foregoing:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)&nbsp;if the disclosure in the LifePoint Disclosure Documents is affirmatively permitted by a
covenant in this Agreement (such as selling ownership interests in an entity that owns a Hospital
in accordance with <U>Section&nbsp;5.8</U> or entering into Contracts which Purchaser can choose to
exclude pursuant to <U>Section&nbsp;5.14</U> ) or if disclosures are informational and do not disclose
matters that create adverse consequences, then such disclosures are within the scope of the
intended purposes of the LifePoint Disclosure Schedules;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B)&nbsp;disclosure in <U>Exhibits A-4</U> and <U>A-5</U> to the effect that (1)&nbsp;any of the
Related Entities is not duly organized, validly existing and in good standing under the laws of its
state of organization, (2)&nbsp;any of the Related Entities is not qualified to transact business to the
extent required by any Laws in any jurisdiction in which it has material operations or assets, (3)
such Related Entity will fail to satisfy any of the criteria set forth in <U>Section&nbsp;5.8</U>
necessary for such Person to be an Acquired Entity as of the Effective Time, or (4)&nbsp;any of the
representations and warranties made in Section&nbsp;3.3(a)(ii), the second sentence of Section&nbsp;3.3(b),
Sections&nbsp;3.3(c), 3.3(d), 3.3(e)(ii), the second sentence of Section&nbsp;3.3(f), Section&nbsp;3.3(g) or
Section&nbsp;3.3(h) is not true and correct in every respect (subject to the qualifiers included in such
representations and warranties) is not within the scope of the intended purposes of the LifePoint
Disclosure Schedules and will not be will not be deemed to modify or amend any of LifePoint&#146;s
representations or warranties for purposes of LifePoint&#146;s indemnification obligations under this
Agreement and the conditions to HCA&#146;s obligation to close the transactions contemplated hereby;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(C)&nbsp;disclosures in the following exhibits and schedules will be deemed to modify and amend
LifePoint&#146;s representations and warranties in the sentences to which such exhibits and schedules
apply: (1) <U>Exhibits A-1, A-2, A-3, A-4, A-5, B-1, B-2, B-3</U>; (2)&nbsp;lists of Contracts required
by <U>Schedule&nbsp;3.8(a)</U>; (3)&nbsp;listing of Real Property in <U>Schedule&nbsp;3.10(a)</U>; (4)&nbsp;listings
required by <U>Schedules 3.12(b), (d)&nbsp;and (e)</U> which do not involve a violation of Laws; (5)
Disclosure Schedule exceptions, if any, to <U>Sections&nbsp;3.14(b)(ii) and (iii)</U> and <U>Section
3.14(e)</U>; (6)&nbsp;listings required by <U>Schedules 3.19(a), 3.20 and 3.20(i)</U>; (7)&nbsp;listings of
exceptions to GAAP in <U>Exhibit&nbsp;D</U>; and (8)&nbsp;subject to the provisions of <U>Section&nbsp;5.14</U>,
disclosures of &#147;national contracts&#148; in <U>Schedule&nbsp;6.8</U>; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(D) the following Disclosure Schedule exceptions, if any, will be deemed to modify and amend
LifePoint&#146;s representations and warranties as described below: (1)&nbsp;Disclosure Schedule exceptions,
if any, to <U>Section&nbsp;3.7</U> to the extent that such disclosure only lists Dispositions and
assets that will be restored pursuant to <U>Section&nbsp;7.5</U> will be deemed to modify LifePoint&#146;s
representations and warranties in <U>Section&nbsp;3.7</U>, (2)&nbsp;Disclosure Schedule exceptions, if any,
with respect to <U>Section&nbsp;3.10(f)</U> involving deficiencies not caused by LifePoint will be
</DIV>

<P align="center" style="font-size: 10pt">47
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">deemed to modify LifePoint&#146;s representations and warranties in <U>Section&nbsp;3.10(f)</U> with
respect to such deficiencies; and (3)&nbsp;Disclosure Schedule exceptions, if any, with respect
<U>Section&nbsp;3.19(b)</U> regarding the existence of Court Orders that relate to or arise out of
matters that existed as of the SPA Effective Time will be deemed to modify LifePoint&#146;s
representations and warranties in <U>Section&nbsp;3.10(f)</U> with respect to the existence of such
Court Orders.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)&nbsp;Neither party may amend <U>Exhibits E and F</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;Within 15&nbsp;days after the delivery of the Unwind Notice, LifePoint shall deliver or make
available to Purchaser in Nashville due diligence materials consistent with those previously made
available to LifePoint in the HCA data room in connection with the Initial Closing.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;At least ten days prior to the Closing, LifePoint shall deliver to Purchaser a list of
contracts or other agreements (other than those material Contracts specifically noted as such on
<U>Schedule&nbsp;3.8(a)</U>) under which a chief executive officer, chief financial officer, chief
operating officer or chief nursing officer of any of the Hospitals: (i)&nbsp;is a supplier of goods or
services to the Acquired Entities or the Facilities, (ii)&nbsp;directly or indirectly controls or is a
director, trustee, member, officer, controlling shareholder, employee or agent of any corporation,
firm, association, partnership or other business entity which is a supplier of goods or services to
the Acquired Entities or the Facilities, or (iii)&nbsp;is otherwise a party to any contract or other
agreement with the Acquired Entities or the Facilities.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;Within ten (10)&nbsp;days after the delivery of the Unwind Notice, LifePoint shall provide a
summary of notices of all program reimbursement, proposed or pending audit adjustments,
disallowances, appeals of disallowances, and all other unresolved claims or disputes, in connection
with audits, reviews or inquiries with respect to cost reports of the Facilities for cost reporting
periods ending since the SPA Effective Time.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.6 <U>Closing Conditions</U>. After LifePoint&#146;s exercise of the Unwind Right, LifePoint
will use its best efforts to cause each of the conditions set forth in <U>Article&nbsp;VII</U> to be
satisfied as soon as reasonably practicable, but in all events on or prior to the Closing Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.7 <U>Transfer of Hospital</U>. (a)&nbsp;From and after the date hereof and until the Closing,
LifePoint shall cause the Acquired Entities not to sell or dispose of any Hospital, except in
accordance with the following:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;Any Disposition of a Hospital shall include the entire Hospital Group and all assets and
operations associated with that Hospital. Notwithstanding the foregoing, at LifePoint&#146;s option,
LifePoint may elect to retain current assets and other non-essential assets of, or non-essential
entities that are part of, a Hospital Group in connection with the Disposition of a Hospital, in
which case (A)&nbsp;such retained assets and entities will no longer be subject to the Unwind Right, and
(B)&nbsp;such retained assets will be deemed Disposed Assets and such retained entities will be deemed
Disposed Entities.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Except to the extent required by a binding agreement existing as of the occurrence of an
Unwind Trigger Event, from and after the occurrence of an Unwind Trigger Event, LifePoint shall
cause the Acquired Entities not to sell or dispose of (or agree to sell or

<P align="center" style="font-size: 10pt">48
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">dispose of) any their assets or properties without the prior written consent of Purchaser,
except for dispositions or sales of inventory or obsolete or immaterial property in the ordinary
course of business. Notwithstanding the foregoing or the provisions of <U>Section
5.2(a)(iii)</U>, the Acquired Entities may pay dividends or make distributions of current assets in
respect of their capital stock to the extent reflected in the Closing Date Balance Sheet.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.8 <U>Entities Not Wholly-Owned by LifePoint</U>. (a)&nbsp;Notwithstanding anything herein to the
contrary, if LifePoint owns, directly or indirectly, less than 100% of the Ownership Interests and
other equity securities of a Person, such Person will not be an Acquired Entity unless: (i)
LifePoint owns a majority of the Ownership Interests of such Person; (ii)&nbsp;under generally accepted
accounting policies and Regulation&nbsp;SX promulgated under the Securities Exchange Act of 1934, as
amended, HCA should be able to consolidate the results of operations, assets and liabilities of
such Person with the results of operations, assets and liabilities of HCA and its other
consolidated Affiliates for financial accounting purposes; (iii)&nbsp;the ownership structure of such
Person, its constituent documents, the identity of its owners and the terms of the agreements
relating to such ownership structure do not violate applicable Law in any way that is material to
such Person or Purchaser; and (iv)&nbsp;in the case of a Person that directly or indirectly owns or
operates a Hospital, (A)&nbsp;the constituent documents of such Person include a provision that permits
a wholly-owned Acquired Entity to acquire all of the ownership interests in such Person for no more
than fair market value for cash as determined by an HCA certified appraiser selected by LifePoint
from the list delivered simultaneous with execution hereof (which list can be supplemented by HCA
by written notice to LifePoint by providing additional acceptable appraisers) on no greater than 90
days&#146; written notice, and (B)&nbsp;all material Contracts between LifePoint or its Affiliates and such
Person are lawful and are with an Acquired Entity and would not be in default as a result of the
Closing or are assignable to Purchaser without penalty or approval and, if not with an Acquired
Entity and if requested by Purchaser, LifePoint assigns such Contracts to Purchaser or its
designated Affiliate as of the Effective Time.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Any Initial Acquired Entity that does not qualify as an Acquired Entity as of the
Effective Time due to the requirements set forth in clause (a), above, will be deemed to be a
Disposed Entity. Any Person that otherwise would be a Related Entity but for the requirements set
forth in clause (a), above, will not be considered a Related Entity and the acquisition of any
interests in such Person (and any expenditures by such Person) will not be considered capital
expenditures for purposes of calculating the Capital Expenditures Adjustment Amount. Any assets of
any Acquired Entity that have been transferred to a Person that does not qualify as an Acquired
Entity as of the Effective Time due to the requirements set forth in clause (a), above, will be
deemed to be Disposed Assets.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.9 <U>Condition of Assets</U>. Except for matters for which HCA is providing special
indemnification in conjunction with the Initial Closing, pursuant to either <U>Section&nbsp;9.2(f)</U>
of the SPA or the Environmental Indemnity Agreement delivered in accordance with the SPA, from and
after the occurrence of an Unwind Trigger Event and until the Closing, LifePoint shall use
commercially reasonable efforts, and shall cause its applicable Affiliates to use commercially
reasonable efforts, to maintain, subject to ordinary wear and tear, all real property improvements,
inventory, machinery, equipment and other tangible personal property owned or leased by LifePoint
or its Affiliates and used in connection with the operation of the Business other than Excluded
Assets. Subject to the compliance by LifePoint with the obligations set forth in the
</DIV>

<P align="center" style="font-size: 10pt">49
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">preceding sentence, and except as specifically provided in <U>Article&nbsp;III</U>, Purchaser
acknowledges that it will take possession and ownership of such assets and properties by operation
of its purchase of the Acquired Company Ownership Interests and the Related Company Ownership
Interests pursuant to this Agreement AS IS, WHERE IS AND WITH ALL FAULTS. ALL OTHER WARRANTIES,
EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION, ANY IMPLIED WARRANTIES OF MERCHANTABILITY AND
FITNESS FOR A PARTICULAR PURPOSE AND ANY WARRANTIES REGARDING HABITABILITY OR FITNESS FOR
HABITATION, ARE EXPRESSLY DISCLAIMED.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.10 <U>Consultative Process</U>. From and after the delivery of the Unwind Notice until the
Closing, Purchaser shall designate an individual or individuals whom LifePoint&#146;s representatives
may contact during normal business hours for the purpose of approving actions or transactions for
which the consent of Purchaser is required under this Agreement. The written approval of a
designated individual as contemplated in this <U>Section&nbsp;5.10</U> shall constitute the consent of
Purchaser to the transaction or action so approved. Failure of a designated individual to respond
within five Business Days of receipt of a written request for such approval shall constitute the
consent of Purchaser to the transaction or action in question. Unless and until Purchaser gives
written notice to LifePoint to the contrary, such designated individuals shall be Gregg Gerken.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.11 <U>Intercompany Accounts</U>. Except as otherwise provided in this Agreement, at or
prior to the Effective Time, (a)&nbsp;all indebtedness and other amounts (i)&nbsp;owed by LifePoint, Seller
Group, or any of their Affiliates (other than an Acquired Entity) to an Acquired Entity or (ii)
owed by an Acquired Entity to LifePoint, Seller Group, or any of their Affiliates (other than an
Acquired Entity) shall be paid, canceled or eliminated (whether or not then due), and (b)&nbsp;all
Encumbrances relating to any of the aforesaid indebtedness or amounts shall be canceled and shall
be discharged of record and (c)&nbsp;all arrangements calling for the transfer of funds by any Acquired
Entity in connection with LifePoint&#146;s cash management program shall be terminated as of the
Effective Time. Indebtedness and other amounts owed solely among Acquired Entities shall not be
paid, cancelled or eliminated.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.12 <U>Resignations</U>. LifePoint shall obtain the written resignations of all directors,
governing board members and officers of the Acquired Entities, such resignations to be effective as
of the Effective Time. To the extent that any such officer or director is also an employee of an
Acquired Entity, such resignation shall be applicable only to the Person&#146;s position as an officer
or director and not to such Person&#146;s employment. Nothing in this <U>Section&nbsp;5.12</U> shall be
interpreted to expand or extend any existing rights of indemnification that may exist with respect
to any directors, governing board members and officers of the Acquired Entities.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.13 <U>Tax Filings</U>. Prior to the Effective Date, LifePoint will cause the Acquired
Entities, in accordance with applicable law, to file with the necessary federal, state and local
Governmental Authorities registrations related to Taxes comparable to those required by
<U>Schedule&nbsp;5.14</U> of the SPA (&#147;<U>Tax Filings</U>&#148;). LifePoint will provide Purchaser with
the status of each such Tax Filing within five days of a written request from Purchaser.
</DIV>

<P align="center" style="font-size: 10pt">50
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.14 <U>Excluded Contracts</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Not later than 15&nbsp;days after the date on which LifePoint exercises the Unwind Right,
LifePoint will deliver to Purchaser <U>Schedule&nbsp;3.8(a)</U> of this Agreement together with copies
of each Contract included in such schedule. Subject to the provisions of <U>Section&nbsp;5.14(b)</U>,
Purchaser may reject any such Contract that (i)&nbsp;violates applicable Law; (ii)&nbsp;contains material and
adverse obligations (either monetary or non-monetary) after the Closing that are extraordinary
relative to the obligations of LifePoint and its Affiliates prior to the Closing (i.e., &#147;balloon
payments&#148; or &#147;balloon obligations&#148;), but only to the extent that such future obligations are not
reflected in the Indebtedness Adjustment Amount or the Final Net Working Capital Adjustment Amount,
provided, however, that Purchaser may not reject any physician recruiting or physician employment
agreements that comply with LifePoint&#146;s policies regarding such agreements pursuant to this clause
(ii); and (iii)&nbsp;unless the material terms and provisions of such Contracts are consistent in all
material respects with comparable arrangements of LifePoint and its Affiliates in similar
transactions, (A)&nbsp;any commercial third party payor agreement that is not terminable within 18
months after the Effective Time, without cause and without penalty, (B)&nbsp;any Contract (other than
Leases or other Contracts related to the Real Property), any equipment lease or any capitalized
lease that (1)&nbsp;is not terminable within three years of the Effective Time, without cause and
without penalty, and (2)&nbsp;following the Effective Time obligates Purchaser to a payment, liability
or obligation, the value of which exceeds $100,000 annually or $250,000 in the aggregate, (C)
material management agreements; and (D)&nbsp;material non-competition agreements and similar
arrangements (any of the foregoing Contracts ultimately rejected by Purchaser in accordance with
provisions of this <U>Section&nbsp;5.14(a)</U> are collectively referred to as &#147;<U>Excluded
Contracts</U>&#148;). If Purchaser seeks to reject any Contract in accordance with this <U>Section
5.14(a)</U>, within 20&nbsp;days after Purchaser&#146;s receipt of <U>Schedule&nbsp;3.8(a)</U> and complete
copies of the Contracts referred to therein, Purchaser shall notify LifePoint in writing of its
intention to reject one or more Contracts and its reasons therefor. For five days after receipt of
such notice, Purchaser and LifePoint shall consult in good faith as to what action, if any, should
be taken with respect to any such Contract to address concerns raised by Purchaser. If Purchaser
and LifePoint do not jointly agree on whether any Contract falls within the rejection criteria set
forth in this <U>Section&nbsp;5.14(a)</U> within such five day period, such Contract shall not be
deemed an Excluded Contract as of the Effective Time and the matter will be submitted to
arbitration pursuant to the provisions of <U>Section&nbsp;11.1</U>; provided that, if the Contract in
question is one that Purchaser continues in good faith to believe violates applicable Law, then
such Contract shall be (solely for purposes of Closing but not for ultimate determination) deemed
an Excluded Contract as of the Effective Time and the matter will be submitted to arbitration
pursuant to the provisions of <U>Section&nbsp;11.1</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Notwithstanding the provisions of <U>Section&nbsp;5.14(a)</U>, Purchaser acknowledges and
agrees that it cannot reject any Contract that existed as of the SPA Effective Time unless (i)&nbsp;such
Contract has been amended or modified after the SPA Effective Time, and (ii)&nbsp;but for such amendment
or modification, the Contract would not meet the rejection criteria cited by Purchaser in
accordance with <U>Section&nbsp;5.14(a)</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.15 <U>CON Challenges</U>. LifePoint covenants and agrees that until the earlier of the
Effective Time and the Final Order Date, LifePoint shall (i)&nbsp;take all administrative and judicial
actions necessary to maintain the CONs (and, any Replacement CONs) in full force and effect
</DIV>

<P align="center" style="font-size: 10pt">51
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">and to respond to the CON Challenges (including any challenges to any Replacement CONs),
including the filing of any necessary appeals, requests for injunctions or requests for stays; (ii)
if an Order is issued or threatened to be issued, (A)&nbsp;take all administrative and judicial actions
necessary to appeal such Order or to otherwise attempt to have such Order stayed, reversed,
revoked, voided or otherwise made ineffective, and (B)&nbsp;use its best efforts to have such Order
modified such that it would not be considered an &#147;Order&#148; as such term is defined in this Agreement
if an appropriate administrative or judicial avenue for such modification is available; and (iii)
if a CON Revocation Order is issued, apply for and vigorously pursue the grant of Replacement CONs
(provided, however, that LifePoint shall only be required to apply for Replacement CONs once).
LifePoint agrees (a)&nbsp;to keep Purchaser fully informed of all actions, notices, steps, proceedings
and other matters related to the CON Challenges and the other actions contemplated by clauses (i) &#150;
(iii), above, including providing copies of all written correspondence and pleadings to Purchaser
and providing Purchaser with regular and timely updates regarding the status of any appeal, inquiry
or other action against the CONs or in pursuit of Replacement CONs and (b)&nbsp;at the request of
Purchaser, consult with Purchaser regarding such matters. To the extent LifePoint has informed
Purchaser of LifePoint&#146;s actions, notices, steps, proceedings and other matters related to the CON
Challenges and the other actions contemplated by clasues (i) &#150; (iii), including (where applicable)
providing copies of written correspondence and pleadings regarding such matters to Purchaser and/or
consulted with Purchaser regarding such matters, Purchaser will give LifePoint notice within a
reasonable period under the circumstances of any material objections it may have to LifePoint&#146;s
defense of the CON Challenges and the other matters contemplated by clauses (i)-(iii), above;
provided, that Purchaser&#146;s notification (or failure to notify) LifePoint of such objections will
not alter or amend LifePoint&#146;s obligations under clauses (i)&nbsp;through (iii)&nbsp;or LifePoint&#146;s right to
rely upon its CON experts and counsel in accordance with this Section&nbsp;5.15. LifePoint shall be
entitled to reasonably rely on the advice and recommendations of its CON experts and West Virginia
CON Counsel with respect to strategic decisions concerning the conduct of the vigorous defense of
appeals, inquiries or other actions against the CONs or the pursuit of Replacement CONs required by
clases (i)&nbsp;through (iii)&nbsp;above, but Purchaser&#146;s obligations to pursue all available administrative
and judicial actions pursuant to clauses (i)&nbsp;through (iii), above, shall in no way be limited by
reliance on such advice. If LifePoint fails to vigorously defend any appeal, inquiry or other
action against the CONs, or to take any of the actions contemplated in clauses (i)&nbsp;through (iii),
above, in a timely manner, Purchaser shall have the right (in addition to all other legal or
equitable remedies available to it), following notice and an apportunity to cure that is reasonable
under the then current circumstances, to undertake the defense of the CONs, any Replacement CONs or
any other actions contemplated by clauses (i)&nbsp;through (iii), above, with counsel of its choice at
the expense of LifePoint. Purchaser shall reasonably cooperate with LifePoint and its West
Virginia CON counsel and advisors in connection with the actions contemplated by this <U>Section
5.15</U>, including (to the extent deemed necessary and appropriate by LifePoint&#146;s West Virginia
CON counsel) provide such information and assistance as LifePoint may reasonably request. If
Purchaser has undertaken the defense of the CONs as contemplated by this <U>Section&nbsp;5.15</U>,
LifePoint shall reasonably cooperate with Purchaser and its West Virginia CON counsel and advisors
in connection with the actions contemplated by this <U>Section&nbsp;5.15</U>, including (to the extent
deemed necessary and appropriate by Purchaser&#146;s West Virginia CON counsel) provide such information
and assistance as Purchaser may reasonably request.
</DIV>


<P align="center" style="font-size: 10pt">52
</DIV>


<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.16 <U>Closure of Facility; Alternative Arrangements</U>. Without limiting the effect
of <U>Section&nbsp;5.15</U>, if (a)&nbsp;LifePoint shall have delivered an Unwind Notice and (b)&nbsp;the parties
anticipate that the conditions to Closing set forth in Articles VII and VIII cannot be satisfied
prior to the Closing Date but HCA is nonetheless obligated to close the transaction contemplated
hereby pursuant to <U>Section&nbsp;2.5</U> above, (i)&nbsp;HCA and LifePoint will consult with one another
in good faith to determine whether to cease or suspend operations at any of the Hospitals as
required by the applicable Order, (ii)&nbsp;HCA and LifePoint shall consult with one another in good
faith to determine whether alternatives are available that would allow LifePoint to comply with the
Order without forcing the Hospitals to cease operations, such as closing into escrow or similar
arrangement, and (iii)&nbsp;in the event (A)&nbsp;the parties agree to cease or suspend operations at a
Hospital as so required or (B)&nbsp;if the Order Non-Compliance Conditions are not met and LifePoint
determines in good faith to cease or terminate operations of a Hospital as required by an Order,
HCA shall indemnify and hold LifePoint harmless from any Damages incurred by LifePoint as a result
of ceasing or suspending operations of any such Hospital reduced dollar for dollar by any positive
Tax affect actually realized by LifePoint or its Affiliates as a result of ceasing or suspending
such operations. If Purchaser desires to transfer its rights to acquire the Acquired Company
Ownership Interests to a third party that is legally able to acquire said interests, then LifePoint
shall cooperate with Purchaser&#146;s efforts to identify one or more third parties and convey
Purchaser&#146;s rights (but not its obligations) to acquire the Acquired Company Ownership Interests to
such third parties.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.17 <U>Encumbrances</U>. From and after the occurrence of an Unwind Trigger Event and until
the Closing, LifePoint shall not permit the Acquired Entities to enter into or assume any mortgage,
pledge, conditional sale or other title retention agreement or permit any Encumbrance to attach
upon any of its assets, whether now owned or hereafter acquired, except for (i)&nbsp;Permitted
Encumbrances (other than Encumbrances that are Permitted Encumbrances under clause (j)&nbsp;of the
definition of &#147;Permitted Encumbrance&#148; which LifePoint will not permit without the prior written
consent of HCA, which HCA agrees not to withhold unreasonably), or (ii)&nbsp;Encumbrances incurred in
the ordinary course of business and in conformity with past practice on assets and properties of
the Acquired Entities having an original cost or fair value (whichever is less) not exceeding
$250,000 in the aggregate. LifePoint shall timely and fully perform the LifePoint Excluded
Liabilities.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE VI<BR>
COVENANTS OF PURCHASER; CERTAIN ADDITIONAL<BR>
COVENANTS OF THE PARTIES</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.1 <U>Regulatory Approvals</U>. From and after delivery of the Unwind Notice, Purchaser
will (a)&nbsp;use commercially reasonable efforts to obtain, as promptly as practicable, all Permits,
approvals, authorizations and clearances of Governmental Authorities Purchaser believes it must
obtain in order to satisfy its closing conditions under <U>Section&nbsp;7.16(a)</U>, and to make all
filings and declarations with Governmental Authorities Purchaser believes it must make in order to
satisfy its closing conditions under <U>Section&nbsp;7.16(a)</U>, (b)&nbsp;provide such information and
communications to applicable Governmental Authorities as is
necessary in connection with the foregoing or in connection with LifePoint or its Affiliates&#146;
obtaining any of the Permits, approvals, authorizations and clearances of Governmental Authorities
or making any filings or declarations with Governmental Authorities in accordance with <U>Section
5.1</U>, and (c)&nbsp;cooperate with LifePoint
</DIV>

<P align="center" style="font-size: 10pt">53
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">and its Affiliates in obtaining or making, as soon as
practicable, any Permits, approvals, authorizations, clearances, filings and declarations of or
with Governmental Authorities that LifePoint or its Affiliates is required to obtain or make
pursuant to <U>Section&nbsp;5.1</U>. Additionally, Purchaser will use commercially reasonable efforts
to (i)&nbsp;make any required filing, and to assist LifePoint in making its filing, of a pre-merger
notification report form pursuant to the HSR Act within 20&nbsp;days following the delivery of the
Unwind Notice and (ii)&nbsp;file all certificate of need applications to the extent required under
applicable state Law within 30&nbsp;days after the delivery of the Unwind Notice to the extent required
under applicable state Law.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.2 <U>Post-Closing Access</U>. The terms of <U>Section&nbsp;6.2</U> of the SPA are incorporated
by reference and &#147;LifePoint&#148; is substituted for &#147;HCA&#148; in each place that it appears.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.3 <U>WARN Act</U>. Purchaser will not take any action that results in the imposition of
liability on LifePoint, Seller Group or their Affiliates under the WARN Act due to a &#147;plant
closing&#148; or &#147;mass layoff&#148; or otherwise under the provisions of the WARN Act, or any similar state
or local laws relating to plant closings, with respect to the Acquired Entities. All quoted terms
used in this <U>Section&nbsp;6.4</U> and not defined herein shall have the meanings ascribed to such
terms under the WARN Act.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.4 <U>Employee Matters</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;As of the Effective Time, Purchaser shall continue the employment of all of the
then-current employees of the Acquired Entities (including employees of the Business who are then
currently employed by a LifePoint Affiliate other than an Acquired Subsidiary but who will be
employed by an Acquired Entity as of the Effective Time) and, with respect thereto: (i)&nbsp;maintain
the salaries and wages at the levels in effect immediately prior to the Effective Time, (ii)
provide benefits which are substantially similar to the benefits provided to similarly situated
employees of Purchaser and its subsidiaries, (iii)&nbsp;recognize the existing levels of service and
seniority for benefit plan purposes (including but not limited to paid time off, vacation, sick,
extended illness and holiday time), and (iv)&nbsp;provide credit for purposes of eligibility, vesting
and rate of accrual under its benefit plans, programs or policies for service with the Acquired
Entities or their Affiliates. With respect to any self-insured welfare benefit plans maintained by
Purchaser that cover employees of Acquired Entities, Purchaser shall cause such plans to provide
credit for any co-payments or deductibles paid by such employees and waive all pre-existing
condition exclusions and waiting periods that might otherwise apply to such employees, other than
limitations or waiting periods that have not been satisfied under any welfare plans maintained by
the Acquired Entities for their employees prior to the Effective Date.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;With respect to employees of the Acquired Entities whose employment is terminated by
Purchaser within one year of the Effective Time, Purchaser shall provide severance benefits thereto
that are equivalent to or better than the severance benefits typically provided by Purchaser.
Purchaser shall provide, and retain full responsibility for, COBRA
continuation coverage (other than with respect to flexible spending accounts) to any employee
or former employee of the Acquired Entities who is an M&#038;A Qualified Beneficiary (as defined in
Treas. Reg. &#167; 54.4980B-9) and eligible to receive such coverage as of the Effective Time or who
becomes eligible to receive such coverage due to events that arise with respect to employees of the
Acquired Entities after the Effective Time.
</DIV>


<P align="center" style="font-size: 10pt">54
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Notwithstanding any provision herein, no term of this Agreement shall be deemed to create
any contract with any employee, or to give any employee the right to be retained in the employment
of Purchaser, an Acquired Entity, or any related employer, or to interfere with Purchaser&#146;s or an
Acquired Entity&#146;s right to terminate employment of any employee at any time. Nothing in this
Agreement shall diminish Purchaser&#146;s rights to change or terminate its policies regarding salaries,
benefits and other employment matters at any time or from time to time. The representations,
warranties, covenants and agreements contained herein are for the sole benefit of the parties
hereto, and employees are not intended to be and shall not be construed as beneficiaries hereof.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;LifePoint shall provide reasonable access and information to the Purchaser regarding the
Company Plans that are sponsored and maintained by the Acquired Entities. With respect to the
Company Plans that are sponsored by LifePoint or its Affiliates, and in which the Acquired Entities
are merely participating employers, LifePoint and/or its Affiliates will take all necessary and
appropriate action to terminate the participation of the Acquired Entities therein effective
immediately prior to the Closing. With respect to Company Plans that are sponsored by an Acquired
Entity, LifePoint will reasonably cooperate with Purchaser in evaluating such Company Plans and
assisting Purchaser in determining the termination or continuation of all such Company Plans in
connection with the transactions contemplated by this Agreement, prior to the Closing. LifePoint
shall cause all Company Plans that are sponsored by an Acquired Entity to be terminated effective
immediately prior to the Closing, unless Purchaser notifies LifePoint to the contrary. LifePoint
will take all reasonable steps necessary in connection with the above, including providing required
notices to participants and appropriate governmental agencies and adopting all necessary
resolutions and Company Plan amendments. Notwithstanding the above, no provision of this Agreement
shall require Purchaser to assume any Company Plan or any portion thereof, or continue same after
the Closing.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.5 <U>Compliance Program</U>. Purchaser represents and agrees that, as of Closing, it has
or will implement and maintain an effective program to prevent and detect violations of legal
requirements applicable to the delivery of goods and services in connection with any health care
benefits and that such a program will comply with the provisions of the U.S. Sentencing Guidelines
relating to corporate compliance programs and will be mindful of any applicable guidance issued by
the U.S. Department of Health and Human Services. Purchaser agrees that it will maintain such
program for no less than five years following the Effective Time.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.6 <U>Tax Matters</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <U>Termination of Existing Tax Sharing Agreements</U>. LifePoint shall cause all tax
sharing agreements or similar arrangements with respect to or involving the Acquired Entities
(other than agreements or arrangements in existence of the SPA Effective Time) to be
terminated effective as of the Effective Time and, after the Effective Time, the Acquired
Entities shall not be bound thereby or have any liability thereunder.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <U>Payment of Taxes</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;LifePoint shall prepare and file, or cause to be prepared and filed, all Returns of or
which include any of the Acquired Entities (including any amendments thereto)
</DIV>

<P align="center" style="font-size: 10pt">55
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">with respect to any
taxable period ending during the Holding Period (a &#147;<U>LifePoint Tax Period</U>&#148;). Such Returns
shall be prepared in a manner consistent with past practices. LifePoint shall provide Purchaser
with copies of all Returns of only the Acquired Entities upon the request of Purchaser.
Notwithstanding anything to the contrary in this Agreement, LifePoint shall pay any and all Taxes
imposed on or with respect to any Acquired Entity for a LifePoint Tax Period (including, without
limitation, any Taxes imposed on any Acquired Entity as a result of having been a member of the
LifePoint Affiliated Group, and any Taxes that are determined by income or earned surplus
attributable to a LifePoint Tax Period). Purchaser shall prepare and file, or cause to be prepared
and filed, all Returns of or which include any of the Acquired Entities and shall pay all Taxes of
any of the Acquired Entities for all taxable periods other than a LifePoint Tax Period, except to
the extent provided in the preceding sentence and in paragraph (ii)&nbsp;below.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;For purposes of the immediately preceding paragraph (i)&nbsp;and this paragraph (ii), if, for
Tax purposes, the taxable period of an Acquired Entity that includes the Effective Time does not
terminate at the Effective Time (a &#147;<U>Straddle Period</U>&#148;), the parties hereto will, to the
extent permitted by applicable law, elect with the relevant Governmental Authority to treat a
portion of any such Straddle Period as a short taxable period ending as of the Effective Time and
such short taxable period shall be treated as a LifePoint Tax Period for purposes of this
Agreement. In any case where applicable law does not permit such an election to be made then, for
purposes of this Agreement, Taxes with respect to the Acquired Entities for the Straddle Period
shall be allocated to the LifePoint Tax Period using an interim closing-of-the-books method that
complies with Treas. Reg. Section&nbsp;1.1502-76(b)(2)(i) (assuming that such taxable period ended at
the Effective Time) and treating such period as a LifePoint Tax Period for purposes of this
Agreement, except that exemptions, allowances or deductions that are calculated on an annual basis
(such as the deduction for depreciation) shall be apportioned on a per diem basis. In the case of
any Straddle Period described in the preceding sentence, Purchaser shall provide LifePoint and its
authorized representatives with copies of the completed Return for such period and a statement
certifying the amount of Taxes shown on such Return that are chargeable to LifePoint (the &#147;<U>Tax
Statement</U>&#148;) at least 30&nbsp;days prior to the due date for the filing of such Return (including any
extension thereof), and LifePoint and its authorized representatives shall have the right to review
and comment on at LifePoint&#146;s expense each such Return and Tax Statement prior to the filing of
such Return. LifePoint and Purchaser agree to consult and resolve in good faith any issues arising
as a result of the review of such Return and Tax Statement by LifePoint or their authorized
representatives and to mutually consent to the filing of such Return. If the parties hereto are
unable to resolve any dispute within ten Business Days prior to the due date for filing of the
Return in question (including any extension thereof), the parties shall jointly request the
Selected Accounting Firm to resolve any issue in dispute as promptly as possible. If the Selected
Accounting Firm is unable to make a determination with respect to any disputed issue prior to the
due date (including extensions) for the filing of the Return in question, the Purchaser and the
Acquired Entities, as the case may be, may file such
Return without the consent of LifePoint, subject, however, to the obligation thereafter to
file an amended Return reflecting the final decision of the Selected Accounting Firm (which
decision shall be rendered prior to the expiration of the period during which an amended Return may
validly be filed with respect to the applicable taxable period). Not later than five days before
the due date (including any extensions thereof) for payment of Taxes with respect to such Return,
LifePoint shall pay to Purchaser an amount equal to the Taxes shown on the Tax Statement as being
chargeable to LifePoint pursuant to this paragraph (ii). If LifePoint has disputed such
</DIV>

<P align="center" style="font-size: 10pt">56
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">amount,
appropriate adjustments shall be made to the amount paid by LifePoint in order to reflect the
decision of the Selected Accounting Firm in immediately available funds not later than five days
after such decision has been rendered. Any decision rendered by the Selected Accounting Firm in
accordance with this <U>Section&nbsp;6.6(b)(ii)</U> shall be binding and conclusive, and the any
expenses relating to the engagement of the Selected Accounting Firm shall be shared equally by
LifePoint and Purchaser.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;Notwithstanding anything herein to the contrary, LifePoint shall not be liable for any
Taxes for which Purchaser is obligated to pay pursuant to the terms of the SPA.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <U>Refunds and Tax Benefits</U>. Purchaser shall pay to LifePoint, within 30&nbsp;days of
receipt, any refund or credit (including any interest paid or credited with respect thereto)
received by Purchaser or any member of the Purchaser Affiliated Group of Taxes relating to any
LifePoint Tax Period or portions of Straddle Periods at or before the Effective Time. Purchaser
shall, if LifePoint so requests, at LifePoint&#146;s expense cause the relevant Acquired Entity (or
other relevant member of the Purchaser Affiliated Group) to file for any refund or credit to which
LifePoint believes it is entitled pursuant to this <U>Section&nbsp;6.6(c)</U>. Any Proceeding with
respect to such a claim shall be governed by the provisions of this <U>Section&nbsp;6.6</U>, including
the provisions of <U>Section&nbsp;6.6(e)</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) <U>Cooperation</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;LifePoint, on the one hand, and Purchaser and the Acquired Entities, on the other hand,
agree to furnish or cause to be furnished to each other or their respective representatives, upon
request, as promptly as practicable, such information and assistance (including access to books and
records) relating to the Acquired Entities as is reasonably necessary for the preparation of any
Return, claim for refund, audit or similar matter, or the prosecution or defense of any claim, suit
or proceeding relating to any proposed adjustment of Taxes.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;Except as otherwise provided in <U>Section&nbsp;6.6(b)(ii)</U>, if LifePoint and Purchaser
disagree as to the matters governed by this <U>Section&nbsp;6.6</U>, LifePoint and Purchaser shall
promptly consult with each other in an effort to resolve such dispute. If any such disagreement
cannot be resolved within 15&nbsp;days after either party asserts in writing that such dispute cannot be
resolved, the Selected Accounting Firm shall act as an arbitrator to resolve such disagreement.
The Selected Accounting Firm&#146;s determination shall be binding and conclusive, and any expenses
relating to the engagement of such Selected Accounting firm shall be shared equally by LifePoint
and Purchaser.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) <U>Post-Closing Audits and Other Proceedings</U>. In the case of any audit, examination
or other proceeding (&#147;<U>Proceeding</U>&#148;) with respect to Taxes for which LifePoint is or may be
liable pursuant to this Agreement (other than a Proceeding relating to Taxes for a Straddle
Period), Purchaser shall promptly notify LifePoint in writing of any such Proceeding, and Purchaser
shall timely execute or cause to be executed powers of attorney or other documents necessary to
enable LifePoint to take all actions desired by LifePoint with respect to such Proceeding to the
extent such Proceeding may affect the amount of Taxes for which
</DIV>


<P align="center" style="font-size: 10pt">57
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">LifePoint is liable pursuant to
this Agreement; provided that, in acting on behalf of the Acquired Entities, LifePoint shall take
no position that Purchaser determines will result in any negative Tax consequence to Purchaser or
the Acquired Entities after the Effective Time. LifePoint shall have the sole right to control any
such Proceedings, (including any Proceedings to initiate claims for refunds of or credits with
respect to any Taxes for which LifePoint is liable pursuant to this Agreement and that LifePoint
believes are available) including the right to initiate any claim for refund or credit, file any
amended Return or take any other action that it deems appropriate with respect to such Taxes (or
refunds or credits). All costs and expenses incurred in connection with any such Proceeding shall
be borne by LifePoint, and Purchaser and the Acquired Entities shall be reimbursed by LifePoint for
any and all reasonable direct costs and expenses incurred by them in connection with such
Proceeding. Any settlement of a Proceeding shall be made subject to Purchaser&#146;s prior written
consent. In the event that Purchaser&#146;s consent is withheld, Purchaser will assume the control,
costs and expenses of the Proceeding. If such Proceeding is ultimately resolved by payment of an
amount in excess of the amount in the original settlement proposal (or receipt of a refund in an
amount less than the amount in the original settlement proposal), Purchaser will pay the amount of
such excess (or shall pay LifePoint the amount of such refund shortfall). If such Proceeding is
ultimately resolved by payment of an amount less than the amount of the original settlement
proposal (or a refund or credit in an amount greater than the original settlement proposal),
LifePoint will reimburse Purchaser for its costs and expenses to the extent of such difference.
Notwithstanding the foregoing, (i)&nbsp;LifePoint shall control all Proceedings in connection with any
Tax claim relating to Taxes of any Acquired Entity for a Straddle Period and (ii)&nbsp;Purchaser shall
control any Tax claim that would reasonably be expected to have a material adverse effect on the
business, financial condition or results of operation of Purchaser or the Acquired Entities for any
taxable periods ending after the Closing Date, excluding a Straddle Period addressed in 6.6(e)(i).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) <U>Timing Adjustments</U>. In the event that a final determination (which shall include
the execution of a Form 870-AD or successor form) results in a timing difference (<U>e.g.</U>, an
acceleration of income or delay of deductions) that would increase LifePoint&#146;s liability for Taxes
pursuant to <U>Article&nbsp;VI</U> or results in a timing difference (<U>e.g.</U>, an acceleration of
deductions or delay of income) that would increase Purchaser&#146;s liability for Taxes pursuant to
<U>Article&nbsp;VI</U>, LifePoint or Purchaser, as the case may be, shall promptly make payments to
Purchaser or LifePoint as and when Purchaser or LifePoint, as the case may be, actually realizes
any Tax benefits as a result of such timing difference (or under such other method for determining
the present value of any such anticipated Tax benefits as agreed to by the parties). Such Tax
benefit for federal, state and local income tax purposes shall be computed for any year using
Purchaser&#146;s or LifePoint&#146;s, as the case may be, actual tax liability.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) <U>Parties Agree to Act in Good Faith</U>. LifePoint and Purchaser agree to act in good
faith in accordance with Section&nbsp;47-1-203 of the Tennessee Code Annotated in taking any actions
pursuant to this <U>Section&nbsp;6.6</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) <U>Effectiveness of Section&nbsp;6.6</U>. The provisions of this <U>Section&nbsp;6.6</U> shall not
become effective until the Effective Time. Prior to such time, the provisions of <U>Section
6.7</U> of the SPA will govern the subject matter of this <U>Section&nbsp;6.6</U>.
</DIV>


<P align="center" style="font-size: 10pt">58
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.7 <U>Tax Elections and Allocations</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Reserved.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Purchaser and LifePoint each agree to take any and all actions at or prior to Closing as
the other shall reasonably request a reasonable time prior to Closing to help the other effectuate
a like-kind exchange of the Real Property pursuant to Section&nbsp;1031 of the Code, and/or Revenue
Procedure 2000-37 (governing reverse like-kind exchanges), including, without limitation (i)
entering into a like-kind exchange trust agreement authorized by a &#147;qualified intermediary&#148; or a
qualified exchange accommodation arrangement authorized with a &#147;qualified exchange titleholder&#148;, if
necessary, (ii)&nbsp;paying the Purchase Price to the qualified intermediary to acquire the replacement
property in accordance with the instructions of the qualified intermediary or to the qualified
exchange titleholder in accordance with the instructions of the qualified exchange titleholder, as
applicable, and (iii)&nbsp;assigning this Agreement or a portion thereof to one or more Affiliates of
the Acquired Entities or entering into a separate agreement for the purchase of Real Property with
one or more Affiliates of the Acquired Entities in order to effectuate a like-kind exchange;
provided, however, that in no event shall Purchaser be required to take title to any real property
other than the Real Property; provided, further, neither LifePoint nor Purchaser shall be required
to incur any additional expenses or liability in order to effectuate the like-kind exchange, and
the like-kind exchange shall not delay the Closing. LifePoint and Purchaser each agree to pay the
other an amount equal to all additional third party costs and expenses incurred by the other as a
result of effectuating the transactions contemplated hereby in the manner contemplated by this
<U>Section&nbsp;6.7(b)</U> (including such costs incurred in connection with the negotiation of the
like-kind exchange trust agreement or the qualified exchange accommodation agreement contemplated
hereby, including, without limitation, the reasonable fees and expenses of the other&#146;s agents,
representatives, accountants and counsel). Any such amounts shall be paid promptly upon receipt of
evidence of such costs and expenses. LifePoint and Purchaser each also agree to indemnify, defend
and hold Purchaser harmless from and against any and all claims and other liabilities of any kind
arising with regard to <U>Section&nbsp;6.7(b)</U>. Notwithstanding anything to the contrary provided
herein, neither Purchaser nor LifePoint makes any representations or warranties as to the tax
treatment for the transaction contemplated in this <U>Section&nbsp;6.7(b)</U> or the ability of the
transaction contemplated to qualify for like-kind exchange treatment pursuant to Section&nbsp;1031 of
the Code. In no event shall either party be released from any liability under this Agreement by
reason of structuring the transaction as a like-kind exchange as contemplated by this <U>Section
6.7(b)</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <U>Purchase Price Allocation</U>. The parties agree that Purchaser shall prepare a
preliminary allocation of the Purchase Price (and all other capitalized costs) among the Shares of
an Acquired Entity which is not a disregarded entity for federal income tax purposes and
among the assets of any Acquired Entity (&#147;<U>Purchased Assets</U>&#148;) to the extent that sale
of such Acquired Entity is treated as sale of assets to Purchaser for tax purposes (&#147;<U>Tax
Allocation</U>&#148;). The Tax Allocation among the Purchased Assets shall be made in accordance with
Code Section&nbsp;1060 and the Treasury Regulations thereunder (and any similar provisions of state,
local or foreign law, as appropriate). Purchaser shall deliver its preliminary Tax Allocation to
LifePoint within one hundred twenty (120)&nbsp;Business Days after the Closing Date, and LifePoint shall
have thirty (30)&nbsp;Business Days after receiving the preliminary Tax Allocation (&#147;<U>Seller&#146;s Review
Period</U>&#148;) to object to the preliminary Tax Allocation. If LifePoint timely raises any such
</DIV>



<P align="center" style="font-size: 10pt">59
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">objections, Purchaser and LifePoint will attempt to resolve such objections in good faith;
provided, however, that if Purchaser and LifePoint are unable to resolve such issues within thirty
(30)&nbsp;Business Days after the end of Seller&#146;s Review Period, then either Purchaser or LifePoint may
elect, by written notice to the other, to have the objections resolved by the Selected Accounting
Firm, whose decision shall be binding on the parties in the absence of manifest error. If
LifePoint fails to object to the preliminary Tax Allocation within the Seller&#146;s Review Period, then
such preliminary Tax Allocation shall be deemed acceptable to LifePoint, and such preliminary Tax
Allocation shall be binding upon the parties, unless Purchaser in good faith determines that
adjustments are necessary and so notifies LifePoint in writing of such adjustment(s). If
Purchaser notifies LifePoint of any adjustment(s), then LifePoint shall have the right to object to
the adjustment(s) by giving written notice of objection to Purchaser within ten (10)&nbsp;Business Days
after receipt of Purchaser&#146;s notice of adjustment(s). Purchaser and LifePoint will attempt to
resolve such objections in good faith within ten (10)&nbsp;Business Days after Purchaser receives
LifePoint&#146;s notice of objection; provided, however, that if Purchaser and LifePoint are unable to
resolve such issues within ten (10)&nbsp;Business Days, then either Purchaser or LifePoint may elect, by
written notice to the other, to have the objections resolved by the Selected Accounting Firm, whose
decision shall be binding on the parties in the absence of manifest error. Thereafter, Purchaser,
LifePoint, and their respective Affiliates shall report, act and file Returns (including, but not
limited to Internal Revenue Service Form&nbsp;8594) in all respects and for all purposes consistent with
such finally determined Tax Allocation. Neither Purchaser nor LifePoint shall take any position
(whether in audits, Returns, or otherwise) that is inconsistent with such Tax Allocation, unless
required to do so by applicable law. Prior to filing IRS Form&nbsp;8594 (asset acquisition statement
under Section&nbsp;1060) with respect to the transactions described herein, the parties shall provide to
each other a true and correct copy of IRS Form&nbsp;8594 which each intends to file with respect to the
transactions described herein.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.8 <U>Certain National and Regional Contracts</U>. Certain Affiliates of LifePoint have
entered into contracts and/or leases with third parties to provide equipment, supplies and services
on a national or regional basis to LifePoint and its Affiliates, including certain of the Acquired
Entities. Certain of such contracts and/or leases are listed on <U>Schedule&nbsp;6.8</U> (such
contracts and/or leases, the &#147;National Contracts&#148;). At the Closing, at the option of LifePoint,
such Affiliates of LifePoint shall assign to Purchaser or the Acquired Entities, and Purchaser or
the Acquired Entities (as applicable) shall assume, the rights, benefits and obligations of such
Affiliates in, to and under all or a portion of the National Contracts to the extent they relate to
the Facilities.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.9 <U>Cost Reports</U>. From and after the Effective Time, the parties shall comply with
the terms and agreements set forth in <U>Exhibit&nbsp;E</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.10 <U>Closing Conditions</U>. After LifePoint&#146;s exercise of the Unwind Right, Purchaser
will use its best efforts to cause the conditions set forth in <U>Article&nbsp;VIII</U> hereof to be
satisfied as soon as reasonably practicable, but in all circumstances prior to the Closing Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.11 <U>Insurance Arrangements</U>. If LifePoint or its Affiliates maintain a West Virginia
physician malpractice insurance program as of the time LifePoint sends the Unwind Notice, LifePoint
shall, or shall cause a LifePoint Affiliate to, offer to the Acquired Entities and HCA shall, or
shall cause an HCA Affiliate to assume, the physician malpractice insurance coverage on the
following terms and conditions:
</DIV>

<P align="center" style="font-size: 10pt">60
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;HCA shall cause its captive insurance company to execute a Reinsurance Agreement with
LifePoint&#146;s captive insurance company that would transfer risk to the HCA captive insurance company
for all staff physician claims reported after the Effective Time. This agreement will provide for:
(i)&nbsp;crediting to the HCA captive insurance company all unearned premiums on policies in force at
the Effective Time; (ii)&nbsp;flow of funds for premiums received after the Effective Time from
Lexington Insurance Company (or other then applicable insurance companies that issue policies to
the staff physicians under the physician malpractice program) to the LifePoint captive insurance
company to the HCA captive insurance company; and (iii)&nbsp;the provision by HCA&#146;s captive insurance
company of a letter of credit as needed for collateral on the program.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;HCA shall execute a Services Agreement which will spell out specific duties of HCA and
LifePoint with regard to the program.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;The form of the Services and Reinsurance Agreements will be based in all material respects
on the Services and Reinsurance Agreements entered into upon the Initial Closing Date (except that
everywhere LifePoint appears, it is to be changed to HCA and anywhere a LifePoint Affiliate appears
it is to be changed to an HCA Affiliate and vice versa) and shall be on terms not inconsistent with
the foregoing provisions of this <U>Section&nbsp;6.11</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.12 <U>HCA Joinder Conveyance</U>. If the CON Challenges continue when there has been an
agreement by LifePoint to make a Disposition, at LifePoint&#146;s request, HCA agrees to enter into a
commercially reasonable arrangement to assure the purchaser of such assets or operations and all
applicable Governmental Authorities (a)&nbsp;that HCA is in agreement with the transaction insofar as
this Agreement or applicable Law gives HCA any interest in the applicable assets or operations, and
(b)&nbsp;that there is no reason for any Governmental Authority to delay issuance of a CON to a third
party purchaser of any Hospital (or the related Acquired Entity) because of uncertainty (caused by
the CON Challenges) relating to the CONs issued to LifePoint.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.13 <U>PIP; Transition Patients; Government Patient Receivables; and Misdirected
Payments</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;<I>PIP</I>. (i)&nbsp;If Purchaser or any of its Affiliates (including, after giving effect to the
Closing, the Acquired Entities) receives any PIP from the Medicare program associated with the
operations of the Hospitals relating solely to periods that begin and end during the Holding
Period, Purchaser will pay LifePoint an amount equal to such PIP received by Purchaser or its
Affiliates. If Purchaser or any of its Affiliates (including, after giving effect to the Closing,
the Acquired Entities) receives any PIP from the Medicare program associated with the operations of
the Hospitals relating to both the Holding Period and to periods before or after the Holding
Period, Purchaser will pay LifePoint an amount equal to the PIP actually received by Purchaser or
its Affiliates for such period multiplied by a fraction, the numerator of which shall be the total
number of days during the Holding Period attributable to such PIP and the denominator of which
shall be the total number of days attributable to such PIP.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;If LifePoint or any of its Affiliates receives any PIP from the Medicare program
associated with the operations of the Hospitals relating solely to periods either (A)&nbsp;ending prior
to the SPA Effective Time or (B)&nbsp;beginning after the Effective Time, LifePoint will pay
</DIV>

<P align="center" style="font-size: 10pt">61
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Purchaser an amount equal to such PIP received by LifePoint or its Affiliates. If LifePoint or any of its
Affiliates receives any PIP from the Medicare program associated with the operations of the
Hospitals relating to both the Holding Period and to periods before or after the Holding Period,
LifePoint will pay Purchaser an amount equal to the PIP actually received by LifePoint or its
Affiliates for such period multiplied by a fraction, the numerator of which shall be the total
number of days other than days during the Holding Period attributable to such PIP and the
denominator of which shall be the total number of days attributable to such PIP.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;<I>Payments on SPA Transition Patient Receivables</I>. To appropriately allocate payments
received by LifePoint, Purchaser or their respective Affiliates with respect to SPA Transition
Services provided to SPA Transition Patients, the parties agree as follows:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;To the extent LifePoint and its Affiliates have not prepared &#147;Transition Patient
Receivables&#148; (as defined in the SPA) as of the Effective Time with respect to services provided by
any of the Acquired Entities, Purchaser will cause the Acquired Entities to prepare claims for the
SPA Transition Patients following their discharge from the Facilities (the accounts receivable
resulting from such claims, whether prepared pursuant to <U>Section&nbsp;6.14</U> of the SPA or
pursuant to this <U>Section&nbsp;6.13</U>, the &#147;SPA Transition Patient Receivables&#148;).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;If Purchaser or any of its Affiliates receives any payments on any SPA Transition Patient
Receivable, Purchaser will pay LifePoint an amount equal to (x)&nbsp;the payments (including deposits,
deductibles and co-payments paid, whether received by Purchaser or LifePoint) with respect to the
applicable SPA Transition Patient Receivable multiplied by a fraction, the numerator of which shall
be the total charges for the SPA Transition Services provided to the applicable SPA Transition
Patient during the Holding Period, and the denominator of which shall be the sum of the total
charges of the SPA Transition Services provided to the applicable SPA Transition Patient prior to
and after the SPA Effective Time (including charges for medicine, drugs and supplies), minus (y)
any deposits, deductibles or co-payments paid by the applicable SPA Transition Patient during the
Holding Period and included in the Excluded Assets.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;If LifePoint or any of its Affiliates receives any payments on any SPA Transition
Patient Receivable, LifePoint will pay HCA an amount equal to (x)&nbsp;the payments (including deposits,
deductibles and co-payments paid, whether received by Purchaser or LifePoint) with respect to the
applicable SPA Transition Patient Receivable multiplied by a fraction, the
numerator of which shall be the total charges for the SPA Transition Services provided to the
applicable SPA Transition Patient prior to the SPA Effective Time, and the denominator of which
shall be the sum of the total charges of the SPA Transition Services provided to the applicable SPA
Transition Patient prior to and after the SPA Effective Time (including charges for medicine, drugs
and supplies), minus (y)&nbsp;any deposits, deductibles or co-payments paid by the applicable SPA
Transition Patient (A)&nbsp;prior to the SPA Effective Time and included in the &#147;Excluded Assets&#148; (as
defined in the SPA), or (B)&nbsp;and not included in the Excluded Assets, or (C)&nbsp;after the Effective
Time.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;<I>Payments on Transition Patient Receivables</I>. To appropriately allocate payments received
by Purchaser or its Affiliates (including, after giving effect to the Closing, the Acquired
Entities) with respect to Transition Services provided to Transition Patients, Purchaser will cause
the Acquired Entities to prepare claims (the accounts receivable resulting from such claims, the
</DIV>

<P align="center" style="font-size: 10pt">62
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&#147;Transition Patient Receivables&#148;) for the Transition Patients following their discharge from the
Facilities. If Purchaser or any of its Affiliates receives any payments on any Transition Patient
Receivable, Purchaser will pay LifePoint an amount equal to (x)&nbsp;the payments (including deposits,
deductibles and co-payments paid, whether received by Purchaser or LifePoint) with respect to the
applicable Transition Patient Receivable multiplied by a fraction, the numerator of which shall be
the total charges for the Transition Services provided to the applicable Transition Patient during
the Holding Period, and the denominator of which shall be the sum of the total charges of the
Transition Services provided to the applicable Transition Patient prior to, during and, after the
Holding Period (including charges for medicine, drugs and supplies), minus (y)&nbsp;any deposits,
deductibles or co-payments paid by the applicable Transition Patient during the Holding Period and
included in the Excluded Assets. If LifePoint receives any payments on the Transition Patient
Receivables (other than payments from Purchaser in accordance with this <U>Section&nbsp;6.13(c)</U> or
payments of deposits, deductibles or co-payments), LifePoint will deliver such misdirected payments
to Purchaser in accordance with <U>Section&nbsp;6.13(g)</U> and Purchaser will allocate such payments
in accordance with this <U>Section&nbsp;6.13(c)</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;<I>Split Bill SPA Transition Patients</I>. Notwithstanding the provisions of <U>Section
6.13(b)</U>, to the extent a third party payor requires the parties to submit split bills for SPA
Transition Patients (i.e., a bill for the portion of the SPA Transition Services provided prior to
the SPA Effective Time and a separate bill for the portion of the SPA Transition Services provided
after the SPA Effective Time), (i)&nbsp;the provisions of <U>Section&nbsp;6.13(b)</U> will not apply to
billing and collection for such SPA Transition Services, (ii)&nbsp;Purchaser will be responsible for
billing and collection for all such pre-SPA Effective Time Transition Services (and, as provided in
the SPA, such accounts receivable for such SPA Transition Services will be &#147;Excluded Assets&#148; under
the SPA), and (iii)&nbsp;LifePoint will be responsible for billing and collection for all such post-SPA
Effective Time SPA Transition Services provided during the Holding Period (and the accounts
receivable for such Holding Period SPA Transition Services will be Excluded Assets under this
Agreement).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;<I>Split Bill Transition Patient Receivables</I>. Notwithstanding the provisions of <U>Section
6.13(c)</U>, to the extent a third party payor requires the parties to submit split bills for
Transition Patients (i.e., a bill for the portion of the Transition Services provided prior to the
Effective Time and a separate bill for the portion of the Transition Services provided after the
Effective Time), (i)&nbsp;the provisions of <U>Section&nbsp;6.13(c)</U> will not apply to billing and
collection for such Transition
Services, (ii)&nbsp;LifePoint will be responsible for billing and collection for all such
pre-Effective Time Transition Services provided during the Holding Period (and the accounts
receivable for such Transition Services will be Excluded Assets under this Agreement), and (iii)
Purchaser will be responsible for billing and collection for all such post-Effective Time
Transition Services (and the accounts receivable for such Transition Services will not be Excluded
Assets under this Agreement).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;<I>Government Patient Receivables</I>. On or before Closing, LifePoint will cause the Acquired
Entities to establish a &#147;lock box&#148; at a financial institution selected by LifePoint and reasonably
acceptable to Purchaser. After the Closing, Purchaser will cause the Acquired Entities to deposit
in such lock box all cash, checks, drafts or similar items of payment received after the Effective
Time with respect to the Government Patient Receivables. Purchaser hereby assigns all such amounts
deposited into the lock box to LifePoint in full satisfaction of
</DIV>

<P align="center" style="font-size: 10pt">63
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Purchaser&#146;s obligation in Exhibit
F hereto to transfer to LifePoint an amount equal to the value of the Government Patient
Receivables. After the Effective Time, &#147;lock box&#148; arrangements established pursuant to <U>Section
6.14</U> of the SPA with respect to the &#147;Government Patient Receivables&#148; at the Facilities may be
terminated.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;<I>Misdirected Payments</I>. In addition to the other payments contemplated by this <U>Section
6.13</U> (or elsewhere in this Agreement), (i)&nbsp;if Purchaser or any of its Affiliates receives any
amount from patients or third-party payors which relate to services rendered by the Acquired
Entities during the Holding Period, Purchaser will remit such amount to LifePoint within ten days
of receiving such amount; and (ii)&nbsp;if LifePoint or any of its Affiliates receives any amount from
patients or third-party payors which relate to services rendered by the Acquired Entities other
than during the Holding Period LifePoint will remit such amount to Purchaser within ten days of
receiving such amount.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;<I>Payments to Purchaser</I>. LifePoint will make all payments it is required to make to
Purchaser pursuant to this <U>Section&nbsp;6.13</U> within ten days following the day LifePoint
receives such payments by depositing such amounts into an account specified in writing by
Purchaser.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;<I>Payments to LifePoint</I>. Purchaser will make all payments it is required to make to
LifePoint pursuant to this <U>Section&nbsp;6.13</U> within ten days following day Purchaser receives
such payments by depositing such amounts into an account specified in writing by LifePoint.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j)&nbsp;<I>Resolution of Disputes</I>. If any party disputes the amount of payment required to be made
pursuant to this <U>Section&nbsp;6.13</U>, (i)&nbsp;the parties will negotiate in good faith to resolve such
dispute, and (ii)&nbsp;if the parties are unable to resolve such dispute within 45&nbsp;days after the
underlying claim is made, then on five business days notice to the other party, either party may
submit the dispute to the Selected Accounting Firm and such dispute will be resolved in accordance
with the procedures of <U>Section&nbsp;2.2(d)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k)&nbsp;<I>Effectiveness of Section&nbsp;6.13</I>. The provisions of this <U>Section&nbsp;6.13</U> shall not
become effective until the Effective Time. Prior to such time, the provisions of <U>Section
6.14</U> of the SPA will govern the subject matter of this <U>Section&nbsp;6.13</U>. Additionally, as
contemplated by <U>Section&nbsp;10.1(b)</U>, this <U>Section&nbsp;6.13</U> will not be applicable to the
Clinch Valley Entities or any of the Initial Acquired Entities that has been the subject of a
Disposition or a Deemed Disposition (or an
Initial Facility that has been the subject of a Disposition or a Deemed Disposition); the
provisions of <U>Section&nbsp;6.14 </U>of the SPA shall survive the closing of the transactions
contemplated hereby for such Initial Acquired Entities and Initial Facilities.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE VII<BR>
CONDITIONS TO OBLIGATIONS OF PURCHASER</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject to <U>Section&nbsp;2.5</U> above, except as may be waived in writing by Purchaser, the
obligations of Purchaser to purchase the Acquired Company Ownership Interests and the Related
Company Ownership Interests and to consummate the transactions contemplated hereby on the Closing
Date shall be subject to the satisfaction on or prior to the Closing Date of the following
conditions:
</DIV>

<P align="center" style="font-size: 10pt">64
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.1 <U>Representations and Warranties</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;All representations and warranties of LifePoint set forth in <U>Sections&nbsp;3.2(b)</U>,
<U>3.2(c)</U>, <U>3.2(d)</U>, <U>3.2(g)</U>, <U>3.2(h)</U>, <U>3.2(i)</U>, <U>3.3(b)</U>,
<U>3.3(c)</U>, <U>3.3(d)</U>, <U>3.3(f)</U>, <U>3.3(g)</U> and <U>3.3(h)</U> and in the first
sentence of <U>Section&nbsp;3.13(a)</U> shall be true and correct as of the Closing Date in each case
as if made on and as of the Closing Date.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;If the effect of any failure or alleged failure of a representation or warranty of
LifePoint to be true and correct can be remedied by LifePoint through the payment of money or the
giving of an absolute first dollar indemnity to Purchaser and/or an Affiliate of Purchaser, and
LifePoint pays such money or gives such an indemnity, the related failure or alleged failure shall
be deemed waived by Purchaser.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;For the avoidance of doubt, (i)&nbsp;Purchaser agrees that Purchaser shall not be excused from
consummating the transactions contemplated by this Agreement based on the failure or alleged
failure of any representation or warranty made by LifePoint to be true except to the extent
provided in clause (a), above, (ii)&nbsp;Purchaser will not assert the failure or alleged failure of any
representation or warranty made by LifePoint to be true as a basis for not consummating the
transactions contemplated by this Agreement unless the representations set forth in <U>Sections
3.2(b)</U>, <U>3.2(c)</U>, <U>3.2(d)</U>, <U>3.2(g)</U>, <U>3.2(h)</U>, <U>3.2(i)</U>,
<U>3.3(b)</U>, <U>3.3(c)</U>, <U>3.3(d)</U>, <U>3.3(f)</U>, <U>3.3(g)</U> and <U>3.3(h)</U>
and in the first sentence of <U>Section&nbsp;3.13(a)</U> are not true and correct in all respects, and
(iii)&nbsp;except for the conditionality provided by this Article&nbsp;VII, the sole remedy of Purchaser for
any failure of a representation and warranty made by LifePoint to be true and correct is to be
indemnified as and to the extent set forth in <U>Article&nbsp;IX</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.2 <U>Compliance with Agreement</U>. On and as of the Closing Date, LifePoint shall have
performed and complied with each covenant and agreement required by this Agreement to be performed
and complied with by it on or before the Closing Date; provided that this condition will be deemed
to be satisfied unless both (a)&nbsp;Purchaser shall have given LifePoint written notice of such failure
to perform or comply and LifePoint shall not have cured such failure to perform or comply within 30
days after receipt of such notice and (b)&nbsp;the respects in which such covenants and obligations have
not been
performed would reasonably be expected to have had a Business Material Adverse Effect. For the
avoidance of doubt, Purchaser agrees that (i)&nbsp;Purchaser shall not be excused from consummating the
transactions contemplated by this Agreement based on LifePoint&#146;s failure or alleged failure to have
performed and complied with each covenant and agreement required by this Agreement to be performed
by LifePoint on or before the Closing Date except as provided in clauses (a)&nbsp;and (b), above, (ii)
Purchaser will not assert the failure or alleged failure of LifePoint to have performed and
complied with each such covenant and requirement except as provided in clauses (a)&nbsp;and (b), above,
and (iii)&nbsp;except for the conditionality provided by this <U>Article&nbsp;VII</U>, the sole remedy of
Purchaser for any failure of LifePoint to perform or comply with any such covenant or requirement
is to be indemnified as and to the extent set forth in <U>Article&nbsp;IX</U>. In no event shall any
dispute over a reduction in the Purchase Price based on the failure or alleged failure of LifePoint
to comply with any such covenant or agreement delay or postpone the Closing.
</DIV>

<P align="center" style="font-size: 10pt">65
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.3 <U>Closing Certificates</U>. LifePoint shall have delivered to Purchaser a certificate,
dated as of the Closing Date certifying the fulfillment of the conditions specified in <U>Sections
7.1</U> and <U>7.2</U> signed on behalf of LifePoint by a Vice President thereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.4 <U>Secretary&#146;s Certificates</U>. At the Closing, Purchaser shall have received copies of
the following, in each case certified as of the Closing Date by a Secretary or an Assistant
Secretary of LifePoint:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;resolutions of the respective boards of directors or governing boards of LifePoint and
Seller Group (and to the extent required by law or their Constituent Documents, shareholder or
other equity holders) authorizing the execution, delivery and performance of this Agreement and the
other agreements that LifePoint or Seller Group are required to execute and deliver pursuant to the
terms of this Agreement; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;the signature and incumbency of the respective officers of LifePoint and Seller Group
authorized to execute and deliver this Agreement and the other agreements and certificates that
LifePoint or Seller Group is required to deliver on or before the Closing Date pursuant to this
Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.5 <U>Reserved</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.6 <U>Services Agreements</U>. With respect to any Services Agreements between Purchaser
and LifePoint or their Affiliates with respect to the Facilities or the Acquired Entities, from and
after the Effective Time, LifePoint and its Affiliates shall be deemed released from any guaranties
or continuing obligations with respect thereto.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.7 <U>Good Standing Certificates</U>. At the Closing, LifePoint shall have delivered to
Purchaser good standing certificates issued with respect to each of the Acquired Entities issued by
the Secretary of State of the relevant entity&#146;s state of organization and qualification. Each such
good standing certificate shall be dated as of a date that is not more than 60&nbsp;days prior to the
Closing Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.8 <U>Title Work and Surveys</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <U>Title Work and Surveys</U>. Within 30&nbsp;days of the date of LifePoint&#146;s delivery of the
Unwind Notice, LifePoint shall cause to be furnished to Purchaser Title Work and Surveys for the
Real Property (which, in the case of Real Property that was included in the &#147;Real Property&#148; (as
defined in the SPA) as of the SPA Effective Time, may be updates of the Title Work and Surveys
delivered to LifePoint pursuant to the SPA), in each case showing good and marketable fee simple or
leasehold title in the Acquired Entities and disclosing no Encumbrances other than the Permitted
Encumbrances. Such Title Work and Surveys shall be prepared in accordance with the terms and
requirements set forth in the SPA for the original Title Work and Surveys delivered to LifePoint
pursuant to the SPA. Purchaser and LifePoint shall each pay one-half (1/2) the costs and expenses
of obtaining the updated Title Work and Surveys.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <U>Title Policies</U>. At the Closing, LifePoint will cause to be furnished to Purchaser
a pro forma of a then current ALTA Form&nbsp;Owner&#146;s Title Policy or Leasehold Policy, as applicable,
(the &#147;<U>Title Policy</U>&#148;) for any Real Property acquired since the Initial Closing issued
</DIV>


<P align="center" style="font-size: 10pt">66
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">by the
title insurance company providing the Title Work (the &#147;<U>Title Company</U>&#148;). The Title Policies
shall be issued as of the Closing Date in an amount equal to the portion of the Purchase Price
being allocated to such portion of the Real Property and shall insure to the applicable Acquired
Entity good and marketable fee simple or leasehold title, as the case may be, to such Real
Property, subject only to the (i)&nbsp;Permitted Encumbrances and (ii)&nbsp;taxes for the then current and
subsequent years &#147;not yet due and payable.&#148; The Title Policy shall have all standard and general
exceptions deleted so as to afford full &#147;extended form coverage&#148; as permitted by applicable State
title insurance regulations and shall contain such endorsements as were provided with the Title
Policies delivered in connection with the Initial Closing or their current equivalent, including
without limitation, a so-called non-imputation endorsement. LifePoint and its Affiliates shall
execute such certificates and affidavits as may be reasonably necessary in connection with the
issuance of the Title Policies as described in this <U>Section&nbsp;7.8(b)</U>. LifePoint and
Purchaser shall each pay one-half (1/2) of all premiums, costs and expenses of the Title Policies.
In lieu of providing such Title Policies, LifePoint may provide evidence reasonably satisfactory to
Purchaser that the applicable Acquired Entity already has such insurance.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.9 <U>Books</U>. LifePoint shall have delivered to Purchaser the original corporate minute
books of each Acquired Entity including true and complete copies of the Constituent Documents of
each Acquired Entity and other records included in the Business.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.10 <U>Miscellaneous</U>. LifePoint shall have executed and delivered all necessary
documentation and taken all action necessary to cause each relevant domain name registrar to
transfer or register in the name of Purchaser all internet domain names owned, used or registered
by or for Seller Group, Acquired Entities or their Affiliates and used primarily in connection with
the Business.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.11 <U>Resignations</U>. LifePoint will cause to deliver to Purchaser the original
resignations set forth in <U>Section&nbsp;5.12</U> above.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.12 <U>Post-Signing Breaches of Representations and Warranties</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;As of the Closing, there shall not be one or more material breaches of representations or
warranties of LifePoint set forth in this Agreement that are not qualified as to &#147;materiality&#148; or
similar qualifiers for which (i)&nbsp;Purchaser has given LifePoint written notice, (ii)&nbsp;for which the
aggregate amount of Damages resulting from such breaches exceeds 0.3% (three-tenths of one percent)
of the Purchase Price, and (iii)&nbsp;for which LifePoint has not agreed to indemnify Purchaser for
Damages resulting from such breach from the first dollar of Damages without regard to the
limitations set forth in <U>Section&nbsp;9.4(a)(i)</U>); provided, however, that in determining the
aggregate amount of the Damages resulting from such breaches, no Damages that arise out of or
relate to any such breach will be included in such calculation to the extent LifePoint otherwise
has full economic responsibility pursuant to this Agreement; and provided further, however, that in
the event Purchaser is required to disregard this Closing condition pursuant to <U>Section
2.5</U>, LifePoint will be deemed to have waived the indemnification limitations under <U>Section
9.4(a)(i)</U> with respect to the applicable issue.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;As of the Closing, there shall not be any breaches of representations or warranties of
LifePoint set forth in this Agreement that are qualified as to &#147;materiality&#148; or similar
</DIV>


<P align="center" style="font-size: 10pt">67
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">qualifiers
for which (i)&nbsp;Purchaser has given LifePoint written notice, and (ii)&nbsp;for which LifePoint either (A)
has not agreed to indemnify Purchaser for Damages resulting from such breach from the first dollar
of Damages without regard to the limitations set forth in <U>Section&nbsp;9.4(a)(i)</U>), or (B)&nbsp;does
not otherwise have full economic responsibility pursuant to this Agreement; provided, however, that
in the event Purchaser is required to disregard this Closing condition pursuant to <U>Section
2.5</U>, LifePoint will be deemed to have waived the indemnification limitations under <U>Section
9.4(a)(i)</U> with respect to the applicable issue and assumed full economic responsibility for
such matter.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.13 <U>Damage, Destruction or Loss</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;If any non-material damage, destruction or loss is known to have occurred after the SPA
Effective Time and prior to the Effective Time with respect to any assets of any Hospital Group, at
the Effective Time, LifePoint shall pay or assign to Purchaser (i)&nbsp;all insurance proceeds
previously paid to LifePoint or its Affiliates arising out of such damage, destruction or loss that
have not been used to repair or replace the damaged, destroyed or lost assets, (ii)&nbsp;all future
insurance proceeds to which LifePoint or its Affiliates is entitled arising out of such damage,
destruction or loss (except to the extent LifePoint has not been reimbursed through insurance
proceeds for its payment of the cost of repairing or replacing the damaged, destroyed or lost
assets), and (iii)&nbsp;to the extent that such insurance proceeds are limited by a deductible under
such policies, payment of an amount equal to such deductible minus $100,000 (but if such amount is
a negative number, Purchaser will not be required to reimburse LifePoint for such amount or share
any of the insurance proceeds described in clauses (i)&nbsp;and (ii), above).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;If a material damage, destruction or loss is known to have occurred prior to the Effective
Time with respect to any assets of any Hospital Group, at the Effective Time, LifePoint shall (i)
pay or assign to Purchaser the insurance proceeds described in clauses (a)(i)
and (ii), above, and (ii)&nbsp;indemnify Purchaser (with first dollar indemnification) for any
other Damages that Purchaser suffers as a result of such damage, destruction or loss.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;LifePoint shall cause any such proceeds pursuant to such insurance policies in respect of
such damage, destruction or loss to be paid to Purchaser.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.14 <U>Waiver of Conditions</U>. Purchaser may waive any conditions in writing of this
<U>Article&nbsp;VII</U> to the extent permitted by applicable law. Except as otherwise provided herein
or agreed to by the parties prior to the Closing, the consequences of any knowing written waiver
shall be (a)&nbsp;the elimination of the waived condition as a valid basis for Purchaser to refuse to
close the transactions contemplated by this Agreement, and (b)&nbsp;the release of LifePoint from any
claim by Purchaser for resulting injuries and Damages with respect to that waived condition.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.15 <U>Restoration of Assets Retained in Consolidated Group</U>. To the extent (a)&nbsp;any
assets (other than current assets) held by the Initial Acquired Entities as of the SPA Effective
Time (or any assets acquired during the Holding Period to replace such assets) shall have been
sold, transferred, or otherwise disposed of in a transaction with LifePoint or any of its
Affiliates as the buyer, LifePoint or one of its Affiliates continues to own such assets at the
Effective Time), and (c)&nbsp;such assets are, individually or in the aggregate, essential to the
operation of the applicable Acquired Entity or Hospital Group, then at or prior to the Effective
Time, LifePoint
</DIV>

<P align="center" style="font-size: 10pt">68
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">shall have either (i)&nbsp;caused such assets to be returned to (and title to such
assets vested in) the Acquired Entities, or (ii)&nbsp;caused the applicable Person or Hospital Group to
acquired suitable replacement assets.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.16 <U>Consents, Authorizations, Etc</U>. Purchaser shall have obtained documentation or
other evidence reasonably satisfactory to Purchaser that:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Purchaser has (i)&nbsp;received all required Permits of Governmental Authorities that Purchaser
must as a matter of Law receive prior to Closing in order to consummate the transactions
contemplated herein; and (ii)&nbsp;received reasonable assurance from the applicable Governmental
Authorities that such Permits as are required to operate the Facilities as operated by LifePoint
and its Affiliates during the Holding Period (other than Permits the failure of which to obtain
would not reasonably be expected to have a Hospital Group Material Adverse Effect) shall be issued
promptly following the Effective Time and be effective as of the Effective Time;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;All waiting periods under the HSR Act and any similar state Law shall have expired or been
terminated; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;All of the Acquired Entities that operate Facilities and have historically participated in
the Medicare and/or Medicaid programs will continue to participate in such programs following the
Closing.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.17 <U>No Action or Proceeding</U>. On the Closing Date, (a)&nbsp;no valid judgment, order or
decree of any court or other Governmental Authority restraining, enjoining or otherwise preventing
the consummation of this Agreement or
the transactions contemplated hereby shall be outstanding, and (b)&nbsp;no action, suit,
investigation or proceeding brought by any Governmental Authority shall be pending before any court
or other Governmental Authority or threatened in writing by any Governmental Authority to restrain,
enjoin or otherwise prevent the consummation of this Agreement or any of the transactions
contemplated hereby, which action, suit, investigation or proceeding, in the reasonable opinion of
Purchaser, may result in a decision, ruling or finding that has or would reasonably be expected to
have a material adverse effect on the validity or enforceability of this Agreement, or on the
ability of LifePoint to perform its obligations under this Agreement.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE VIII<BR>
CONDITIONS TO OBLIGATIONS OF LIFEPOINT</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject to <U>Section&nbsp;2.5</U>, above, except as may be waived in writing by LifePoint, the
obligations of LifePoint to consummate the transactions contemplated hereby on the Closing Date
shall be subject to the satisfaction on or prior to the Closing Date of the following conditions:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.1 <U>Representations and Warranties</U>. All representations and warranties of Purchaser
set forth in this Agreement shall be true and correct as of the Closing Date in each case as if
made on and as of the Closing Date (except to the extent such representations and warranties
specifically speak as of an earlier date, in which case as of such date); provided, however, that
this condition will be deemed to be satisfied so long as the failure of such representations and
</DIV>

<P align="center" style="font-size: 10pt">69
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">warranties to be true and correct (without regard to any qualifiers with respect to materiality
contained in such representations and warranties) as of the Closing Date would not reasonably be
expected to have a material adverse effect on Purchaser&#146;s ability to perform its obligations under
and consummate the transactions contemplated by this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.2 <U>Compliance with Agreement</U>. On and as of the Closing Date, Purchaser shall have
performed and complied with each covenant and agreement required by this Agreement to be performed
and complied with by it on or before the Closing Date; provided that this condition will be deemed
to be satisfied unless both (a)&nbsp;LifePoint shall have given Purchaser written notice of such failure
to perform or comply and Purchaser shall not have cured such failure to perform or comply within 30
days after receipt of such notice and (b)&nbsp;the respects in which such covenants and obligations have
not been performed would reasonably be expected to have a material adverse effect on Purchaser&#146;s
ability to perform its obligations under and consummate the transactions contemplated by this
Agreement. For the avoidance of doubt, LifePoint agrees that (i)&nbsp;LifePoint shall not be excused
from consummating the transactions contemplated by this Agreement based on Purchaser&#146;s failure or
alleged failure to have performed and complied with each covenant and agreement required by this
Agreement to be performed by Purchaser on or before the Closing Date except as provided in clauses
(a)&nbsp;and (b), above, (ii)&nbsp;LifePoint will not assert the failure or alleged failure of Purchaser to
have performed and complied with each such covenant and requirement except as provided in clauses
(a)&nbsp;and (b), above, and (iii)&nbsp;except for the conditionality provided by this <U>Article&nbsp;VIII</U>,
the sole remedy of LifePoint for any failure of Purchaser to perform or
comply with any such covenant or requirement is to be indemnified as and to the extent set
forth in <U>Article&nbsp;IX</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.3 <U>Closing Certificates</U>. Purchaser shall have delivered to LifePoint a certificate,
dated as of the Closing Date and signed on behalf of Purchaser by the President or a Vice President
thereof, certifying the fulfillment of the conditions specified in <U>Sections&nbsp;8.1</U> and
<U>8.2</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.4 <U>Secretary&#146;s Certificate</U>. At the Closing, LifePoint shall have received copies of
the following, in each case certified as of the Closing Date by a Secretary or an Assistant
Secretary of Purchaser:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;resolutions of the board of directors of Purchaser (and to the extent required by law or
their Constituent Documents, shareholder or other equity holders) authorizing the execution,
delivery and performance of this Agreement and the other agreements that Purchaser is required to
execute and deliver pursuant to the terms of this Agreement; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;the signature and incumbency of the officers of Purchaser authorized to execute and
deliver this Agreement and the other agreements and certificates that Purchaser is required to
deliver on or before the Closing Date pursuant to this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.5 <U>Consent, Authorizations, Etc</U>. LifePoint shall have obtained documentation or
other evidence reasonably satisfactory to LifePoint that:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;LifePoint has received all required Permits of Governmental Authorities that LifePoint
must, as a matter of Law, receive prior to the Closing in order to consummate the transactions
herein contemplated; and
</DIV>


<P align="center" style="font-size: 10pt">70
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;all waiting periods under the HSR Act and any similar state Law shall have expired or been
terminated.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.6 <U>No Action or Proceeding</U>. On the Closing Date, (a)&nbsp;no valid judgment, order or
decree of any court or other Governmental Authority restraining, enjoining or otherwise preventing
the consummation of this Agreement or the transactions contemplated hereby shall be outstanding,
and (b)&nbsp;no action, suit, investigation or proceeding brought by any Governmental Authority shall be
pending before any court or other Governmental Authority or threatened in writing by any
Governmental Authority to restrain, enjoin or otherwise prevent the consummation of this Agreement
or any of the transactions contemplated hereby, which action, suit, investigation or proceeding, in
the reasonable opinion of LifePoint, may result in a decision, ruling or finding that has or would
reasonably be expected to have a material adverse effect on the validity or enforceability of this
Agreement or on the ability of Purchaser to perform its obligations under this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.7 <U>Good Standing Certificate</U>. At the Closing, Purchaser shall have delivered to
LifePoint a good standing certificate issued with respect to Purchaser by the Secretary of State of
Purchaser&#146;s state of incorporation. Such good
standing certificate shall be dated as of a date that is not more than 60&nbsp;days prior to the
Closing Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.8 <U>Constituent Documents</U>. Purchaser shall have delivered to LifePoint true and
complete copies of Purchaser&#146;s Constituent Documents.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.9 <U>Waiver of Conditions</U>. LifePoint may waive any conditions in writing of this
<U>Article&nbsp;VIII</U> to the extent permitted by applicable law. Except as otherwise provided
herein or agreed to by the parties prior to the Closing, the consequences of any knowing written
waiver shall be (a)&nbsp;the elimination of the waived condition as a valid basis for LifePoint to
refuse to close the transactions contemplated by this Agreement, and (b)&nbsp;the release of Purchaser
from any claim by LifePoint for resulting injuries and Damages with respect to that waived
condition.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE IX<BR>
INDEMNIFICATION</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.1 <U>Survival</U>. Except as otherwise provided in this <U>Article&nbsp;IX</U>, (a)&nbsp;each
representation and warranty contained in <U>Articles III</U> and <U>IV</U> shall survive the
Closing for sixteen months after the Closing Date, provided that the representations and warranties
contained in (i) <U>Section&nbsp;3.12</U> (ERISA), <U>3.13</U> (Government Program Participation),
<U>3.14</U> (Taxes) and <U>3.18</U> (Environmental Conditions) shall survive the Closing for a
period of six years and (ii) <U>Sections&nbsp;3.2(c)</U>, <U>3.2(d)</U>, <U>3.3(d)</U> and
<U>3.3(e)</U> shall survive until the expiration of the applicable statute of limitations, and (b)
covenants in this Agreement shall survive the Closing. The period from the date hereof until the
last date on which a representation, warranty, covenant or other obligation survives pursuant to
this <U>Section&nbsp;9.1</U> shall be known as the &#147;<U>Survival Period</U>.&#148; No party, affiliate of
any party, nor any shareholder, director, officer, employee, or affiliate of any of the foregoing
shall incur any liability whatsoever as a result of any inaccuracy in or breach of any applicable
representation or warranty, except for indemnification obligations pursuant to this <U>Article
IX</U> with respect to those inaccuracies, breaches, or failures as to which written notice of
which has been received prior to the expiration of the applicable Survival Period.
</DIV>

<P align="center" style="font-size: 10pt">71
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.2 <U>Indemnification by LifePoint</U>. Subject to the provisions of this <U>Article
IX</U>, LifePoint shall indemnify and hold harmless Purchaser, any Affiliate of Purchaser, and the
respective officers, directors, shareholders, employees, agents and representatives of Purchaser
and its Affiliates (each, a &#147;<U>Purchaser Indemnitee</U>&#148;) from and after the Effective Time, from
and against any Damages actually incurred by such Purchaser Indemnitee as a result of:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;the Excluded Assets and Excluded Contracts;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;any inaccuracy in any of the representations and warranties made herein by LifePoint;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;any breach of any of the covenants or agreements made herein by LifePoint;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;any Encumbrance of any landlord, carrier, warehouseman, mechanic or materialman and any
like Encumbrance existing at the Closing and arising in the ordinary course of business for sums
that are not delinquent or which are being contested in good faith through appropriate proceedings;
and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;any LifePoint Excluded Liabilities; provided that nothing herein shall relieve HCA of its
indemnification obligations pursuant to <U>Section&nbsp;9.3</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Notwithstanding the foregoing, the sole recourse of a Purchaser Indemnitee for any and all Damages
relating to or arising from a breach of any of the covenants or agreements contained in
<U>Sections&nbsp;3.14</U> or <U>6.6</U>, to the extent that they relate to Taxes, shall be controlled
by the provisions of <U>Section&nbsp;9.5</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.3 <U>Indemnification by Purchaser</U>. Subject to the provisions of this <U>Article
IX</U>, Purchaser shall indemnify and hold harmless LifePoint, Seller Group, any Affiliate of
LifePoint or Seller Group, and the respective officers, directors, shareholders, employees, agents
and representatives of LifePoint, Seller Group and their respective Affiliates (each a &#147;<U>Seller
Indemnitee</U>&#148;) from and after the Effective Time from and against any Damages actually incurred
by such Seller Indemnitee as a result of:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;any inaccuracy in any of the representations and warranties made herein by Purchaser;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;any breach of any of the covenants or agreements made herein by Purchaser;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;any HCA Excluded Liabilities; provided that nothing herein shall relieve LifePoint of its
indemnification obligations pursuant to <U>Section&nbsp;9.2</U>.; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;any Claims, actions, suits or proceedings arising out of any post-Closing obligation or
action on the part of the Acquired Entities under any Contract which is not an Excluded Contract or
Excluded Liability.
</DIV>



<P align="center" style="font-size: 10pt">72
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Notwithstanding the foregoing, the sole recourse of a Seller Indemnitee for any and all Damages
relating to or arising from a breach of any of the covenants or agreements contained in
<U>Sections&nbsp;3.14</U> or <U>6.6</U>, to the extent that they relate to Taxes, shall be controlled
by the provisions of <U>Section&nbsp;9.5</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.4 <U>Additional Provisions</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Notwithstanding anything in this <U>Article&nbsp;IX</U> to the contrary, the rights of the
parties to be indemnified and held harmless under this Agreement shall be limited as follows:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;No claims for indemnity by a Purchaser Indemnitee for any inaccuracy in a representation
or warranty (other than for breach of <U>Section&nbsp;3.2</U>, <U>3.3</U>, <U>3.4</U>, <U>3.5</U>,
<U>3.12(b)</U> or <U>3.21</U>, which shall each be indemnified from the first dollar of
Damages) made in this Agreement by LifePoint shall be made unless and until the aggregate dollar
amount of all such Claims exceeds six-tenths of one percent (0.6%) of the Purchase Price, in which
case LifePoint shall be obligated to indemnify, defend and hold harmless the Purchaser Indemnitee
for all Damages above and beyond such amount (excluding the initial six-tenths of one percent
(0.6%) of the Purchase Price) provided that materiality qualifications (and the like) will not be
taken into account in determining the magnitude of the damages occasioned by a breach for purposes
of calculating the amount of Damages.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;The maximum aggregate liability of LifePoint for Claims pursuant to <U>Sections&nbsp;9.2
(b)</U> and <U>(c)</U> shall be limited to the Purchase Price.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;The maximum aggregate liability of HCA for Claims pursuant to <U>Sections&nbsp;9.3 (a)</U>
and <U>(b)</U> shall be limited to the Purchase Price.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The liability of a party with respect to any claim for indemnity by an Indemnitee pursuant
to this <U>Article&nbsp;IX</U> shall be offset dollar for dollar by (i)&nbsp;any insurance proceeds received
by such Indemnitee after the Effective Time in respect of the Damages involved, (ii)&nbsp;any positive
Tax effect actually recognized by the Indemnitee in respect of the Damages involved, and (iii)&nbsp;any
other recovery made by such Indemnitee from any third party on account of the Damages involved.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.5 <U>Tax Indemnification</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;LifePoint shall indemnify, defend and hold Purchaser and the Acquired Entities harmless
from and against any and all Damages for Taxes imposed on or with respect to any Acquired Entity
for a LifePoint Tax Period (including, without limitation, any Taxes imposed on any Acquired Entity
as a result of having been a member of the LifePoint Affiliated Group under Treas. Reg. Section
1.1502-6 or any similar provision of state, local or foreign law, and also including any Tax
liability for a LifePoint Tax Period with respect to any Acquired Entity as a transferee or
successor, by contract, law or equity). Notwithstanding the foregoing, LifePoint shall not
indemnify, defend or hold harmless Purchaser and the Acquired Entities from and against any and all
Damages for Taxes attributable to (i)&nbsp;any Taxes for which Purchaser is obligated to pay pursuant to
the terms of the SPA or (ii)&nbsp;any action taken (which would otherwise give rise to an Tax indemnity
payment by LifePoint or its Affiliates) after the Effective Time by Purchaser or the Acquired
Entities (other than any such action expressly required or
</DIV>


<P align="center" style="font-size: 10pt">73
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">otherwise expressly contemplated by this
Agreement or with the written consent of LifePoint) (a &#147;<U>Purchaser Tax Act</U>&#148;).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Purchaser shall indemnify, defend and hold LifePoint and the LifePoint Affiliated Group
harmless from and against any and all Damages for (i)&nbsp;Taxes of any of the Acquired Entities, except
to the extent LifePoint is otherwise required to indemnify Purchaser for such Taxes pursuant to
<U>Section&nbsp;9.5(a)</U>, and (ii)&nbsp;Taxes attributable to a Purchaser Tax Act.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;The amount of any Taxes for which indemnification is provided under this <U>Section
9.5</U> shall not be (A)&nbsp;increased to take account of any net Tax cost incurred by the Indemnitee
arising from the receipt of indemnity payments hereunder or (B)&nbsp;reduced to take
account of any net Tax benefit realized by the Indemnitee arising from the incurrence or
payment of any such Taxes. Any indemnity payment under this Agreement shall be treated as an
adjustment to the Purchase Price for United States federal Tax purposes, unless otherwise required
by Law.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Any indemnity payment required to be made pursuant to this <U>Section&nbsp;9.5</U> shall be
paid within 30&nbsp;days after the Indemnitee makes written demand upon the indemnifying party, but in
no case earlier than five Business Days prior to the date on which the relevant Taxes are required
to be paid to the relevant Governmental Authority (including estimated Tax payments).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;In no event shall the indemnities provided for in this <U>Section&nbsp;9.5</U> be subject to
the provisions of <U>Section&nbsp;9.4</U> of this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;The provisions of this <U>Section&nbsp;9.5</U> shall not become effective until the Effective
Time. Prior to such time, the provisions of <U>Section&nbsp;9.5</U> of the SPA will govern the subject
matter of this <U>Section&nbsp;9.5</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.6 <U>Claims Procedures</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;If a party seeks indemnification for Damages hereunder, the party seeking indemnification
(the &#147;<U>Indemnitee</U>&#148;) shall promptly notify the party from whom indemnification is sought (the
&#147;<U>Indemnifying Party</U>&#148;) in writing of the existence and nature of such Damages (a
&#147;<U>Claim</U>&#148;), and shall include in the Claim a reasonably detailed description of all related
claims, demands, actions or proceedings, if any, out of which the Damages arise; provided, however,
that so long as a Claim is delivered within the applicable Survival Period, failure or delay by the
Indemnitee to deliver a Claim in compliance with this provision shall only reduce the obligation of
the Indemnifying Party to the extent that such failure impairs the Indemnifying Party&#146;s ability to
defend the claim or mitigate Damages, in which case the Indemnifying Party shall have no obligation
to indemnify the Indemnitee to the extent of Damages, caused by such failure.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;In the event of a Claim related to a claim by a third party, the Indemnifying Party may
elect to retain counsel of its choice to represent the Indemnitee in connection with such Claim and
shall pay the fees, charges and disbursements of such counsel. The Indemnitee may participate, at
its own expense and through legal counsel of its choice, provided that (i)&nbsp;the Indemnifying Party
may elect to control the defense of the Indemnitee in connection with such Claim and (ii)&nbsp;the
Indemnitee and their counsel shall cooperate with the
</DIV>


<P align="center" style="font-size: 10pt">74
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Indemnifying Party and its counsel in
connection with such Claim. The Indemnifying Party shall not settle any such Proceeding without
the relevant Indemnitees&#146; prior written consent (which shall not be unreasonably withheld), unless
the terms of such settlement provide for no relief other than the payment of monetary damages.
Notwithstanding the foregoing, if the Indemnifying Party elects not to retain counsel and assume
control of such defense or if both the Indemnifying Party and any Indemnitee are parties to or
subjects of such proceeding and conflicts of interests exist between the Indemnifying Party and
such Indemnitee, then the Indemnitee shall retain counsel reasonably acceptable to the Indemnifying
Party in connection with such proceeding and assume control of the defense in connection therewith,
and the fees,
charges and disbursements of no more than one such counsel per jurisdiction selected by the
Indemnitee shall be reimbursed by the Indemnifying Party.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;If the Indemnifying Party shall, within a reasonable time after said notice, fail to
defend, the Indemnitee shall have the right, but not the obligation, and without waiving any rights
against the Indemnifying Party, to undertake the defense of, and with the consent of the
Indemnifying Party (such consent not to be withheld unreasonably), to compromise or settle the
Claim on behalf, for the account, and at the risk and expense, of the Indemnifying Party and shall
be entitled to collect the amount of any settlement or judgment or decree and all costs and
expenses (including, without limitation, reasonable attorney&#146;s fees) in connection therewith from
the Indemnifying Party. Under no circumstances will the Indemnifying Party have any liability in
connection with any settlement of any Proceeding that is entered into without its prior written
consent (which shall not be unreasonably withheld). Except as provided in this <U>Section
9.6(c)</U>, the Indemnitee shall not compromise or settle any Claim.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;From and after the delivery of a Claim, at the reasonable request of the Indemnifying
Party, each Indemnitee shall grant the Indemnifying Party and its counsel, experts and
representatives full access, during normal business hours, to the books, records, personnel and
properties of the Indemnitee to the extent reasonably related to the Claim at no cost to the
Indemnifying Party.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;If the Indemnitee or its Affiliates subsequently recover all or part of a third-party
claim from any other Person legally obligated to pay the claim, the Indemnitee shall repay to the
Indemnifying Party the amounts recovered up to an amount not exceeding the payment made by the
Indemnifying Party to the Indemnitee by way of indemnity.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.7 Exclusive Remedy. From and after the Closing, the exclusive remedy of each party in
connection with this Agreement and the transactions contemplated hereby shall be as provided in
this <U>Article&nbsp;IX</U>.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE X<BR>
TERMINATION OF AGREEMENTS AND RELEASE</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.1 <U>Termination</U>. (a)&nbsp;Subject to the provisions of <U>Section&nbsp;10.1(b)</U>, as of
the Effective Time, the SPA shall be terminated and the parties thereto will have no further
obligations or rights thereunder, except that the rights and obligations of the parties under the
following sections of the SPA shall survive the Closing of the transactions contemplated hereby:
(i) <U>Article&nbsp;I</U>, <U>Sections&nbsp;2.3</U>, <U>6.3</U>, and <U>6.8</U>, and <U>Articles XI</U>
and <U>XII</U>; (ii)&nbsp;solely to the extent they relate to
</DIV>

<P align="center" style="font-size: 10pt">75
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Claims that have been asserted and remain
outstanding as of the Effective Time, <U>Article&nbsp;III</U>, <U>Article&nbsp;IV</U>, and <U>Sections
9.1</U>, <U>9.2</U>, <U>9.3</U>, <U>9.4</U> (other than <U>Section&nbsp;9.4(a)(i)</U>, which shall
not survive the Closing of the transactions contemplated hereby), <U>9.6</U> and <U>9.7</U>; and
(iii)&nbsp;solely to the extent that they relate to Claims that have been asserted and remain
outstanding as of the Effective Time or third party claims brought against a &#147;Seller Indemnitee&#148;
(as defined in the SPA) before or after the Effective Time, <U>Sections&nbsp;6.4</U>, <U>6.5</U>, and
<U>6.6</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Notwithstanding the provisions of <U>Section&nbsp;10.1(a)</U>, insofar as the SPA relates to
the Clinch Valley Entities or any of the Initial Acquired Entities that has been the subject of a
Disposition or a deemed Disposition, the SPA shall survive the closing of the transactions
contemplated hereby.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.2 <U>Release</U>. Each of LifePoint and Purchaser hereby agrees that, as of the Effective
Time, each of LifePoint and Purchaser, on behalf of itself and its Affiliates, does hereby release
and forever discharge the other, their respective Affiliates, and the officers, directors, agents,
shareholders and partners of each (&#147;<U>Covered Parties</U>&#148;) from any and all actions and causes
of action (whether at law or in equity), losses, damages, costs, expenses, liabilities, obligations
and claims or demands of any kind, that exists under the SPA or the transactions contemplated,
other than the Post Termination Rights, whether known or unknown, foreseen or unforeseen
(collectively, the &#147;<U>Claims</U>&#148;).
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE XI<BR>
ARBITRATION</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.1 <U>Arbitration</U>. (a)&nbsp;In case of a dispute, controversy or claim arising out of,
relating to or in connection with (i)&nbsp;the determination of the Damages Adjustment Amount, (ii)&nbsp;if
elected by either party in accordance with <U>Section&nbsp;2.2(d)</U>, the determination of the Capital
Expenditures Adjustment Amount and the Disposition Adjustment Amount, or (iii)&nbsp;whether HCA has
validly rejected a Contract in accordance with <U>Section&nbsp;5.14</U> and the parties have not
resolved such dispute, controversy or claim within the applicable resolution periods specified in
<U>Sections&nbsp;2.2</U> and <U>5.14</U> have expired, either of the parties may demand binding
arbitration of the matter unless the amount of the damage or loss is at issue in pending litigation
with a third party, in which event arbitration shall not be commenced until such amount is
ascertained or both parties agree to arbitration. Unless otherwise agreed by the parties, the
arbitration shall be administered by the American Arbitration Association (the &#147;<U>AAA</U>&#148;) and
shall be conducted by three neutral arbitrators, each having experience in the area of healthcare
mergers and acquisitions, at least one of whom shall be a practicing attorney and one third of whom
shall be a certified public accountant. Within 15&nbsp;days of commencement of arbitration, HCA and
LifePoint shall each select one neutral qualified arbitrator. Within ten days of their
appointment, the two neutral arbitrators so selected shall select the third neutral qualified
arbitrator from a list of arbitrators provided by the AAA having experience in the area of
healthcare mergers and acquisitions. The third arbitrator shall act as chair of the arbitration
panel. If the arbitrators selected by the parties are unable or fail to agree upon the third
arbitrator, the third arbitrator shall be selected by the AAA. The arbitrators shall set a limited
time period and establish procedures designed to reduce the cost and time for discovery while
allowing the parties an opportunity, adequate in the sole judgment of the arbitrators, to discover
relevant information from the opposing parties about the subject matter of the dispute. Any
dispute regarding discovery, or the relevance or scope thereof,
</DIV>

<P align="center" style="font-size: 10pt">76
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">shall be determined by the chair of
the arbitration panel and shall be governed by the Federal Rules of Civil Procedure. The decision
of a majority of the three arbitrators as to the validity and amount of any claim shall be binding
and conclusive upon the parties to this Agreement. The award by the arbitrators shall be in
writing, shall be signed by a majority of the arbitrators and shall include a statement of written
findings of fact and conclusions regarding the reasons for the disposition of any claim.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Judgment upon any award rendered by the arbitrators may be entered in any court having
jurisdiction. Any such arbitration shall be held in Nashville, Tennessee under the Commercial
Arbitration Rules then in effect of the AAA. The arbitrators shall designate which party is the
prevailing party in the dispute, taking into account, among other factors, the amount in dispute
and the amount of the award. The non-prevailing party shall pay all costs and fees associated with
the arbitration. &#147;Costs and fees&#148; for purposes of this subsection mean all reasonable pre-award
expenses of the arbitration, including the arbitrators&#146; fees, administrative fees, travel expenses,
and out of pocket expenses such as copying and telephone.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;By agreeing to arbitration, the parties do not intend to deprive any court with
jurisdiction of its ability to issue a preliminary injunction, attachment or other form of
provisional remedy in aid of the arbitration and a request of such provisional remedies by a party
to a court shall not be deemed a waiver of the agreement to arbitrate.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE XII<BR>
MISCELLANEOUS</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.1 <U>Fees and Expenses</U>. Except as otherwise provided in this Agreement, LifePoint
shall pay its own expenses (in connection with this Agreement and also including those expenses of
the Acquired Entities in connection with this Agreement and the transactions contemplated hereby
incurred prior to the Effective Time) and Purchaser shall pay its own expenses (including any fees
and expenses of Merrill Lynch &#038; Co. and those of the Acquired Entities in connection with this
Agreement and the transactions contemplated hereby incurred after the Effective Time) in connection
with this Agreement and the transactions contemplated hereby. LifePoint and Purchaser shall each
pay one-half of all recording fees, transfer fees, transfer taxes, sales taxes, if any, and
documentary or stamp taxes, if any, relating to the sale and the transactions provided for herein.
Purchaser shall reimburse LifePoint for one-half of its unamortized loan costs directly related to
the Initial Closing after giving effect to the exclusion of the Clinch Valley Entities as reflected
on LifePoint&#146;s financial statements; LifePoint shall provide Purchaser reasonable details and
supporting information therefor. Except as set forth in the following sentence, each party shall
pay its own fees and expenses, including for purposes of this Section, attorney fees, with respect
to the preparation of pre-merger report forms under the HSR Act. Purchaser shall pay the HSR
filing fees of all parties with respect to the filing of notifications under the HSR Act. Further,
and notwithstanding the foregoing, Purchaser will bear all fees and expenses of all parties,
resulting from or relating to any investigation or challenge of the transactions contemplated
hereby initiated by the United States Federal Trade Commission, the United States Department of
Justice or the Attorney General of any state on, prior to or after the Closing under antitrust or
similar Laws, including costs and expenses resulting from or relating to any &#147;second request&#148;
issued in connection with the parties&#146; HSR Act filings made in connection with the
</DIV>

<P align="center" style="font-size: 10pt">77
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">transactions
contemplated hereby. Purchaser shall also pay all fees and expenses in connection with the filing
of any applicable certificates of need and the related proceedings.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.2 <U>Entire Agreement</U>. Except for documents and agreements executed pursuant hereto,
this Agreement supersedes all prior oral discussions and written agreements between the parties
with respect to the subject matter of this Agreement
(including any term sheet or similar agreement or document relating to the transactions
contemplated hereby). This Agreement, including the exhibits and schedules hereto and other
documents delivered in connection herewith, contains the sole and entire agreement between the
parties hereto with respect to the subject matter hereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.3 <U>Waiver</U>. Any term or condition of this Agreement may be waived at any time by the
party which is entitled to the benefit thereof. Any such waiver must be in writing and must be
duly executed by such party. A waiver on one occasion shall not be deemed to be a waiver of the
same or any other breach, provision or requirement on any other occasion.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.4 <U>Amendment</U>. This Agreement may be modified or amended only by a written
instrument duly executed by each of the parties hereto.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.5 <U>Counterparts; Facsimile Signatures; Reproductions</U>. This Agreement may be
executed simultaneously in any number of counterparts, each of which shall be deemed an original,
but all of which shall constitute one and the same instrument. Facsimile signatures on this
Agreement shall be deemed to be original signatures for all purposes. This Agreement and all
documents relating hereto, including (i)&nbsp;consents, waivers and modifications which may hereafter be
executed, (ii)&nbsp;the documents delivered at the Closing, and (iii)&nbsp;financial statements, certificates
and other information previously or hereafter furnished to LifePoint or to Purchaser, may be
reproduced by LifePoint and by Purchaser by any photographic, photostatic, microfilm, micro-card,
miniature photographic or other similar process and, unless otherwise required by Law, LifePoint
and Purchaser may destroy any original documents so reproduced. LifePoint and Purchaser agree and
stipulate that any such reproduction shall be admissible in evidence as the original itself in any
judicial, arbitral or administrative proceeding (whether or not the original is in existence and
whether or not such reproduction was made by LifePoint or Purchaser in the regular course of
business) and that any enlargement, facsimile or further reproduction of such reproduction shall
likewise be admissible in evidence.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.6 <U>No Third Party Beneficiary</U>. The terms and provisions of this Agreement are
intended solely for the benefit of LifePoint, Purchaser and their respective successors or assigns,
and it is not the intention of the parties to confer third party beneficiary rights upon any other
Person.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.7 <U>Governing Law, Construction</U>. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED
IN ACCORDANCE WITH THE LAWS OF THE STATE OF TENNESSEE APPLICABLE TO A CONTRACT EXECUTED AND
PERFORMED IN SUCH STATE. The parties hereto agree that no provisions of this Agreement or any
related document shall be construed for or against or interpreted to the advantage or disadvantage
of any party hereto by any court or other Governmental Authority by reason of any party&#146;s having or
being
</DIV>

<P align="center" style="font-size: 10pt">78
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">deemed to have structured or drafted such provision, each party having participated equally
in the structuring and drafting hereof.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.8 <U>Binding Effect</U>. This Agreement shall be binding upon and inure to the benefit of
the parties and their respective successors and permitted assigns, including successors by merger
or otherwise.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.9 <U>No Assignment</U>. Neither this Agreement nor any right hereunder or part hereof may
be assigned by any party hereto without the prior written consent of the other parties hereto;
provided, however, that LifePoint, on the one hand, and Purchaser, on the other hand, may assign
some or all of their respective rights and obligations under this Agreement to other Persons who
(a)&nbsp;are wholly-owned (directly or indirectly) by LifePoint or Purchaser, respectively, and (b)
agree to be bound by the terms and conditions of this Agreement. Notwithstanding the assignment of
this Agreement or any rights or obligations hereunder, the assignor shall be jointly and severally
liable with its assignee for its obligations hereunder.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.10 <U>Headings, Gender, Etc</U>. The headings used in this Agreement have been inserted
for convenience and do not constitute provisions to be construed or interpreted in connection with
this Agreement. Unless the context of this Agreement otherwise requires, (a)&nbsp;words of any gender
will be deemed to include each other gender, (b)&nbsp;words using the singular or plural number also
will include the plural or singular number, respectively, (c)&nbsp;the terms &#147;hereof&#148;, &#147;herein&#148;,
&#147;hereby&#148; and derivative or similar words will refer to this entire Agreement, (d)&nbsp;the terms
&#147;Article,&#148; &#147;Section,&#148; &#147;Schedule&#148; and &#147;Exhibit&#148; will refer to the specified Article or Section of
this Agreement or the specified Schedule or Exhibit to this Agreement, and (e)&nbsp;the terms &#147;material
contract,&#148; &#147;material permit,&#148; &#147;material assets,&#148; &#147;material increase,&#148; &#147;material taxes,&#148; &#147;material
default,&#148; &#147;substantially all&#148; and phrases of similar import will be deemed to be measured with
respect to the Hospital Group to which it relates against their effect on the financial condition
and operations of such Hospital Group.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.11 <U>Public Announcement</U>. On or before the Closing, the parties hereto will each
consult with one another prior to making or issuing public statements or announcements with respect
to this Agreement or the transactions contemplated hereby and will use good faith efforts to agree
on the text of a joint public statement or announcement and/or will use good faith efforts to
obtain the other parties&#146; approval of the text of any public statement or announcement to be made
solely on behalf of a party; provided that the foregoing shall not preclude any party from making
such disclosure as may be required by applicable Law or the rules of any securities exchange or
market on which securities of such party are listed or quoted.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.12 <U>Access to Information</U>. LifePoint and Purchaser agree that, from time to time
after the Closing, upon the reasonable request of another party hereto, they will cooperate and
will cause their respective Affiliates to cooperate with each other to effect the orderly
transition of the business, operations and affairs of the Acquired Entities. Without limiting the
generality of the foregoing, (a)&nbsp;LifePoint will give and will cause its Affiliates to give
representatives of the Acquired Entities reasonable access to all Books and Records of LifePoint
reasonably requested by Purchaser in the preparation of any post-Closing financial statements,
reports or Returns of the Acquired Entities with the reasonable cost thereof to be borne by
Purchaser; and (b)&nbsp;Purchaser will give and will cause the Acquired Entities to give representatives
of LifePoint
</DIV>

<P align="center" style="font-size: 10pt">79
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">reasonable access to all pre-Closing Books and Records of the
Acquired Entities reasonably requested by LifePoint in the preparation of any post-Closing
financial statements, reports or Returns of LifePoint with the reasonable cost thereof to be borne
by LifePoint. The rights of access granted in this Agreement shall be exercised in such a manner
as not to cause unreasonable expense or interfere unreasonably with the operation of the business
of the Person granting access.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.13 <U>Severability; Invalid Provisions</U>. If any provision of this Agreement is held to
be illegal, invalid or unenforceable under any present or future Law, (a)&nbsp;such provisions will be
fully severable; (b)&nbsp;this Agreement will be construed and enforced as if such illegal, invalid or
unenforceable provision had never comprised a part hereof; (c)&nbsp;the remaining provisions of this
Agreement will remain in full force and effect and will not be affected by the illegal, invalid or
unenforceable provision or by its severance herefrom; and (d)&nbsp;in lieu of such illegal, invalid or
unenforceable provision, there will be added automatically as a part of this Agreement a legal,
valid and enforceable provision as similar in terms and effect to such illegal, invalid or
unenforceable provision as may be possible.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.14 <U>Cooperation</U>. Upon request, each of the parties hereto shall cooperate with the
other in good faith, at the requesting party&#146;s expense, in furnishing information, testimony and
other assistance in connection with any actions, proceedings, arrangements, or disputes involving
any of the parties hereto (other than in a dispute among such parties or entities) and based upon
contracts, arrangements or acts of the Acquired Entities which were in effect or occurred prior to
the Effective Time and which relate to the business of the Acquired Entities. Purchaser shall
cause the Acquired Entities to provide any information or documents reasonably requested by
LifePoint in connection with Tax or other disputes, settlements, investigations, proceeding or
other matters in respect of any period ending at or prior to the Effective Time. The party
requesting documents or information pursuant to this Section shall pay all fees and expenses paid
to unaffiliated third parties by the party providing such documents or information in connection
with providing such information or document. In addition, following the Closing, the parties
hereto shall cooperate fully with each other and make available to the other, as reasonably
requested, and to any taxing authority, all information, records, documents relating to Tax
liabilities or potential Tax liabilities and tax bases of the Acquired Entities, and shall preserve
all such information, records and documents at least until the expiration of any applicable statute
of limitations or extension thereof. At or prior to Closing, Purchaser shall provide LifePoint any
reasonable certificate or other document from any governmental authority or any other person that
may be necessary to mitigate, reduce or eliminate any Tax that could be imposed with respect to the
transactions contemplated hereby.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.15 <U>Venue; Waiver of Jury Trial</U>. To the fullest extent permitted by applicable law,
each party hereto (a)&nbsp;agrees that any claim, action or proceeding by such party seeking any relief
whatsoever arising out of, or in connection with, this Agreement or the transactions contemplated
hereby shall be brought only in any Tennessee State court located in Davidson County and not in any
other State or Federal court in the United States of America or any court in any other country,
(ii)&nbsp;agrees to submit to the exclusive jurisdiction of such courts located in Davidson County for
purposes of all legal proceedings arising out of, or in connection with, this Agreement or the
transactions contemplated hereby, (iii)&nbsp;waives and agrees not to assert any objection that it may
now or hereafter have to the laying of the venue of any such proceeding
</DIV>

<P align="center" style="font-size: 10pt">80
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">brought in such a court or
any claim that any such proceeding brought in such a court has been brought in an inconvenient
forum, and (iv)&nbsp;agrees that a final judgment in any such action or proceeding shall be conclusive
and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided
by applicable Law. <U><B>EACH OF THE PARTIES IRREVOCABLY AND UNCONDITIONALLY WAIVES, TO THE FULLEST
EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHTS TO TRIAL BY JURY IN CONNECTION WITH ANY
LITIGATION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS
CONTEMPLATED HEREBY</B></U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.16 <U>Damages</U>. NOTWITHSTANDING ANYTHING IN THIS AGREEMENT TO THE CONTRARY, NEITHER
PARTY NOR ANY AFFILIATE THEREOF SHALL BE LIABLE FOR ANY CONSEQUENTIAL, INCIDENTAL, SPECIAL OR
PUNITIVE DAMAGES.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.17 <U>No Inferences</U>. Inasmuch as this Agreement is the result of negotiations between
sophisticated parties of equal bargaining power represented by counsel, no inference in favor of,
or against, either party shall be drawn from the fact that any portion of this Agreement has been
drafted by or on behalf of such party.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.18 <U>Tax and Medicare Advice and Reliance</U>. Except as expressly provided in this
Agreement, none of the parties (nor any of the parties&#146; respective counsel, accountants or other
representatives) has made or is making any representations to any other party (or to any other
party&#146;s counsel, accountants or other representatives) concerning the consequences of the
transactions contemplated hereby under applicable tax laws or under the laws governing the Medicare
program. Each party has relied solely upon the tax and Medicare advice of its own employees or of
representatives engaged by such party and not on any such advice provided by any other party
hereto.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.19 <U>Post-Closing Operations</U>. Purchaser acknowledges that it is an experienced and
knowledgeable owner and operator of facilities and assets similar to the Acquired Entities and the
Facilities and will rely on its own expertise in operating the Facilities from and after the
Closing. Purchaser covenants for the benefit of LifePoint to operate the Facilities in material
compliance with all applicable Laws, including Laws relating to the regulation of the Facilities
and operation of the Business and all Environmental Laws, from and after the Closing.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.20 <U>Capital Expenditures</U>. This Agreement shall not be deemed to be an acquisition
or obligation of a capital expenditure or of funds within the meaning of the certificate of need
statute of any state, until the appropriate Governmental Authority shall have granted a certificate
of need or the appropriate approval or ruled that no certificate of need or other approval is
required; provided, however, that nothing in this <U>Section&nbsp;12.20</U> is intended to modify the
parties&#146; obligations under <U>Section&nbsp;2.5</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.21 <U>Reasonable Access</U>. In each instance where a party is granted access pursuant to
this Agreement, such access shall be reasonable and shall be granted during normal business hours
and shall be coordinated through persons as may be designated in writing by the granting party for
such purpose. The right of access and
inspection shall be made in such a manner as not
</DIV>

<P align="center" style="font-size: 10pt">81
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">to interfere unreasonably with the operation
of the granting party. Notwithstanding the foregoing, each party understands that (a)&nbsp;with respect
to documents and information deemed by the granting party in good faith to be market sensitive or
competitive in nature (other than with respect to an obligation to indemnify), (i)&nbsp;the party
granting access will identify such documents and information, (ii)&nbsp;if requested by the party
seeking access, the granting party will provide such documents and information to the other party&#146;s
outside attorneys and accountants (who will be bound by confidentiality agreements) for their
review, and (ii)&nbsp;any report by such attorneys and accountants to the accessing party with respect
to such documents and information will be in writing and subject to prior review and reasonable
approval by the granting party to confirm that any market sensitive or competitive information is
not made available to the requesting party, (b)&nbsp;litigation and other materials (including
internal/external legal audit letters or reviews, patient records and similar patient information,
PRO information, National Data Bank reports, peer and quality review information and other
physician-specific confidential information) that are deemed privileged or confidential and
materials which may not be disclosed without violating confidentiality agreements with third
parties will not be made available except to the extent permitted by law, and (c)&nbsp;no party shall be
obligated to generate or produce information in any prescribed format not customarily produced by
such party.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.22 <U>Further Assurance Clause</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;On and after the Closing Date, LifePoint, the Acquired Entities and Purchaser will take
all appropriate action and execute all documents, instruments or conveyances of any kind which may
be reasonably necessary or advisable to carry out any of the provisions hereof, including, without
limitation, putting Purchaser in possession and operational control of the Business and the
Facilities.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The parties acknowledge and agree that it is their intent that LifePoint and its
Affiliates transfer to the Acquired Entities all Real Property held by LifePoint and its Affiliates
that is used or held for use in the operation of the Business other than the Excluded Assets. To
the extent any Real Property (or building, improvements and fixtures on or forming a part of the
Real Property or any appurtenances or rights pertaining thereto) identified on any Exhibit or
Schedule (or which should have been identified on such Exhibit or Schedule) is (1)&nbsp;misidentified,
incorrectly described, or incorrectly identified as being owned or leased by a particular entity,
or (2)&nbsp;any such Real Property which should have been included on any Exhibit or Schedule is
inadvertently not included on such Exhibit or Schedule and such errors are discovered subsequent to
execution of this Agreement, the parties agree that the applicable Exhibit or Schedule shall be
amended by mutual written agreement prior to Closing to correct such errors. In the event that any
such errors are discovered subsequent to the Closing, to the extent necessary to effect the intent
of this Agreement, the parties agree that such Exhibit or Schedule shall be amended by a written
post-Closing addendum to this Agreement to correct such errors and LifePoint and its Affiliates
shall execute and deliver or cause to be executed and delivered, deeds, assignments, instruments of
correction, or such other instruments or documents of transfer or conveyance, and to take or cause
to be taken, such other steps as may be necessary, to correctly vest or convey such real property
in or to the applicable Acquired Entity in accordance with the intent of this Agreement. The
obligations pursuant to this paragraph shall survive the Closing.
</DIV>


<P align="center" style="font-size: 10pt">82
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.23 <U>Notices</U>. The notice provisions of the SPA for LifePoint and HCA are incorporated
by reference.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>&#091;The following page is the signature page.&#093;</B>
</DIV>


<P align="center" style="font-size: 10pt">83
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have caused this Repurchase Agreement to be executed as of the
date first above written.
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="48%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="40%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="6%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><B>HCA INC.</B></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Gregg Gerken</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Gregg Gerken</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Vice President</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><B>LIFEPOINT HOSPITALS, INC.</B></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ William F. Carpenter III</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">William F. Carpenter III</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">President and Chief Executive Officer</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">84
</DIV>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
